000175178812/312024Q3false000002991512/312024Q3falsehttp://fasb.org/us-gaap/2024#OtherAssetsCurrenthttp://fasb.org/us-gaap/2024#OtherAssetsCurrenthttp://fasb.org/us-gaap/2024#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2024#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2024#OtherAssetsCurrenthttp://fasb.org/us-gaap/2024#OtherAssetsCurrenthttp://fasb.org/us-gaap/2024#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2024#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2024#OtherAssetsCurrenthttp://fasb.org/us-gaap/2024#OtherAssetsCurrenthttp://fasb.org/us-gaap/2024#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2024#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2024#OtherAssetsCurrenthttp://fasb.org/us-gaap/2024#OtherAssetsCurrenthttp://fasb.org/us-gaap/2024#OtherAssetsCurrenthttp://fasb.org/us-gaap/2024#OtherAssetsCurrenthttp://fasb.org/us-gaap/2024#OtherAssetsCurrenthttp://fasb.org/us-gaap/2024#OtherAssetsCurrenthttp://fasb.org/us-gaap/2024#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2024#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrenthttp://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrentxbrli:sharesiso4217:USDxbrli:sharesiso4217:USDxbrli:pureiso4217:EURiso4217:CADutr:Boe00017517882024-01-012024-09-300001751788dow:TheDowChemicalCompanyMember2024-01-012024-09-300001751788dow:A0500NotesDueMarch152027Memberdow:TheDowChemicalCompanyMember2024-01-012024-09-300001751788dow:A1125NotesDueMarch152032Memberdow:TheDowChemicalCompanyMember2024-01-012024-09-300001751788dow:A1875NotesDueMarch152040Memberdow:TheDowChemicalCompanyMember2024-01-012024-09-300001751788dow:A4625NotesDueOctober12044Memberdow:TheDowChemicalCompanyMember2024-01-012024-09-3000017517882024-09-300001751788dow:TheDowChemicalCompanyMember2024-09-3000017517882024-07-012024-09-3000017517882023-07-012023-09-3000017517882023-01-012023-09-3000017517882023-12-3100017517882022-12-3100017517882023-09-300001751788us-gaap:CommonStockMember2024-09-300001751788us-gaap:CommonStockMember2024-06-300001751788us-gaap:CommonStockMember2023-09-300001751788us-gaap:CommonStockMember2023-06-300001751788us-gaap:CommonStockMember2023-12-310001751788us-gaap:CommonStockMember2022-12-310001751788us-gaap:AdditionalPaidInCapitalMember2024-06-300001751788us-gaap:AdditionalPaidInCapitalMember2023-06-300001751788us-gaap:AdditionalPaidInCapitalMember2023-12-310001751788us-gaap:AdditionalPaidInCapitalMember2022-12-310001751788us-gaap:AdditionalPaidInCapitalMember2024-07-012024-09-300001751788us-gaap:AdditionalPaidInCapitalMember2023-07-012023-09-300001751788us-gaap:AdditionalPaidInCapitalMember2024-01-012024-09-300001751788us-gaap:AdditionalPaidInCapitalMember2023-01-012023-09-300001751788us-gaap:AdditionalPaidInCapitalMember2024-09-300001751788us-gaap:AdditionalPaidInCapitalMember2023-09-300001751788us-gaap:RetainedEarningsMember2024-06-300001751788us-gaap:RetainedEarningsMember2023-06-300001751788us-gaap:RetainedEarningsMember2023-12-310001751788us-gaap:RetainedEarningsMember2022-12-310001751788us-gaap:RetainedEarningsMember2024-07-012024-09-300001751788us-gaap:RetainedEarningsMember2023-07-012023-09-300001751788us-gaap:RetainedEarningsMember2024-01-012024-09-300001751788us-gaap:RetainedEarningsMember2023-01-012023-09-300001751788us-gaap:RetainedEarningsMember2024-09-300001751788us-gaap:RetainedEarningsMember2023-09-300001751788us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-06-300001751788us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-300001751788us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310001751788us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310001751788us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-07-012024-09-300001751788us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-07-012023-09-300001751788us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-09-300001751788us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-09-300001751788us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-09-300001751788us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-09-300001751788us-gaap:TreasuryStockCommonMember2024-06-300001751788us-gaap:TreasuryStockCommonMember2023-06-300001751788us-gaap:TreasuryStockCommonMember2023-12-310001751788us-gaap:TreasuryStockCommonMember2022-12-310001751788us-gaap:TreasuryStockCommonMember2024-07-012024-09-300001751788us-gaap:TreasuryStockCommonMember2023-07-012023-09-300001751788us-gaap:TreasuryStockCommonMember2024-01-012024-09-300001751788us-gaap:TreasuryStockCommonMember2023-01-012023-09-300001751788us-gaap:TreasuryStockCommonMember2024-09-300001751788us-gaap:TreasuryStockCommonMember2023-09-300001751788dow:TheDowChemicalCompanyMember2024-07-012024-09-300001751788dow:TheDowChemicalCompanyMember2023-07-012023-09-300001751788dow:TheDowChemicalCompanyMember2023-01-012023-09-300001751788dow:TheDowChemicalCompanyMember2023-12-310001751788dow:TheDowChemicalCompanyMember2022-12-310001751788dow:TheDowChemicalCompanyMember2023-09-300001751788us-gaap:CommonStockMemberdow:TheDowChemicalCompanyMember2024-09-300001751788us-gaap:CommonStockMemberdow:TheDowChemicalCompanyMember2024-06-300001751788us-gaap:CommonStockMemberdow:TheDowChemicalCompanyMember2023-06-300001751788us-gaap:CommonStockMemberdow:TheDowChemicalCompanyMember2023-09-300001751788us-gaap:CommonStockMemberdow:TheDowChemicalCompanyMember2023-12-310001751788us-gaap:CommonStockMemberdow:TheDowChemicalCompanyMember2022-12-310001751788us-gaap:AdditionalPaidInCapitalMemberdow:TheDowChemicalCompanyMember2024-06-300001751788us-gaap:AdditionalPaidInCapitalMemberdow:TheDowChemicalCompanyMember2023-06-300001751788us-gaap:AdditionalPaidInCapitalMemberdow:TheDowChemicalCompanyMember2023-12-310001751788us-gaap:AdditionalPaidInCapitalMemberdow:TheDowChemicalCompanyMember2022-12-310001751788us-gaap:AdditionalPaidInCapitalMemberdow:TheDowChemicalCompanyMember2024-07-012024-09-300001751788us-gaap:AdditionalPaidInCapitalMemberdow:TheDowChemicalCompanyMember2023-07-012023-09-300001751788us-gaap:AdditionalPaidInCapitalMemberdow:TheDowChemicalCompanyMember2024-01-012024-09-300001751788us-gaap:AdditionalPaidInCapitalMemberdow:TheDowChemicalCompanyMember2023-01-012023-09-300001751788us-gaap:AdditionalPaidInCapitalMemberdow:TheDowChemicalCompanyMember2024-09-300001751788us-gaap:AdditionalPaidInCapitalMemberdow:TheDowChemicalCompanyMember2023-09-300001751788us-gaap:RetainedEarningsMemberdow:TheDowChemicalCompanyMember2024-06-300001751788us-gaap:RetainedEarningsMemberdow:TheDowChemicalCompanyMember2023-06-300001751788us-gaap:RetainedEarningsMemberdow:TheDowChemicalCompanyMember2023-12-310001751788us-gaap:RetainedEarningsMemberdow:TheDowChemicalCompanyMember2022-12-310001751788us-gaap:RetainedEarningsMemberdow:TheDowChemicalCompanyMember2024-07-012024-09-300001751788us-gaap:RetainedEarningsMemberdow:TheDowChemicalCompanyMember2023-07-012023-09-300001751788us-gaap:RetainedEarningsMemberdow:TheDowChemicalCompanyMember2024-01-012024-09-300001751788us-gaap:RetainedEarningsMemberdow:TheDowChemicalCompanyMember2023-01-012023-09-300001751788us-gaap:RetainedEarningsMemberdow:DowInc.Member2024-07-012024-09-300001751788us-gaap:RetainedEarningsMemberdow:DowInc.Member2023-07-012023-09-300001751788us-gaap:RetainedEarningsMemberdow:DowInc.Member2024-01-012024-09-300001751788us-gaap:RetainedEarningsMemberdow:DowInc.Member2023-01-012023-09-300001751788us-gaap:RetainedEarningsMemberdow:TheDowChemicalCompanyMember2024-09-300001751788us-gaap:RetainedEarningsMemberdow:TheDowChemicalCompanyMember2023-09-300001751788us-gaap:AccumulatedOtherComprehensiveIncomeMemberdow:TheDowChemicalCompanyMember2024-06-300001751788us-gaap:AccumulatedOtherComprehensiveIncomeMemberdow:TheDowChemicalCompanyMember2023-06-300001751788us-gaap:AccumulatedOtherComprehensiveIncomeMemberdow:TheDowChemicalCompanyMember2023-12-310001751788us-gaap:AccumulatedOtherComprehensiveIncomeMemberdow:TheDowChemicalCompanyMember2022-12-310001751788us-gaap:AccumulatedOtherComprehensiveIncomeMemberdow:TheDowChemicalCompanyMember2024-07-012024-09-300001751788us-gaap:AccumulatedOtherComprehensiveIncomeMemberdow:TheDowChemicalCompanyMember2023-07-012023-09-300001751788us-gaap:AccumulatedOtherComprehensiveIncomeMemberdow:TheDowChemicalCompanyMember2024-01-012024-09-300001751788us-gaap:AccumulatedOtherComprehensiveIncomeMemberdow:TheDowChemicalCompanyMember2023-01-012023-09-300001751788us-gaap:AccumulatedOtherComprehensiveIncomeMemberdow:TheDowChemicalCompanyMember2024-09-300001751788us-gaap:AccumulatedOtherComprehensiveIncomeMemberdow:TheDowChemicalCompanyMember2023-09-300001751788us-gaap:NoncontrollingInterestMemberdow:TheDowChemicalCompanyMember2024-09-300001751788us-gaap:NoncontrollingInterestMemberdow:TheDowChemicalCompanyMember2023-09-300001751788srt:MaximumMember2024-09-300001751788dow:HydrocarbonsEnergyMemberdow:PackagingSpecialtyPlasticsMember2024-07-012024-09-300001751788dow:HydrocarbonsEnergyMemberdow:PackagingSpecialtyPlasticsMember2023-07-012023-09-300001751788dow:HydrocarbonsEnergyMemberdow:PackagingSpecialtyPlasticsMember2024-01-012024-09-300001751788dow:HydrocarbonsEnergyMemberdow:PackagingSpecialtyPlasticsMember2023-01-012023-09-300001751788dow:PackagingandSpecialtyPlasticsMemberdow:PackagingSpecialtyPlasticsMember2024-07-012024-09-300001751788dow:PackagingandSpecialtyPlasticsMemberdow:PackagingSpecialtyPlasticsMember2023-07-012023-09-300001751788dow:PackagingandSpecialtyPlasticsMemberdow:PackagingSpecialtyPlasticsMember2024-01-012024-09-300001751788dow:PackagingandSpecialtyPlasticsMemberdow:PackagingSpecialtyPlasticsMember2023-01-012023-09-300001751788dow:PackagingSpecialtyPlasticsMember2024-07-012024-09-300001751788dow:PackagingSpecialtyPlasticsMember2023-07-012023-09-300001751788dow:PackagingSpecialtyPlasticsMember2024-01-012024-09-300001751788dow:PackagingSpecialtyPlasticsMember2023-01-012023-09-300001751788dow:IndustrialSolutionsMemberdow:IndustrialIntermediatesInfrastructureMember2024-07-012024-09-300001751788dow:IndustrialSolutionsMemberdow:IndustrialIntermediatesInfrastructureMember2023-07-012023-09-300001751788dow:IndustrialSolutionsMemberdow:IndustrialIntermediatesInfrastructureMember2024-01-012024-09-300001751788dow:IndustrialSolutionsMemberdow:IndustrialIntermediatesInfrastructureMember2023-01-012023-09-300001751788dow:PolyurethanesConstructionChemicalsMemberdow:IndustrialIntermediatesInfrastructureMember2024-07-012024-09-300001751788dow:PolyurethanesConstructionChemicalsMemberdow:IndustrialIntermediatesInfrastructureMember2023-07-012023-09-300001751788dow:PolyurethanesConstructionChemicalsMemberdow:IndustrialIntermediatesInfrastructureMember2024-01-012024-09-300001751788dow:PolyurethanesConstructionChemicalsMemberdow:IndustrialIntermediatesInfrastructureMember2023-01-012023-09-300001751788dow:OtherMemberdow:IndustrialIntermediatesInfrastructureMember2024-07-012024-09-300001751788dow:OtherMemberdow:IndustrialIntermediatesInfrastructureMember2023-07-012023-09-300001751788dow:OtherMemberdow:IndustrialIntermediatesInfrastructureMember2024-01-012024-09-300001751788dow:OtherMemberdow:IndustrialIntermediatesInfrastructureMember2023-01-012023-09-300001751788dow:IndustrialIntermediatesInfrastructureMember2024-07-012024-09-300001751788dow:IndustrialIntermediatesInfrastructureMember2023-07-012023-09-300001751788dow:IndustrialIntermediatesInfrastructureMember2024-01-012024-09-300001751788dow:IndustrialIntermediatesInfrastructureMember2023-01-012023-09-300001751788dow:CoatingsandPerformanceMonomersMemberdow:PerformanceMaterialsCoatingsMember2024-07-012024-09-300001751788dow:CoatingsandPerformanceMonomersMemberdow:PerformanceMaterialsCoatingsMember2023-07-012023-09-300001751788dow:CoatingsandPerformanceMonomersMemberdow:PerformanceMaterialsCoatingsMember2024-01-012024-09-300001751788dow:CoatingsandPerformanceMonomersMemberdow:PerformanceMaterialsCoatingsMember2023-01-012023-09-300001751788dow:ConsumerSolutionsMemberdow:PerformanceMaterialsCoatingsMember2024-07-012024-09-300001751788dow:ConsumerSolutionsMemberdow:PerformanceMaterialsCoatingsMember2023-07-012023-09-300001751788dow:ConsumerSolutionsMemberdow:PerformanceMaterialsCoatingsMember2024-01-012024-09-300001751788dow:ConsumerSolutionsMemberdow:PerformanceMaterialsCoatingsMember2023-01-012023-09-300001751788dow:PerformanceMaterialsCoatingsMember2024-07-012024-09-300001751788dow:PerformanceMaterialsCoatingsMember2023-07-012023-09-300001751788dow:PerformanceMaterialsCoatingsMember2024-01-012024-09-300001751788dow:PerformanceMaterialsCoatingsMember2023-01-012023-09-300001751788us-gaap:CorporateMember2024-07-012024-09-300001751788us-gaap:CorporateMember2023-07-012023-09-300001751788us-gaap:CorporateMember2024-01-012024-09-300001751788us-gaap:CorporateMember2023-01-012023-09-300001751788dow:U.S.CanadaMember2024-07-012024-09-300001751788dow:U.S.CanadaMember2023-07-012023-09-300001751788dow:U.S.CanadaMember2024-01-012024-09-300001751788dow:U.S.CanadaMember2023-01-012023-09-300001751788dow:EuropeMiddleEastAfricaAndIndiaMember2024-07-012024-09-300001751788dow:EuropeMiddleEastAfricaAndIndiaMember2023-07-012023-09-300001751788dow:EuropeMiddleEastAfricaAndIndiaMember2024-01-012024-09-300001751788dow:EuropeMiddleEastAfricaAndIndiaMember2023-01-012023-09-300001751788srt:AsiaPacificMember2024-07-012024-09-300001751788srt:AsiaPacificMember2023-07-012023-09-300001751788srt:AsiaPacificMember2024-01-012024-09-300001751788srt:AsiaPacificMember2023-01-012023-09-300001751788srt:LatinAmericaMember2024-07-012024-09-300001751788srt:LatinAmericaMember2023-07-012023-09-300001751788srt:LatinAmericaMember2024-01-012024-09-300001751788srt:LatinAmericaMember2023-01-012023-09-300001751788dow:FlexiblePackagingAndLaminatingAdhesivesMemberdow:PackagingSpecialtyPlasticsMember2024-09-300001751788dow:CirculusHoldingsPBLLCMember2024-07-012024-09-300001751788dow:CirculusHoldingsPBLLCMember2024-08-010001751788dow:AssetwritedownsandwriteoffsMemberdow:A2023RestructuringProgramMemberdow:IndustrialIntermediatesInfrastructureMember2024-01-012024-03-310001751788dow:AssetwritedownsandwriteoffsMemberdow:A2023RestructuringProgramMemberdow:PerformanceMaterialsCoatingsMember2024-07-012024-09-300001751788us-gaap:EmployeeSeveranceMemberdow:A2023RestructuringProgramMemberus-gaap:CorporateMember2024-07-012024-09-300001751788dow:AssetwritedownsandwriteoffsMemberdow:A2023RestructuringProgramMemberus-gaap:CorporateMember2024-07-012024-09-300001751788us-gaap:EmployeeSeveranceMemberdow:A2023RestructuringProgramMemberdow:PackagingSpecialtyPlasticsMember2023-01-012023-03-310001751788dow:AssetwritedownsandwriteoffsMemberdow:A2023RestructuringProgramMemberdow:PackagingSpecialtyPlasticsMember2023-01-012023-03-310001751788dow:A2023RestructuringProgramMemberdow:PackagingSpecialtyPlasticsMember2023-01-012023-03-310001751788us-gaap:EmployeeSeveranceMemberdow:A2023RestructuringProgramMemberdow:IndustrialIntermediatesInfrastructureMember2023-01-012023-03-310001751788dow:AssetwritedownsandwriteoffsMemberdow:A2023RestructuringProgramMemberdow:IndustrialIntermediatesInfrastructureMember2023-01-012023-03-310001751788dow:A2023RestructuringProgramMemberdow:IndustrialIntermediatesInfrastructureMember2023-01-012023-03-310001751788us-gaap:EmployeeSeveranceMemberdow:A2023RestructuringProgramMemberdow:PerformanceMaterialsCoatingsMember2023-01-012023-03-310001751788dow:AssetwritedownsandwriteoffsMemberdow:A2023RestructuringProgramMemberdow:PerformanceMaterialsCoatingsMember2023-01-012023-03-310001751788dow:A2023RestructuringProgramMemberdow:PerformanceMaterialsCoatingsMember2023-01-012023-03-310001751788us-gaap:EmployeeSeveranceMemberdow:A2023RestructuringProgramMemberus-gaap:CorporateMember2023-01-012023-03-310001751788dow:AssetwritedownsandwriteoffsMemberdow:A2023RestructuringProgramMemberus-gaap:CorporateMember2023-01-012023-03-310001751788dow:A2023RestructuringProgramMemberus-gaap:CorporateMember2023-01-012023-03-310001751788us-gaap:EmployeeSeveranceMemberdow:A2023RestructuringProgramMember2023-01-012023-03-310001751788dow:AssetwritedownsandwriteoffsMemberdow:A2023RestructuringProgramMember2023-01-012023-03-310001751788dow:A2023RestructuringProgramMember2023-01-012023-03-310001751788us-gaap:EmployeeSeveranceMemberdow:A2023RestructuringProgramMember2023-03-310001751788dow:AssetwritedownsandwriteoffsMemberdow:A2023RestructuringProgramMember2023-03-310001751788dow:A2023RestructuringProgramMember2023-03-310001751788us-gaap:EmployeeSeveranceMemberdow:A2023RestructuringProgramMemberdow:IndustrialIntermediatesInfrastructureMember2023-04-012023-06-300001751788dow:AssetwritedownsandwriteoffsMemberdow:A2023RestructuringProgramMemberdow:IndustrialIntermediatesInfrastructureMember2023-04-012023-06-300001751788dow:A2023RestructuringProgramMemberdow:IndustrialIntermediatesInfrastructureMember2023-04-012023-06-300001751788us-gaap:EmployeeSeveranceMemberdow:A2023RestructuringProgramMember2023-04-012023-06-300001751788dow:AssetwritedownsandwriteoffsMemberdow:A2023RestructuringProgramMember2023-04-012023-06-300001751788dow:A2023RestructuringProgramMember2023-04-012023-06-300001751788us-gaap:EmployeeSeveranceMemberdow:A2023RestructuringProgramMember2023-06-300001751788dow:AssetwritedownsandwriteoffsMemberdow:A2023RestructuringProgramMember2023-06-300001751788dow:A2023RestructuringProgramMember2023-06-300001751788us-gaap:EmployeeSeveranceMemberdow:A2023RestructuringProgramMember2023-07-012023-09-300001751788dow:AssetwritedownsandwriteoffsMemberdow:A2023RestructuringProgramMember2023-07-012023-09-300001751788dow:A2023RestructuringProgramMember2023-07-012023-09-300001751788us-gaap:EmployeeSeveranceMemberdow:A2023RestructuringProgramMember2023-09-300001751788dow:AssetwritedownsandwriteoffsMemberdow:A2023RestructuringProgramMember2023-09-300001751788dow:A2023RestructuringProgramMember2023-09-300001751788us-gaap:EmployeeSeveranceMemberdow:A2023RestructuringProgramMemberdow:IndustrialIntermediatesInfrastructureMember2023-10-012023-12-310001751788dow:AssetwritedownsandwriteoffsMemberdow:A2023RestructuringProgramMemberdow:IndustrialIntermediatesInfrastructureMember2023-10-012023-12-310001751788dow:A2023RestructuringProgramMemberdow:IndustrialIntermediatesInfrastructureMember2023-10-012023-12-310001751788us-gaap:EmployeeSeveranceMemberdow:A2023RestructuringProgramMemberus-gaap:CorporateMember2023-10-012023-12-310001751788dow:AssetwritedownsandwriteoffsMemberdow:A2023RestructuringProgramMemberus-gaap:CorporateMember2023-10-012023-12-310001751788dow:A2023RestructuringProgramMemberus-gaap:CorporateMember2023-10-012023-12-310001751788us-gaap:EmployeeSeveranceMemberdow:A2023RestructuringProgramMember2023-10-012023-12-310001751788dow:AssetwritedownsandwriteoffsMemberdow:A2023RestructuringProgramMember2023-10-012023-12-310001751788dow:A2023RestructuringProgramMember2023-10-012023-12-310001751788us-gaap:EmployeeSeveranceMemberdow:A2023RestructuringProgramMember2023-12-310001751788dow:AssetwritedownsandwriteoffsMemberdow:A2023RestructuringProgramMember2023-12-310001751788dow:A2023RestructuringProgramMember2023-12-310001751788us-gaap:EmployeeSeveranceMemberdow:A2023RestructuringProgramMemberdow:IndustrialIntermediatesInfrastructureMember2024-01-012024-03-310001751788dow:A2023RestructuringProgramMemberdow:IndustrialIntermediatesInfrastructureMember2024-01-012024-03-310001751788us-gaap:EmployeeSeveranceMemberdow:A2023RestructuringProgramMember2024-01-012024-03-310001751788dow:AssetwritedownsandwriteoffsMemberdow:A2023RestructuringProgramMember2024-01-012024-03-310001751788dow:A2023RestructuringProgramMember2024-01-012024-03-310001751788us-gaap:EmployeeSeveranceMemberdow:A2023RestructuringProgramMember2024-03-310001751788dow:AssetwritedownsandwriteoffsMemberdow:A2023RestructuringProgramMember2024-03-310001751788dow:A2023RestructuringProgramMember2024-03-310001751788us-gaap:EmployeeSeveranceMemberdow:A2023RestructuringProgramMember2024-04-012024-06-300001751788dow:AssetwritedownsandwriteoffsMemberdow:A2023RestructuringProgramMember2024-04-012024-06-300001751788dow:A2023RestructuringProgramMember2024-04-012024-06-300001751788us-gaap:EmployeeSeveranceMemberdow:A2023RestructuringProgramMember2024-06-300001751788dow:AssetwritedownsandwriteoffsMemberdow:A2023RestructuringProgramMember2024-06-300001751788dow:A2023RestructuringProgramMember2024-06-300001751788us-gaap:EmployeeSeveranceMemberdow:A2023RestructuringProgramMemberdow:PerformanceMaterialsCoatingsMember2024-07-012024-09-300001751788dow:A2023RestructuringProgramMemberdow:PerformanceMaterialsCoatingsMember2024-07-012024-09-300001751788dow:A2023RestructuringProgramMemberus-gaap:CorporateMember2024-07-012024-09-300001751788us-gaap:EmployeeSeveranceMemberdow:A2023RestructuringProgramMember2024-07-012024-09-300001751788dow:AssetwritedownsandwriteoffsMemberdow:A2023RestructuringProgramMember2024-07-012024-09-300001751788dow:A2023RestructuringProgramMember2024-07-012024-09-300001751788us-gaap:EmployeeSeveranceMemberdow:A2023RestructuringProgramMember2024-09-300001751788dow:AssetwritedownsandwriteoffsMemberdow:A2023RestructuringProgramMember2024-09-300001751788dow:A2023RestructuringProgramMember2024-09-300001751788dow:AccruedAndOtherCurrentLiabilitiesMemberdow:A2023RestructuringProgramMember2024-09-300001751788dow:AccruedAndOtherCurrentLiabilitiesMemberdow:A2023RestructuringProgramMember2023-12-310001751788dow:OtherNoncurrentObligationsMemberdow:A2023RestructuringProgramMember2024-09-300001751788dow:OtherNoncurrentObligationsMemberdow:A2023RestructuringProgramMember2023-12-310001751788dow:A2023RestructuringProgramMember2024-01-012024-09-300001751788us-gaap:EmployeeSeveranceMemberdow:A2023RestructuringProgramMember2024-01-012024-09-300001751788dow:AssetwritedownsandwriteoffsMemberdow:A2023RestructuringProgramMember2024-01-012024-09-300001751788dow:RestructuringImplementationCostsMemberdow:A2023RestructuringProgramMemberdow:AdditionalCashExpendituresMember2024-09-300001751788dow:RestructuringImplementationCostsMemberdow:A2023RestructuringProgramMember2024-07-012024-09-300001751788dow:RestructuringImplementationCostsMemberdow:A2023RestructuringProgramMember2024-01-012024-09-300001751788dow:RestructuringImplementationCostsMemberdow:A2023RestructuringProgramMember2023-07-012023-09-300001751788dow:RestructuringImplementationCostsMemberdow:A2023RestructuringProgramMember2023-01-012023-09-300001751788dow:PackagingSpecialtyPlasticsMember2024-01-012024-03-310001751788us-gaap:NonoperatingIncomeExpenseMember2024-07-012024-09-300001751788us-gaap:NonoperatingIncomeExpenseMember2023-07-012023-09-300001751788us-gaap:NonoperatingIncomeExpenseMember2024-01-012024-09-300001751788us-gaap:NonoperatingIncomeExpenseMember2023-01-012023-09-300001751788us-gaap:NonoperatingIncomeExpenseMembersrt:WarehouseMember2024-07-012024-09-300001751788us-gaap:NonoperatingIncomeExpenseMembersrt:WarehouseMember2024-01-012024-09-300001751788dow:COLIMonetizationMember2024-09-300001751788dow:COLIMonetizationMember2023-12-310001751788srt:MinimumMember2024-09-300001751788us-gaap:AccountsPayableMember2024-09-300001751788us-gaap:AccountsPayableMember2023-12-310001751788dow:SadaraChemicalCompanyMember2024-09-300001751788dow:SadaraChemicalCompanyMember2023-12-310001751788dow:EquatePetrochemicalCompanyKscMember2024-09-300001751788dow:EquatePetrochemicalCompanyKscMember2023-12-310001751788dow:AccountsReceivableFacilityUSMember2024-09-300001751788dow:AccountsReceivableFacilityEuropeMember2024-09-300001751788us-gaap:NotesPayableToBanksMember2024-09-300001751788us-gaap:NotesPayableToBanksMember2023-12-310001751788dow:PromissoryNotesandDebenturesFinalMaturityYearOneMemberus-gaap:LoansPayableMember2024-09-300001751788dow:PromissoryNotesandDebenturesFinalMaturityYearTwoMemberus-gaap:LoansPayableMember2023-12-310001751788dow:PromissoryNotesandDebenturesFinalMaturityYearFourMemberus-gaap:LoansPayableMember2024-09-300001751788dow:PromissoryNotesandDebenturesFinalMaturityYearFiveMemberus-gaap:LoansPayableMember2023-12-310001751788dow:PromissoryNotesandDebenturesFinalMaturityYearFiveMemberus-gaap:LoansPayableMember2024-09-300001751788dow:PromissoryNotesAndDebenturesFinalMaturityYearSixMemberus-gaap:LoansPayableMember2023-12-310001751788dow:PromissoryNotesandDebenturesFinalMaturityYearSixandThereafterMemberus-gaap:LoansPayableMember2024-09-300001751788dow:PromissoryNotesAndDebenturesFinalMaturityYearSevenAndThereafterMemberus-gaap:LoansPayableMember2023-12-310001751788dow:ForeignCurrencyLoansMemberus-gaap:LoansPayableMember2024-09-300001751788dow:ForeignCurrencyLoansMemberus-gaap:LoansPayableMember2023-12-310001751788us-gaap:MediumTermNotesMember2024-09-300001751788us-gaap:MediumTermNotesMember2023-12-310001751788dow:FinanceLeasesMember2024-09-300001751788dow:FinanceLeasesMember2023-12-310001751788dow:SeniorUnsecuredNotesMember2024-03-310001751788dow:SeniorUnsecuredNotes5.15PercentDue2034Member2024-03-310001751788dow:SeniorUnsecuredNotes5.60PercentDue2054Member2024-03-310001751788dow:A2.100NotesDueNovember2030Member2024-04-012024-06-300001751788dow:A2.100NotesDueNovember2030Member2024-06-300001751788dow:A4.250NotesDueOctober2034Member2024-04-012024-06-300001751788dow:A4.250NotesDueOctober2034Member2024-06-300001751788dow:A5.250NotesDueNovember2041Member2024-04-012024-06-300001751788dow:A5.250NotesDueNovember2041Member2024-06-300001751788dow:A4.375NotesDueNovember2042Member2024-04-012024-06-300001751788dow:A4.375NotesDueNovember2042Member2024-06-300001751788dow:SundryIncomeExpenseNetMemberdow:A4.250NotesDueOctober2034Member2024-04-012024-06-300001751788dow:SundryIncomeExpenseNetMemberdow:A4.375NotesDueNovember2042Member2024-04-012024-06-300001751788dow:SundryIncomeExpenseNetMemberdow:A2.100NotesDueNovember2030Member2024-04-012024-06-300001751788dow:SundryIncomeExpenseNetMemberdow:A5.250NotesDueNovember2041Member2024-04-012024-06-300001751788dow:InterNotesMember2024-01-012024-09-300001751788dow:ForeignCurrencyLoansMember2024-09-300001751788dow:FiveYearCompetitiveAdvanceandRevolvingCreditFacilityMemberus-gaap:RevolvingCreditFacilityMember2024-09-300001751788dow:BilateralRevolvingCreditFacilityDueOctober2024Memberus-gaap:RevolvingCreditFacilityMember2024-09-300001751788dow:BilateralRevolvingCreditFacilityDueMarch2025FacilityOneMemberus-gaap:RevolvingCreditFacilityMember2024-09-300001751788dow:BilateralRevolvingCreditFacilityDueMarch2025FacilityTwoMemberus-gaap:RevolvingCreditFacilityMember2024-09-300001751788dow:BilateralRevolvingCreditFacilityDueSeptember2025FacilityOneMemberus-gaap:RevolvingCreditFacilityMember2024-09-300001751788dow:BilateralRevolvingCreditFacilityDueSeptember2025FacilityTwoMemberus-gaap:RevolvingCreditFacilityMember2024-09-300001751788dow:BilateralRevolvingCreditFacilityDueNovember2025Memberus-gaap:RevolvingCreditFacilityMember2024-09-300001751788dow:BilateralRevolvingCreditFacilityDueFebruary2026Memberus-gaap:RevolvingCreditFacilityMember2024-09-300001751788dow:BilateralRevolvingCreditFacilityDueMarch2026Memberus-gaap:RevolvingCreditFacilityMember2024-09-300001751788dow:BilateralRevolvingCreditFacilityDueNovember2026FacilityOneMemberus-gaap:RevolvingCreditFacilityMember2024-09-300001751788dow:BilateralRevolvingCreditFacilityDueNovember2026FacilityTwoMemberus-gaap:RevolvingCreditFacilityMember2024-09-300001751788dow:BilateralRevolvingCreditFacilityDueMarch2027Memberus-gaap:RevolvingCreditFacilityMember2024-09-300001751788dow:BilateralRevolvingCreditFacilityDueMay2027Memberus-gaap:RevolvingCreditFacilityMember2024-09-300001751788dow:BilateralRevolvingCreditFacilityDueJune2027Memberus-gaap:RevolvingCreditFacilityMember2024-09-300001751788dow:BilateralRevolvingCreditFacilityDueSeptember2027Memberus-gaap:RevolvingCreditFacilityMember2024-09-300001751788dow:BilateralRevolvingCreditFacilityDueOctober2027Memberus-gaap:RevolvingCreditFacilityMember2024-09-300001751788dow:BilateralRevolvingCreditFacilityDueNovember2027Memberus-gaap:RevolvingCreditFacilityMember2024-09-300001751788dow:BilateralRevolvingCreditFacilityDueMay2028Memberus-gaap:RevolvingCreditFacilityMember2024-09-300001751788dow:AccrualForEnvironmentalLossContingenciesSuperFundSitesMember2024-09-300001751788dow:AccrualForEnvironmentalLossContingenciesSuperFundSitesMember2023-12-310001751788dow:LegacyAgriculturalChemicalProductsMember2023-01-012023-03-310001751788dow:LegacyAgriculturalChemicalProductsMember2024-09-300001751788dow:LegacyAgriculturalChemicalProductsMember2023-12-310001751788dow:LegacyHistoricalProductClaimsArbitrationMember2024-07-012024-09-300001751788dow:LegacyHistoricalProductClaimsArbitrationMember2024-09-300001751788dow:DowSiliconesCorporationMember2024-09-300001751788dow:DowSiliconesCorporationMember2023-12-310001751788dow:DowV.NovaChemicalsCorporationEthyleneAssetMatterMemberMember2019-09-182019-09-180001751788dow:DowV.NovaChemicalsCorporationEthyleneAssetMatterMemberMember2024-09-300001751788dow:DowV.NovaChemicalsCorporationEthyleneAssetMatterMemberMember2023-12-310001751788us-gaap:FairValueDisclosureItemAmountsDomain2024-09-300001751788us-gaap:PerformanceGuaranteeMember2024-09-300001751788us-gaap:PerformanceGuaranteeMember2023-12-310001751788dow:TotalProjectFinancingMemberdow:SadaraChemicalCompanyMember2024-09-300001751788dow:TotalProjectFinancingMemberdow:SadaraChemicalCompanyMember2023-12-310001751788dow:AccountsReceivableFacilitiesPerformanceGuaranteeMember2024-09-300001751788dow:AccountsReceivableFacilitiesPerformanceGuaranteeMember2023-12-310001751788dow:SadaraChemicalCompanyMemberus-gaap:PerformanceGuaranteeMember2024-09-300001751788dow:SadaraChemicalCompanyMemberus-gaap:PerformanceGuaranteeMemberdow:SadaraChemicalCompanyMember2024-09-300001751788us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2024-06-300001751788us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-06-300001751788us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-12-310001751788us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-12-310001751788us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2024-07-012024-09-300001751788us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-07-012023-09-300001751788us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2024-01-012024-09-300001751788us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-01-012023-09-300001751788us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-07-012024-09-300001751788us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-07-012023-09-300001751788us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-01-012024-09-300001751788us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-01-012023-09-300001751788us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2024-09-300001751788us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2023-09-300001751788us-gaap:AccumulatedTranslationAdjustmentMember2024-06-300001751788us-gaap:AccumulatedTranslationAdjustmentMember2023-06-300001751788us-gaap:AccumulatedTranslationAdjustmentMember2023-12-310001751788us-gaap:AccumulatedTranslationAdjustmentMember2022-12-310001751788us-gaap:AccumulatedTranslationAdjustmentMember2024-07-012024-09-300001751788us-gaap:AccumulatedTranslationAdjustmentMember2023-07-012023-09-300001751788us-gaap:AccumulatedTranslationAdjustmentMember2024-01-012024-09-300001751788us-gaap:AccumulatedTranslationAdjustmentMember2023-01-012023-09-300001751788us-gaap:AccumulatedTranslationAdjustmentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-07-012024-09-300001751788us-gaap:AccumulatedTranslationAdjustmentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-07-012023-09-300001751788us-gaap:AccumulatedTranslationAdjustmentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-01-012024-09-300001751788us-gaap:AccumulatedTranslationAdjustmentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-01-012023-09-300001751788us-gaap:AccumulatedTranslationAdjustmentMember2024-09-300001751788us-gaap:AccumulatedTranslationAdjustmentMember2023-09-300001751788us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-06-300001751788us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-06-300001751788us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-12-310001751788us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2022-12-310001751788us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-07-012024-09-300001751788us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-07-012023-09-300001751788us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-01-012024-09-300001751788us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-01-012023-09-300001751788us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-07-012024-09-300001751788us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-07-012023-09-300001751788us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-01-012024-09-300001751788us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-01-012023-09-300001751788us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-09-300001751788us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2023-09-300001751788us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2024-06-300001751788us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2023-06-300001751788us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2023-12-310001751788us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2022-12-310001751788us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2024-07-012024-09-300001751788us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2023-07-012023-09-300001751788us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2024-01-012024-09-300001751788us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2023-01-012023-09-300001751788us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-07-012024-09-300001751788us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-07-012023-09-300001751788us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-01-012024-09-300001751788us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-01-012023-09-300001751788us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2024-09-300001751788us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2023-09-300001751788us-gaap:NoncontrollingInterestMember2024-06-300001751788us-gaap:NoncontrollingInterestMember2023-06-300001751788us-gaap:NoncontrollingInterestMember2023-12-310001751788us-gaap:NoncontrollingInterestMember2022-12-310001751788us-gaap:NoncontrollingInterestMember2024-07-012024-09-300001751788us-gaap:NoncontrollingInterestMember2023-07-012023-09-300001751788us-gaap:NoncontrollingInterestMember2024-01-012024-09-300001751788us-gaap:NoncontrollingInterestMember2023-01-012023-09-300001751788us-gaap:NoncontrollingInterestMember2024-09-300001751788us-gaap:NoncontrollingInterestMember2023-09-300001751788us-gaap:PensionPlansDefinedBenefitMember2024-07-012024-09-300001751788us-gaap:PensionPlansDefinedBenefitMember2023-07-012023-09-300001751788us-gaap:PensionPlansDefinedBenefitMember2024-01-012024-09-300001751788us-gaap:PensionPlansDefinedBenefitMember2023-01-012023-09-300001751788us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2024-07-012024-09-300001751788us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2023-07-012023-09-300001751788us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2024-01-012024-09-300001751788us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember2023-01-012023-09-3000017517882024-01-012024-03-3100017517882023-01-012023-03-310001751788us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-03-310001751788dow:PerformanceStockUnitsPSUsMember2023-01-012023-03-310001751788dow:EmployeeStockPurchasePlanMember2024-09-300001751788dow:EmployeeStockPurchasePlanMember2024-01-012024-09-300001751788dow:EmployeeMemberdow:EmployeeStockPurchasePlanMember2024-07-012024-09-300001751788us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-09-300001751788us-gaap:InterestRateSwapMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-12-310001751788us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-09-300001751788us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-12-310001751788us-gaap:InterestRateSwapMemberus-gaap:NondesignatedMember2024-09-300001751788us-gaap:InterestRateSwapMemberus-gaap:NondesignatedMember2023-12-310001751788us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2024-09-300001751788us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2023-12-310001751788dow:CommodityContractHydrocarbonsMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-09-300001751788dow:CommodityContractHydrocarbonsMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-12-310001751788dow:CommodityContractHydrocarbonsMemberus-gaap:NondesignatedMember2024-09-300001751788dow:CommodityContractHydrocarbonsMemberus-gaap:NondesignatedMember2023-12-310001751788us-gaap:InterestRateContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentAssetsMember2024-09-300001751788us-gaap:InterestRateContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-09-300001751788us-gaap:InterestRateContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentAssetsMember2023-12-310001751788us-gaap:InterestRateContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-12-310001751788us-gaap:InterestRateContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberdow:DeferredchargesandotherassetsMember2024-09-300001751788us-gaap:InterestRateContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberdow:DeferredchargesandotherassetsMember2023-12-310001751788us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentAssetsMember2024-09-300001751788us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentAssetsMember2023-12-310001751788us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberdow:DeferredchargesandotherassetsMember2024-09-300001751788us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberdow:DeferredchargesandotherassetsMember2023-12-310001751788us-gaap:CommodityContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentAssetsMember2024-09-300001751788us-gaap:CommodityContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-09-300001751788us-gaap:CommodityContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherCurrentAssetsMember2023-12-310001751788us-gaap:CommodityContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-12-310001751788us-gaap:CommodityContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberdow:DeferredchargesandotherassetsMember2024-09-300001751788us-gaap:CommodityContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberdow:DeferredchargesandotherassetsMember2023-12-310001751788us-gaap:DesignatedAsHedgingInstrumentMember2024-09-300001751788us-gaap:DesignatedAsHedgingInstrumentMember2023-12-310001751788us-gaap:InterestRateContractMemberus-gaap:NondesignatedMemberus-gaap:OtherCurrentAssetsMember2024-09-300001751788us-gaap:InterestRateContractMemberus-gaap:NondesignatedMember2024-09-300001751788us-gaap:InterestRateContractMemberus-gaap:NondesignatedMemberus-gaap:OtherCurrentAssetsMember2023-12-310001751788us-gaap:InterestRateContractMemberus-gaap:NondesignatedMember2023-12-310001751788us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMemberus-gaap:OtherCurrentAssetsMember2024-09-300001751788us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMemberus-gaap:OtherCurrentAssetsMember2023-12-310001751788us-gaap:CommodityContractMemberus-gaap:NondesignatedMemberus-gaap:OtherCurrentAssetsMember2024-09-300001751788us-gaap:CommodityContractMemberus-gaap:NondesignatedMember2024-09-300001751788us-gaap:CommodityContractMemberus-gaap:NondesignatedMemberus-gaap:OtherCurrentAssetsMember2023-12-310001751788us-gaap:CommodityContractMemberus-gaap:NondesignatedMember2023-12-310001751788us-gaap:CommodityContractMemberus-gaap:NondesignatedMemberdow:DeferredchargesandotherassetsMember2024-09-300001751788us-gaap:CommodityContractMemberus-gaap:NondesignatedMemberdow:DeferredchargesandotherassetsMember2023-12-310001751788us-gaap:NondesignatedMember2024-09-300001751788us-gaap:NondesignatedMember2023-12-310001751788us-gaap:InterestRateContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberdow:AccruedAndOtherCurrentLiabilitiesMember2024-09-300001751788us-gaap:InterestRateContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberdow:AccruedAndOtherCurrentLiabilitiesMember2023-12-310001751788us-gaap:InterestRateContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberdow:OtherNoncurrentObligationsMember2024-09-300001751788us-gaap:InterestRateContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberdow:OtherNoncurrentObligationsMember2023-12-310001751788us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberdow:AccruedAndOtherCurrentLiabilitiesMember2024-09-300001751788us-gaap:ForeignExchangeContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberdow:AccruedAndOtherCurrentLiabilitiesMember2023-12-310001751788us-gaap:CommodityContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberdow:AccruedAndOtherCurrentLiabilitiesMember2024-09-300001751788us-gaap:CommodityContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberdow:AccruedAndOtherCurrentLiabilitiesMember2023-12-310001751788us-gaap:CommodityContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberdow:OtherNoncurrentObligationsMember2024-09-300001751788us-gaap:CommodityContractMemberus-gaap:DesignatedAsHedgingInstrumentMemberdow:OtherNoncurrentObligationsMember2023-12-310001751788us-gaap:InterestRateContractMemberus-gaap:NondesignatedMemberdow:AccruedAndOtherCurrentLiabilitiesMember2024-09-300001751788us-gaap:InterestRateContractMemberus-gaap:NondesignatedMemberdow:AccruedAndOtherCurrentLiabilitiesMember2023-12-310001751788us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMemberdow:AccruedAndOtherCurrentLiabilitiesMember2024-09-300001751788us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMemberdow:AccruedAndOtherCurrentLiabilitiesMember2023-12-310001751788us-gaap:CommodityContractMemberus-gaap:NondesignatedMemberdow:AccruedAndOtherCurrentLiabilitiesMember2024-09-300001751788us-gaap:CommodityContractMemberus-gaap:NondesignatedMemberdow:AccruedAndOtherCurrentLiabilitiesMember2023-12-310001751788us-gaap:CommodityContractMemberus-gaap:NondesignatedMemberdow:OtherNoncurrentObligationsMember2024-09-300001751788us-gaap:CommodityContractMemberus-gaap:NondesignatedMemberdow:OtherNoncurrentObligationsMember2023-12-310001751788us-gaap:InterestRateContractMemberus-gaap:FairValueHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-07-012024-09-300001751788us-gaap:InterestRateContractMemberus-gaap:FairValueHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-07-012023-09-300001751788us-gaap:InterestRateContractMemberus-gaap:FairValueHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-01-012024-09-300001751788us-gaap:InterestRateContractMemberus-gaap:FairValueHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-01-012023-09-300001751788us-gaap:InterestRateContractMemberus-gaap:FairValueHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberdow:InterestExpenseAndAmortizationOfDebtDiscountMember2024-07-012024-09-300001751788us-gaap:InterestRateContractMemberus-gaap:FairValueHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberdow:InterestExpenseAndAmortizationOfDebtDiscountMember2023-07-012023-09-300001751788us-gaap:InterestRateContractMemberus-gaap:FairValueHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberdow:InterestExpenseAndAmortizationOfDebtDiscountMember2024-01-012024-09-300001751788us-gaap:InterestRateContractMemberus-gaap:FairValueHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberdow:InterestExpenseAndAmortizationOfDebtDiscountMember2023-01-012023-09-300001751788dow:ExcludedComponentsMemberus-gaap:FairValueHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberdow:CumulativeTranslationAdjustmentsMember2024-07-012024-09-300001751788dow:ExcludedComponentsMemberus-gaap:FairValueHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberdow:CumulativeTranslationAdjustmentsMember2023-07-012023-09-300001751788dow:ExcludedComponentsMemberus-gaap:FairValueHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberdow:CumulativeTranslationAdjustmentsMember2024-01-012024-09-300001751788dow:ExcludedComponentsMemberus-gaap:FairValueHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberdow:CumulativeTranslationAdjustmentsMember2023-01-012023-09-300001751788dow:ExcludedComponentsMemberus-gaap:FairValueHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberdow:InterestExpenseAndAmortizationOfDebtDiscountMember2024-07-012024-09-300001751788dow:ExcludedComponentsMemberus-gaap:FairValueHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberdow:InterestExpenseAndAmortizationOfDebtDiscountMember2023-07-012023-09-300001751788dow:ExcludedComponentsMemberus-gaap:FairValueHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberdow:InterestExpenseAndAmortizationOfDebtDiscountMember2024-01-012024-09-300001751788dow:ExcludedComponentsMemberus-gaap:FairValueHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberdow:InterestExpenseAndAmortizationOfDebtDiscountMember2023-01-012023-09-300001751788us-gaap:InterestRateContractMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-07-012024-09-300001751788us-gaap:InterestRateContractMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-07-012023-09-300001751788us-gaap:InterestRateContractMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-01-012024-09-300001751788us-gaap:InterestRateContractMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-01-012023-09-300001751788us-gaap:InterestRateContractMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberdow:InterestExpenseAndAmortizationOfDebtDiscountMember2024-07-012024-09-300001751788us-gaap:InterestRateContractMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberdow:InterestExpenseAndAmortizationOfDebtDiscountMember2023-07-012023-09-300001751788us-gaap:InterestRateContractMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberdow:InterestExpenseAndAmortizationOfDebtDiscountMember2024-01-012024-09-300001751788us-gaap:InterestRateContractMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberdow:InterestExpenseAndAmortizationOfDebtDiscountMember2023-01-012023-09-300001751788us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-07-012024-09-300001751788us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-07-012023-09-300001751788us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-01-012024-09-300001751788us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-01-012023-09-300001751788us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CostOfSalesMember2024-07-012024-09-300001751788us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CostOfSalesMember2023-07-012023-09-300001751788us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CostOfSalesMember2024-01-012024-09-300001751788us-gaap:ForeignExchangeContractMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CostOfSalesMember2023-01-012023-09-300001751788us-gaap:CommodityContractMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-07-012024-09-300001751788us-gaap:CommodityContractMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-07-012023-09-300001751788us-gaap:CommodityContractMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-01-012024-09-300001751788us-gaap:CommodityContractMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-01-012023-09-300001751788us-gaap:CommodityContractMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CostOfSalesMember2024-07-012024-09-300001751788us-gaap:CommodityContractMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CostOfSalesMember2023-07-012023-09-300001751788us-gaap:CommodityContractMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CostOfSalesMember2024-01-012024-09-300001751788us-gaap:CommodityContractMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CostOfSalesMember2023-01-012023-09-300001751788dow:ExcludedComponentsMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberdow:CumulativeTranslationAdjustmentsMember2024-07-012024-09-300001751788dow:ExcludedComponentsMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberdow:CumulativeTranslationAdjustmentsMember2023-07-012023-09-300001751788dow:ExcludedComponentsMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberdow:CumulativeTranslationAdjustmentsMember2024-01-012024-09-300001751788dow:ExcludedComponentsMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberdow:CumulativeTranslationAdjustmentsMember2023-01-012023-09-300001751788dow:ExcludedComponentsMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CostOfSalesMember2024-07-012024-09-300001751788dow:ExcludedComponentsMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CostOfSalesMember2023-07-012023-09-300001751788dow:ExcludedComponentsMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CostOfSalesMember2024-01-012024-09-300001751788dow:ExcludedComponentsMemberus-gaap:CashFlowHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:CostOfSalesMember2023-01-012023-09-300001751788us-gaap:ForeignExchangeContractMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-07-012024-09-300001751788us-gaap:ForeignExchangeContractMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-07-012023-09-300001751788us-gaap:ForeignExchangeContractMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-01-012024-09-300001751788us-gaap:ForeignExchangeContractMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-01-012023-09-300001751788dow:ExcludedComponentsMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberdow:CumulativeTranslationAdjustmentsMember2024-07-012024-09-300001751788dow:ExcludedComponentsMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberdow:CumulativeTranslationAdjustmentsMember2023-07-012023-09-300001751788dow:ExcludedComponentsMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberdow:CumulativeTranslationAdjustmentsMember2024-01-012024-09-300001751788dow:ExcludedComponentsMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberdow:CumulativeTranslationAdjustmentsMember2023-01-012023-09-300001751788dow:ExcludedComponentsMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherNonoperatingIncomeExpenseMember2024-07-012024-09-300001751788dow:ExcludedComponentsMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherNonoperatingIncomeExpenseMember2023-07-012023-09-300001751788dow:ExcludedComponentsMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherNonoperatingIncomeExpenseMember2024-01-012024-09-300001751788dow:ExcludedComponentsMemberus-gaap:NetInvestmentHedgingMemberus-gaap:DesignatedAsHedgingInstrumentMemberus-gaap:OtherNonoperatingIncomeExpenseMember2023-01-012023-09-300001751788us-gaap:DesignatedAsHedgingInstrumentMember2024-07-012024-09-300001751788us-gaap:DesignatedAsHedgingInstrumentMember2023-07-012023-09-300001751788us-gaap:DesignatedAsHedgingInstrumentMember2024-01-012024-09-300001751788us-gaap:DesignatedAsHedgingInstrumentMember2023-01-012023-09-300001751788us-gaap:InterestRateContractMemberus-gaap:NondesignatedMember2024-07-012024-09-300001751788us-gaap:InterestRateContractMemberus-gaap:NondesignatedMember2023-07-012023-09-300001751788us-gaap:InterestRateContractMemberus-gaap:NondesignatedMember2024-01-012024-09-300001751788us-gaap:InterestRateContractMemberus-gaap:NondesignatedMember2023-01-012023-09-300001751788us-gaap:InterestRateContractMemberus-gaap:NondesignatedMemberdow:InterestExpenseAndAmortizationOfDebtDiscountMember2024-07-012024-09-300001751788us-gaap:InterestRateContractMemberus-gaap:NondesignatedMemberdow:InterestExpenseAndAmortizationOfDebtDiscountMember2023-07-012023-09-300001751788us-gaap:InterestRateContractMemberus-gaap:NondesignatedMemberdow:InterestExpenseAndAmortizationOfDebtDiscountMember2024-01-012024-09-300001751788us-gaap:InterestRateContractMemberus-gaap:NondesignatedMemberdow:InterestExpenseAndAmortizationOfDebtDiscountMember2023-01-012023-09-300001751788us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2024-07-012024-09-300001751788us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2023-07-012023-09-300001751788us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2024-01-012024-09-300001751788us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2023-01-012023-09-300001751788us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMemberus-gaap:OtherNonoperatingIncomeExpenseMember2024-07-012024-09-300001751788us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMemberus-gaap:OtherNonoperatingIncomeExpenseMember2023-07-012023-09-300001751788us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMemberus-gaap:OtherNonoperatingIncomeExpenseMember2024-01-012024-09-300001751788us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMemberus-gaap:OtherNonoperatingIncomeExpenseMember2023-01-012023-09-300001751788us-gaap:CommodityContractMemberus-gaap:NondesignatedMember2024-07-012024-09-300001751788us-gaap:CommodityContractMemberus-gaap:NondesignatedMember2023-07-012023-09-300001751788us-gaap:CommodityContractMemberus-gaap:NondesignatedMember2024-01-012024-09-300001751788us-gaap:CommodityContractMemberus-gaap:NondesignatedMember2023-01-012023-09-300001751788us-gaap:CommodityContractMemberus-gaap:NondesignatedMemberus-gaap:CostOfSalesMember2024-07-012024-09-300001751788us-gaap:CommodityContractMemberus-gaap:NondesignatedMemberus-gaap:CostOfSalesMember2023-07-012023-09-300001751788us-gaap:CommodityContractMemberus-gaap:NondesignatedMemberus-gaap:CostOfSalesMember2024-01-012024-09-300001751788us-gaap:CommodityContractMemberus-gaap:NondesignatedMemberus-gaap:CostOfSalesMember2023-01-012023-09-300001751788us-gaap:TotalReturnSwapMemberus-gaap:NondesignatedMember2024-07-012024-09-300001751788us-gaap:TotalReturnSwapMemberus-gaap:NondesignatedMember2023-07-012023-09-300001751788us-gaap:TotalReturnSwapMemberus-gaap:NondesignatedMember2024-01-012024-09-300001751788us-gaap:TotalReturnSwapMemberus-gaap:NondesignatedMember2023-01-012023-09-300001751788us-gaap:TotalReturnSwapMemberus-gaap:NondesignatedMemberus-gaap:CostOfSalesMember2024-07-012024-09-300001751788us-gaap:TotalReturnSwapMemberus-gaap:NondesignatedMemberus-gaap:CostOfSalesMember2023-07-012023-09-300001751788us-gaap:TotalReturnSwapMemberus-gaap:NondesignatedMemberus-gaap:CostOfSalesMember2024-01-012024-09-300001751788us-gaap:TotalReturnSwapMemberus-gaap:NondesignatedMemberus-gaap:CostOfSalesMember2023-01-012023-09-300001751788us-gaap:NondesignatedMember2024-07-012024-09-300001751788us-gaap:NondesignatedMember2023-07-012023-09-300001751788us-gaap:NondesignatedMember2024-01-012024-09-300001751788us-gaap:NondesignatedMember2023-01-012023-09-300001751788us-gaap:DerivativeMember2024-07-012024-09-300001751788us-gaap:DerivativeMember2023-07-012023-09-300001751788us-gaap:DerivativeMember2024-01-012024-09-300001751788us-gaap:DerivativeMember2023-01-012023-09-300001751788us-gaap:InterestRateContractMember2024-09-300001751788us-gaap:CommodityContractMember2024-09-300001751788us-gaap:ForeignExchangeContractMember2024-09-300001751788dow:ExcludedComponentsMember2024-09-300001751788dow:ExcludedComponentsMemberus-gaap:NetInvestmentHedgingMember2024-09-300001751788us-gaap:FairValueInputsLevel2Memberus-gaap:HeldtomaturitySecuritiesMember2024-09-300001751788us-gaap:FairValueInputsLevel2Memberus-gaap:HeldtomaturitySecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001751788us-gaap:FairValueInputsLevel2Memberus-gaap:HeldtomaturitySecuritiesMember2023-12-310001751788us-gaap:FairValueInputsLevel2Memberus-gaap:HeldtomaturitySecuritiesMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001751788us-gaap:FairValueInputsLevel2Memberus-gaap:MoneyMarketFundsMember2024-09-300001751788us-gaap:FairValueInputsLevel2Memberus-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001751788us-gaap:FairValueInputsLevel2Memberus-gaap:MoneyMarketFundsMember2023-12-310001751788us-gaap:FairValueInputsLevel2Memberus-gaap:MoneyMarketFundsMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001751788us-gaap:FairValueInputsLevel2Member2024-09-300001751788us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001751788us-gaap:FairValueInputsLevel2Member2023-12-310001751788us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001751788us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EquityMethodInvestmentsMember2024-09-300001751788us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:EquityMethodInvestmentsMember2023-12-310001751788us-gaap:FairValueInputsLevel2Memberus-gaap:USTreasuryAndGovernmentMember2024-09-300001751788us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasuryAndGovernmentMember2024-09-300001751788us-gaap:FairValueInputsLevel2Memberus-gaap:USTreasuryAndGovernmentMember2023-12-310001751788us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:USTreasuryAndGovernmentMember2023-12-310001751788us-gaap:FairValueInputsLevel1Memberus-gaap:CorporateDebtSecuritiesMember2024-09-300001751788us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateDebtSecuritiesMember2024-09-300001751788us-gaap:FairValueInputsLevel1Memberus-gaap:CorporateDebtSecuritiesMember2023-12-310001751788us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateDebtSecuritiesMember2023-12-310001751788us-gaap:FairValueInputsLevel2Memberus-gaap:CorporateDebtSecuritiesMember2024-09-300001751788us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateDebtSecuritiesMember2024-09-300001751788us-gaap:FairValueInputsLevel2Memberus-gaap:CorporateDebtSecuritiesMember2023-12-310001751788us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateDebtSecuritiesMember2023-12-310001751788us-gaap:FairValueInputsLevel3Memberus-gaap:CorporateDebtSecuritiesMember2024-09-300001751788us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateDebtSecuritiesMember2024-09-300001751788us-gaap:FairValueInputsLevel3Memberus-gaap:CorporateDebtSecuritiesMember2023-12-310001751788us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:CorporateDebtSecuritiesMember2023-12-310001751788us-gaap:FairValueInputsLevel1Member2024-09-300001751788us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001751788us-gaap:FairValueInputsLevel1Member2023-12-310001751788us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001751788us-gaap:FairValueInputsLevel2Memberus-gaap:InterestRateContractMember2024-09-300001751788us-gaap:FairValueInputsLevel2Memberus-gaap:InterestRateContractMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001751788us-gaap:FairValueInputsLevel2Memberus-gaap:InterestRateContractMember2023-12-310001751788us-gaap:FairValueInputsLevel2Memberus-gaap:InterestRateContractMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001751788us-gaap:FairValueInputsLevel2Memberus-gaap:ForeignExchangeContractMember2024-09-300001751788us-gaap:FairValueInputsLevel2Memberus-gaap:ForeignExchangeContractMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001751788us-gaap:FairValueInputsLevel2Memberus-gaap:ForeignExchangeContractMember2023-12-310001751788us-gaap:FairValueInputsLevel2Memberus-gaap:ForeignExchangeContractMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001751788us-gaap:FairValueInputsLevel1Memberus-gaap:CommodityContractMember2024-09-300001751788us-gaap:FairValueInputsLevel1Memberus-gaap:CommodityContractMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001751788us-gaap:FairValueInputsLevel1Memberus-gaap:CommodityContractMember2023-12-310001751788us-gaap:FairValueInputsLevel1Memberus-gaap:CommodityContractMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001751788us-gaap:FairValueInputsLevel2Memberus-gaap:CommodityContractMember2024-09-300001751788us-gaap:FairValueInputsLevel2Memberus-gaap:CommodityContractMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001751788us-gaap:FairValueInputsLevel2Memberus-gaap:CommodityContractMember2023-12-310001751788us-gaap:FairValueInputsLevel2Memberus-gaap:CommodityContractMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001751788us-gaap:FairValueMeasurementsRecurringMember2024-09-300001751788us-gaap:FairValueMeasurementsRecurringMember2023-12-310001751788us-gaap:FairValueInputsLevel3Memberdow:SadaraChemicalCompanyMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001751788us-gaap:FairValueInputsLevel3Memberdow:SadaraChemicalCompanyMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001751788us-gaap:FairValueInputsLevel2Memberus-gaap:HeldtomaturitySecuritiesMemberus-gaap:CashAndCashEquivalentsMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001751788us-gaap:FairValueInputsLevel2Memberus-gaap:HeldtomaturitySecuritiesMemberus-gaap:CashAndCashEquivalentsMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001751788us-gaap:FairValueInputsLevel2Memberus-gaap:HeldtomaturitySecuritiesMemberus-gaap:OtherCurrentAssetsMemberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001751788us-gaap:FairValueInputsLevel2Memberus-gaap:HeldtomaturitySecuritiesMemberus-gaap:OtherCurrentAssetsMemberus-gaap:FairValueMeasurementsRecurringMember2023-12-310001751788us-gaap:FairValueMeasuredAtNetAssetValuePerShareMemberus-gaap:FairValueMeasurementsRecurringMemberdow:PrivateMarketSecuritiesMember2024-09-300001751788us-gaap:FairValueMeasuredAtNetAssetValuePerShareMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:RealEstateMember2024-09-300001751788us-gaap:FairValueMeasuredAtNetAssetValuePerShareMemberus-gaap:FairValueMeasurementsRecurringMemberdow:PrivateMarketSecuritiesMember2023-12-310001751788us-gaap:FairValueMeasuredAtNetAssetValuePerShareMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:RealEstateMember2023-12-310001751788us-gaap:FairValueMeasuredAtNetAssetValuePerShareMemberus-gaap:FairValueMeasurementsRecurringMemberdow:PrivateMarketSecuritiesandRealEstateMember2024-09-300001751788us-gaap:FairValueMeasuredAtNetAssetValuePerShareMemberus-gaap:FairValueMeasurementsRecurringMemberdow:PrivateMarketSecuritiesandRealEstateMember2023-12-310001751788us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsNonrecurringMemberdow:ManufacturingAssetsMember2024-03-31
目錄
美國
證券交易委員會
華盛頓特區20549

表格 10-Q

根據1934年證券交易法第13或15(d)條規定的季度報告
截至季度結束 2024年9月30日
或者
根據1934年證券交易法第13或15(d)條規定的過渡報告
在__________至__________的過渡期間

DOWdiamond-red-RGB_8-19.jpg

委員會:
檔案號
註冊人的確切名稱,如其章程所規定的
主要辦公地址和電話號碼
註冊地點或
組織形式
稅務登記號碼:
標識號碼
001-38646陶氏化學特拉華州30-1128146
2211 H.H. Dow Way 密德蘭,MI 48674, 米德蘭, MI 48674
(989) 636-1000
001-03433陶氏化學公司特拉華州38-1285128
2211 H.H. Dow Way 密德蘭,MI 48674, 米德蘭, MI 48674
(989) 636-1000
根據法案第12(b)條註冊的證券:
申請人每一類的名稱交易標誌在其上註冊的交易所的名稱
陶氏化學普通股,每股面值0.01美元陶氏化學公司請使用moomoo賬號登錄查看New York Stock Exchange
陶氏化學公司截至2027年3月15日到期的0.500%票據陶氏化學/27請使用moomoo賬號登錄查看New York Stock Exchange
陶氏化學公司截至2032年3月15日到期的1.125%票據陶氏化學/32請使用moomoo賬號登錄查看New York Stock Exchange
陶氏化學公司2040年3月15日到期的1.875%票據陶氏化學/40請使用moomoo賬號登錄查看New York Stock Exchange
陶氏化學公司2044年10月1日到期的4.625%票據陶氏化學/44請使用moomoo賬號登錄查看New York Stock Exchange


請在複選標誌處註明公司(1)是否已在前12個月內(或對於公司在該期內必須提交此類報告的期限縮短的情況,該期限內)提交了根據1934年證券交易法第13或15(d)條規定必須提交的所有報告以及(2)公司在過去的90天內是否一直受到此類提交要求的影響。
陶氏化學陶氏化學公司

在檢查標記中表明註冊人是否已經在過去的12個月內(或者爲註冊人需要提交這些文件的較短期間)根據S-T法規405規定,遞交了每個互動數據文件。

陶氏化學陶氏化學公司

請在檢查標記中表明註冊人是一個大型加速文件提交人、一個加速文件提交人、一個非加速文件提交人、一個較小的報告公司,還是一個新興成長公司。請參閱《證券交易法1934年規則120億.2》中「大型加速文件提交人」、「加速文件提交人」、「較小報告公司」和「新興成長公司」的定義。

陶氏化學
大型加速報告人
加速
filer
非加速文件提交人較小的報告公司新興成長公司
陶氏化學公司大型加速歸檔人加速
filer
非加速文件提交人
小型報告公司新興成長公司
1

目錄
如果是新興成長型公司,請用複選標記表明註冊人是否選擇不使用延長的過渡期來遵守根據《交易法》第13(a)條規定的任何新的或修訂後的財務會計準則。

陶氏化學
陶氏化學公司

請在複選標誌處註明公司是否爲殼公司(根據交易所法令第12b-2條的定義)。

陶氏化學陶氏化學公司

陶氏化學在2024年9月30日擁有 700,091,690 普通股股票,$0.01 面值,隸屬於陶氏化學的母公司陶氏化學在2024年9月30日擁有 1000.0001美元面值的普通股0.01 面值,隸屬於陶氏化學的母公司陶氏化學在2024年9月30日所有板塊

陶氏化學公司符合《10-Q表格》H(1)(a)和(b)通用指南規定的條件,因此以簡化披露格式提交此表格。
2

目錄
陶氏化學及其子公司
附件:附註、合資公司和附屬機構
10-Q 表季度報告
截至2024年9月30日的季度結束
目錄
  頁碼
陶氏化學及其子公司:
陶氏化學公司及其子公司:
陶氏化學及其附屬公司與陶氏化學公司及其附屬公司:
.

3

目錄
陶氏化學及其子公司
附件:附註、合資公司和附屬機構
根據陶氏化學公司與陶氏化學公司及其一致子公司("TDCC",與陶氏化學公司一起稱爲"陶氏化學"或"本公司")之間的母公司/子公司關係所需,此第10-Q表格上的季度報告是由陶氏化學公司和陶氏化學公司聯合提交的。報告中反映的信息同樣適用於陶氏化學公司與陶氏化學公司,除非另有說明。陶氏化學公司與陶氏化學公司各自代表自己提交此報告中的信息,任何一家公司均不對涉及另一家公司的信息作出任何陳述。

關於前瞻性聲明的謹慎聲明
本報告中的某些陳述屬於《1933年證券法》第27A條和《1934年證券交易法》第21E條的「前瞻性陳述」。這類陳述常涉及預期的未來業務和財務表現、財務狀況和其他事項,並常含有諸如「預測」、「相信」、「估計」、「期望」、「打算」、「可能」、「機會」、「前景」、「計劃」、「項目」、「尋求」、「應該」、「策略」、「目標」、「將」、「將會」、「將繼續」、「可能會導致」、「將會」等類似表述,以及這些詞語的變體或否定形式。

前瞻性陳述基於目前的假設和對未來事件的預期,受颶險、不確定性和其它超出陶氏公司控制範圍的因素的影響,這些因素可能導致實際結果與前瞻性陳述中預期、預測或隱含的結果存在重大差異,並僅於陳述之日持有。這些因素包括但不限於:陶氏產品的銷售;陶氏的費用、未來收入和盈利能力;大流行病或其它公共衛生風險和事件對陶氏業務的全球和區域經濟影響;任何涉及俄羅斯、烏克蘭以及中東持續衝突的制裁、出口限制、供應鏈中斷或增加的經濟不確定性;資本需求和融資需求及可獲得性;技術開發中的意外障礙,包括關於陶氏擬議的資本和運營項目;陶氏實現碳中和承諾的能力,包括在計劃時間內完成和成功啓用加拿大阿爾伯塔綜合乙烯裂解裝置及衍生物設施的完成;陶氏產品和服務的市場規模及在這些市場中競爭的能力;未能成功開發和上市新產品和優化管理產品生命週期;市場對陶氏產品的接受程度和速度;重大訴訟和環境事宜及相關的不確定性和意外費用;競爭技術的成功應用和可能的競爭技術;能夠在美國和國外保護陶氏知識產權的能力;涉及擬議的重組活動和擬議的剝離或收購活動的發展,如減少人員、關閉製造設施和/或資產以及相關退出和處置活動,以及每項前述活動的利益和成本;能源和原材料價格波動;工藝安全管理和產品管理;與陶氏重要客戶和供應商的關係變化;公衆情緒和政治領導力的變化;對環境中塑料的擔憂增加和缺乏規模化的塑料循環經濟;消費者偏好和需求的變化;法律法規、政治條件或行業發展的變化;全球經濟和資本市場條件,如通貨膨脹、市場不確定性、利率和匯率,以及股票和商品價格;業務、物流和供應鏈中斷;安全威脅,如破壞、恐怖主義行爲或戰爭事件,包括俄羅斯、烏克蘭以及中東持續衝突;天氣事件和自然災害;陶氏信息技術網絡和系統的中斷,包括網絡攻擊的影響;以及與陶氏與陶氏杜邦公司分拆相關的風險,例如陶氏對杜邦德尼默公司和/或科蒂華公司承擔某些責任的義務。

在任何前瞻性聲明中,對未來結果或事件的期望或信念是基於管理層目前的計劃和期望,是真誠表達且有合理依據的,但不能保證這種期望或信念會帶來結果或實現。本季度報告第10-Q表格中的第II部分,第1A項目中標題爲「風險因素」的詳細討論包括可能導致實際結果和事件與前瞻性聲明大幅不同的主要風險和不確定性。且公司年度報告表格10-k中的第I部分,第1A項目中,截至2023年12月31日的年度報告中也包含了這些內容。這些只是陶氏化學面臨的風險和不確定性之一。在這個時候,可能有其他陶氏無法識別或當前不認爲對其業務會產生重大影響的風險和不確定性。如果其中任何風險或不確定性演變爲實際事件,它可能對陶氏的業務產生重大不利影響。陶氏化學和TDCC不承擔更新或公開修訂任何前瞻性聲明的責任,除非根據證券和其他適用法律的規定。

道瓊斯的網站及其內容並不被視爲併入本報告參考。
4

目錄
第一部分 - 財務信息
項目1.基本報表

陶氏化學及其子公司
綜合收益表
 
三個月之內結束九個月結束
11,420 9月30日
2024
9月30日
2023
9月30日
2024
9月30日
2023
淨銷售額$10,879 $10,730 $32,559 $34,001 
銷售成本9,809 9,592 28,888 30,096 
研發費用208 197 608 616 
銷售,總務及管理費用396 380 1,228 1,216 
無形資產攤銷76 81 234 243 
重組和資產相關費用 - 淨額24  69 549 
非合併聯營公司的股權收益(損失)2 (7)45 (112)
利息費用和折舊及攤銷費用119 92 256 202 
利息收入36 44 143 186 
爲Dow Inc普通股股東提供的淨收入199 192 595 549 
稅前收入324 417 1,381 1,008 
所得稅費用84 90 145 253 
淨收入240 327 1,236 755 
歸屬於非控股權益的淨收入26 25 67 61 
陶氏化學普通股股東可獲得的淨利潤$214 $302 $1,169 $694 
每股普通股數據:
基本每股收益$0.30 $0.43 $1.65 $0.97 
每股盈利-攤薄$0.30 $0.42 $1.65 $0.97 
703.8 702.3 704.0 703.5 706.4 
184.4703.6 707.5 704.9 709.7 
折舊費用$501 $484 $1,470 $1,443 
資本支出$736 $597 $2,173 $1,598 
詳見合併財務報表附註。

5

目錄
陶氏化學及其子公司
綜合收益的合併報表
 
 三個月之內結束九個月結束
單位:百萬美元(未經審計)9月30日
2024
9月30日
2023
9月30日
2024
9月30日
2023
淨收入$240 $327 $1,236 $755 
其他綜合收益(虧損),淨額
投資的未實現收益(虧損)34 (20)89 72 
累積翻譯調整199 (147)34 (149)
養老金及其他退休福利計劃18 (2)52  
ETF可能面臨的主要風險包括:與跟蹤指數相關的風險、管理風險、市場風險、指數調整的風險、衍生工具風險、股票市場投資風險和新興市場投資風險。31 (25)3 (45)
其他綜合收益(損失)總額282 (194)178 (122)
綜合收益522 133 1,414 633 
歸屬於非控股權益的綜合收益(淨稅影響)26 25 67 61 
陶氏化學歸屬於綜合收益$496 $108 $1,347 $572 
詳見合併財務報表附註。

6

目錄
陶氏化學及其子公司
合併資產負債表

以百萬美元計,除股份數量外(未經審計)
9月30日
2024
12月31日,
2023
資產
流動資產
現金及現金等價物$2,883 $2,987 
應收賬款和票據:
交易(扣除應收賬款減值準備-2024:$111; 2023: $81)
5,380 4,718 
其他1,936 1,896 
存貨6,741 6,076 
其他資產1,037 1,937 
總流動資產17,977 17,614 
投資
非併入報表的聯營企業投資1,303 1,267 
Other investments (investments carried at fair value - 2024: $2,135; 2023: $1,877)
2,854 2,740 
長期應收款項525 438 
投資合計4,682 4,445 
產業
產業62,642 60,203 
減:累計折舊40,549 39,137 
固定資產淨值22,093 21,066 
其他資產
商譽8,684 8,641 
其他無形資產(減去累計攤銷 - 2024年:$5,645; 2023: $5,374)
1,840 2,072 
經營租賃權使用資產1,301 1,320 
遞延所得稅資產1,526 1,486 
待攤費用和其他資產1,286 1,323 
其他資產總計14,637 14,842 
總資產$59,389 $57,967 
負債和股東權益
流動負債
應付票據$111 $62 
一年內到期的長期債務296 117 
應付賬款:
交易5,093 4,529 
其他1,955 1,797 
經營租賃負債 - 流動負債316 329 
應付所得稅257 419 
應計及其他流動負債2,799 2,704 
流動負債合計10,827 9,957 
長期債務16,164 14,907 
其他非流動負債
遞延所得稅負債397 399 
養老金及其他事後福利-非流動負債4,689 4,932 
與石棉有關的負債-非流動負債727 788 
租賃負債-非流動負債1,023 1,032 
其他非流動負債6,721 6,844 
其他非流動負債總額13,557 13,995 
股東權益
普通股(授權 5,000,000,000$,總股數0.01 每股面值;
2024年發行: 782,047,707 股份; 2023年: 778,595,514股)
8 8 
額外實收資本9,055 8,880 
保留盈餘21,459 21,774 
累計其他綜合損失(7,503)(7,681)
按成本覈算的庫藏股(2024年: 81,956,017 分享; 2023年: 76,302,081股)
(4,708)(4,374)
陶氏化學的股東權益18,311 18,607 
非控制權益530 501 
股東權益總計18,841 19,108 
總負債和股權$59,389 $57,967 
詳見合併財務報表附註。
7

目錄
陶氏化學及其子公司
合併現金流量表
 
單位:百萬美元(未經審計)九個月結束
9月30日
2024
9月30日
2023
經營活動
淨收入$1,236 $755 
調整淨利潤以計入經營活動現金流量:
折舊和攤銷2,143 1,954 
遞延所得稅貸項(134)(817)
非合併公司股利淨額小於投資收益221 300 
淨週期性養老金福利貸款(143)(69)
養老金繳納(92)(111)
出售資產、企業和投資的淨收益(58)(49)
重組和資產相關費用 - 淨額69 549 
其他淨虧損332 588 
資產和負債的變動,除收購和剝離公司的影響之外的淨額:
應收賬款和票據(818)365 
存貨(676)777 
應付賬款601 (859)
其他資產和負債,淨額(589)153 
經營活動產生的現金流量- 繼續經營業務2,092 3,536 
經營活動產生的現金流量-已停止運營的業務8 4 
經營活動產生的現金流量2,100 3,540 
投資活動
資本支出(2,173)(1,598)
燃料幣領域的投資開拓(157)(175)
先前租賃資產的購買 (5)
房地產、企業和合並公司出售的款項,扣除轉讓現金款項後的淨額36 66 
房地產和企業的購買,淨現金增加(121)(103)
對非合併公司的投資和貸款(25)(4)
從非合併公司分紅派息和償還貸款 2 
非綜合關聯公司所有權證券出售所得 63 
投資購買(1,381)(1,291)
出售和到期投資的收益2,386 1,244 
其他投資活動,淨額(21)(45)
投資活動所用現金(1,456)(1,846)
籌資活動
短期負債變化(61)(122)
發行超過三個月的短期債務的收益114  
支付超過三個月的短期債務(6) 
長期債務發行所得1,443 76 
開多期債償付款(224)(355)
證券化計劃的收藏28 8 
購買公司股票(494)(500)
發行股票所得款項51 63 
交易融資、債務發行和其他費用(13)(1)
員工支付的股票支付協議(38)(41)
對非控股權益的分配(49)(51)
分紅派息給股東的款項(1,474)(1,481)
籌集融資活動所用現金(723)(2,404)
匯率變動對現金、現金等價物及受限制資金的影響18 (130)
概括
現金及現金等價物淨減少額(61)(840)
期初現金、現金等價物及受限制的現金餘額3,048 3,940 
期末現金、現金等價物及受限制的現金餘額$2,987 $3,100 
減少:包含在"其他流動資產"中的受限制的現金及現金等價物104 20 
期末現金及現金等價物$2,883 $3,080 
見基本報表附註。
8

目錄
陶氏化學及其附屬公司
綜合權益變動表
 
 結束於三個月的期間九個月結束了
以百萬計,每股數量不包括(未經審計)九月三十日,
2024
九月三十日,
2023
九月三十日,
2024
九月三十日,
2023
普通股
期初和期末餘額$8 $8 $8 $8 
資本公積金
期初餘額9,012 8,661 8,880 8,540 
發行/出售普通股 8 51 63 
股份報酬86 77 285 217 
庫藏股發行 - 薪酬和福利計劃(43)(24)(161)(98)
期末餘額9,055 8,722 9,055 8,722 
保留收益
期初餘額21,739 22,570 21,774 23,180 
陶氏化學普通股股東可分享的凈利潤214 302 1,169 694 
分紅派息給股東(490)(492)(1,474)(1,481)
Common control transaction  10  
其他(4)(4)(20)(17)
期末餘額21,459 22,376 21,459 22,376 
累積其他綜合損失
期初餘額(7,785)(7,067)(7,681)(7,139)
其他全面收益(損失)282 (194)178 (122)
期末餘額(7,503)(7,261)(7,503)(7,261)
庫藏股
期初餘額(4,656)(4,175)(4,374)(3,871)
庫藏股購買(95)(127)(495)(505)
庫藏股發行-補償和福利計畫43 24 161 98 
期末餘額(4,708)(4,278)(4,708)(4,278)
陶氏化學的股東權益18,311 19,567 18,311 19,567 
非控制權益530 513 530 513 
股東權益總額$18,841 $20,080 $18,841 $20,080 
每股普通股宣布的分紅派息$0.70 $0.70 $2.10 $2.10 
見基本報表附註。

9

目錄
陶氏化學公司及其子公司
綜合損益表
 
結束於三個月的期間九個月結束了
百萬 (未經審計)九月三十日,
2024
九月三十日,
2023
九月三十日,
2024
九月三十日,
2023
淨銷售額$10,879 $10,730 $32,559 $34,001 
銷貨成本9,800 9,591 28,877 30,093 
研究與開發支出208 197 608 616 
銷售、一般及管理費用396 380 1,228 1,216 
無形資產攤銷76 81 234 243 
重組和資產相關費用-淨額24  69 549 
非併綜合企業盈虧權益2 (7)45 (112)
雜項收入(費用)-淨額118 71 253 169 
利息收入38 47 152 194 
利息支出和債務折扣攤銷199 192 595 549 
稅前收入334 400 1,398 986 
所得税费用84 90 145 253 
凈利潤250 310 1,253 733 
歸屬於非控制權益的凈利潤26 25 67 61 
降表公司普通股股東可獲取的凈利潤$224 $285 $1,186 $672 
折舊$501 $484 $1,470 $1,443 
資本支出$736 $597 $2,173 $1,598 
見基本報表附註。

10

目錄
陶氏化學公司及其子公司
綜合損益表
 
 結束於三個月的期間九個月結束了
百萬 (未經審計)九月三十日,
2024
九月三十日,
2023
九月三十日,
2024
九月三十日,
2023
凈利潤$250 $310 $1,253 $733 
其他綜合收益(損失)- 稅後
投資未實現收益(損失)34 (20)89 72 
累計翻譯調整199 (147)34 (149)
退休金與其他退休福利計劃18 (2)52  
衍生金融工具31 (25)3 (45)
所有其他綜合收益(損失)之金額282 (194)178 (122)
綜合收益532 116 1,431 611 
歸屬於非控股權益的綜合收益(稅後淨額)26 25 67 61 
歸屬於陶氏化學公司的綜合收益$506 $91 $1,364 $550 
見基本報表附註。
11

目錄
陶氏化學公司及其子公司
合併資產負債表

以百萬計算,除每股金額外(未經審計)
九月三十日,
2024
十二月三十一日,
2023
資產
流動資產
現金及現金等價物$2,883 $2,987 
應收帳款及應收票據:
Trade (net of allowance for doubtful receivables - 2024: $111; 2023: $81)
5,380 4,718 
其他1,950 1,997 
存貨6,741 6,076 
其他流動資產999 1,898 
全部流動資產17,953 17,676 
投資
對非合併聯營投資1,303 1,267 
其他投資(按公允價值衡量的投資 - 2024年:$2,135; 2023: $1,877)
2,854 2,740 
非流動應收款512 424 
總投資4,669 4,431 
房產險
房產險62,642 60,203 
減少已提折舊40,549 39,137 
淨資產22,093 21,066 
其他資產
商譽8,684 8,641 
其他無形資產(減除累積攤銷 - 2024年:$5,645; 2023: $5,374)
1,840 2,072 
營運租賃權使用資產1,301 1,320 
透過權益法之投資1,526 1,486 
遞延開支及其他資產1,286 1,323 
其他總資產14,637 14,842 
總資產$59,352 $58,015 
負債及股東權益
流動負債
應付票據$111 $62 
一年內到期的長期負債296 117 
Accounts payable:
交易5,093 4,529 
其他1,992 1,818 
營運租賃負債-流動316 329 
應納所得稅款257 419 
應計負債及其他流動負債2,673 2,575 
流動負債合計10,738 9,849 
長期負債16,164 14,907 
其他非流動負債
遞延所得稅負債397 399 
非流動的退休金和其他退休福利4,689 4,932 
非流動的石棉相關負債727 788 
非流動的營運租賃負債1,023 1,032 
其他非流動負債6,575 6,702 
其他非流動負債總額13,411 13,853 
股東權益
普通股(已授權及發行 100 元面值普通股的股份。截至 0.01 每份面值)
  
資本公積額額外增資9,427 9,091 
保留收益16,585 17,495 
累積其他全面損失(7,503)(7,681)
陶氏化學公司股東權益18,509 18,905 
非控制權益530 501 
總股本19,039 19,406 
負債及股東權益總計$59,352 $58,015 
見基本報表附註。
12

目錄
陶氏化學公司及其子公司
綜合現金流量表
 
百萬 (未經審計)九個月結束了
九月三十日,
2024
九月三十日,
2023
營運活動
凈利潤$1,253 $733 
調整淨利潤以達經營活動所提供之淨現金流量:
折舊與攤提2,143 1,954 
透過透過递延所得稅的貸方(134)(817)
非合併聯屬公司盈利低於收到的股息221 300 
凈周期性退休金利益貸項(143)(69)
退休金捐款(92)(111)
資產、企業和投資銷售之淨利潤(58)(49)
重組和資產相關費用-淨額69 549 
其他淨損失333 589 
資產和負債的變動,考慮併購和出售公司的影響:
應收帳款和票據。(818)365 
存貨(676)777 
應付賬款601 (859)
其他資產和負債,淨額(583)205 
營業活動產生的現金2,116 3,567 
投資活動
資本支出(2,173)(1,598)
投資於燃料幣田開發(157)(175)
購入先前租賃的資產 (5)
自出售財產、企業及已整合公司所得的款項,扣除已出售現金分紅派息36 66 
購併財產和企業,扣除已取得現金(121)(103)
對非整合聯屬公司的投資和貸款(25)(4)
來自非整合聯屬公司的分配和貸款償還 2 
從非整合聯屬公司出售股權所得款項 63 
投資購買(1,381)(1,291)
投資銷售和到期所得款項2,386 1,244 
其他投資活動,淨額(21)(45)
用於投資活動的現金支付(1,456)(1,846)
融資活動
短期應付票據變動(61)(122)
三個月以上短期債務發行所得款項114  
三個月以上短期債務支付款項(6) 
發行長期債務證券所得1,443 76 
長期債務付款(224)(355)
證券化方案的款項收回28 8 
股票發行所得51 63 
交易融資、債務發行和其他成本(13)(1)
員工根據股份支付安排支付的稅款(38)(41)
分配給非控股權益(49)(51)
分紅派息給陶氏化學。(1,984)(2,008)
用於融資活動的現金支付(739)(2,431)
匯率變動對現金、現金等價物及限制性現金的影響18 (130)
摘要
期末現金及現金等價物減少(61)(840)
期初現金、現金等價物及限制性現金3,048 3,940 
期末現金及現金等價物與受限現金$2,987 $3,100 
減少:現金及現金等價物受限,包含在"其他流動資產"中104 20 
期末現金及現金等價物$2,883 $3,080 
見基本報表附註。


13

目錄
陶氏化學公司及其子公司
綜合股權益表
 
 結束於三個月的期間九個月結束了
百萬 (未經審計)九月三十日,
2024
九月三十日,
2023
九月三十日,
2024
九月三十日,
2023
普通股
期初和期末餘額$ $ $ $ 
資本公積金
期初餘額9,341 8,822 9,091 8,627 
陶氏化學母公司股票發行 8 51 63 
股份報酬86 77 285 217 
期末餘額9,427 8,907 9,427 8,907 
保留收益
期初餘額16,964 18,469 17,495 19,472 
可供陶氏化學公司普通股股東使用的淨利潤224 285 1,186 672 
陶氏化學的分紅派息(600)(630)(2,077)(2,008)
其他(3)(5)(19)(17)
期末餘額16,585 18,119 16,585 18,119 
累積其他綜合損失
期初餘額(7,785)(7,067)(7,681)(7,139)
其他全面收益(損失)282 (194)178 (122)
期末餘額(7,503)(7,261)(7,503)(7,261)
陶氏化學公司的股東權益18,509 19,765 18,509 19,765 
非控制權益530 513 530 513 
股東權益總額$19,039 $20,278 $19,039 $20,278 
見基本報表附註。
14

目錄
陶氏化學及其附屬公司
陶氏化學公司及其子公司
(未經查核)

合併財務報表附註
目錄
認股權證頁面
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21


注意事項1 - 基本報表
報告基礎
陶氏化學是陶氏化學公司及其母公司(「TDCC」與陶氏化學公司一起,合稱為「陶氏」或「公司」)的直接母公司。陶氏化學公司及TDCC的未經審計的中期綜合基本報表是根據美國通用會計準則進行編制的,並反映了所有調整(包括正常的累積項);在管理層看來,這些調整被認為是為了對所述期間的結果作出公允呈現是必要的。這些報表應與陶氏化學公司及TDCC合併年度報告(形式10-K)一起閱讀,該報告包括截至2023年12月31日止的審計合併基本報表及相關附註。

鑑於陶氏化學及TDCC之間的母公司/子公司關係,以及考慮到每家公司的基本報表和披露內容基本相似,公司將為這份第10-Q表格的季度報告提交合併報告。 報告中反映的信息同樣適用於陶氏化學和TDCC,除非另有說明。 TDCC與陶氏化學之間的交易被視為TDCC的關聯交易。

除非上下文另有指示,"聯合碳化物" 一詞表示聯合碳化物公司,"陶氏矽利肯" 一詞表示陶氏矽利肯公司,兩者均為公司的全資附屬公司。
15

目錄
注2 - 最近的會計指引
最近採納的會計準則
2024年1月1日,公司採納了《會計準則更新("ASU")2023-02》,"投資-權益法與合營企業(主題323):使用比例攤銷法來計量稅收信貸結構的投資"的修訂,並選擇使用比例攤銷法來覈算某些稅收信貸投資,如ASU所規定。根據比例攤銷法,實體按照所得到的所得稅抵免和其他所得稅優惠,攤銷稅收信貸投資的初始成本,並將淨攤銷和所得稅抵免以及其他所得稅優惠確認爲所得稅費用(利益)的組成部分,並在利潤表中承認。採用該ASU對公司的合併財務報表沒有產生重大影響。

截至2024年9月30日,已發佈但未採用的會計指南
2023年11月,財務會計準則委員會("FASB")發佈了ASU 2023-07,「分部報告(主題280):改進報告分部披露」,旨在通過增加相關分部費用的披露,以便財務報表用戶更好地了解報告分部和整個實體的潛在未來現金流量,從而改善可報告分部的披露要求。修訂通過要求公衆實體披露向首席經營決策者定期提供的重大分部費用,澄清實體何時可以報告一個或多個額外的衡量指標來評估分部績效,要求增強中期披露,爲只有一個報告分部的實體提供新的披露要求,並要求其他新的披露。修訂適用於2023年12月15日後開始的財政年度和2024年12月15日後開始的財政年度內的中期時段,並允許提前採納。預計採納ASU不會對公司的合併基本財務報表產生實質性影響。

在2023年12月,FASB發佈了ASU 2023-09,"所得稅(主題740):改善所得稅披露",旨在增強所得稅披露的透明度、決策有效性和有效性。該ASU中的修訂要求公共實體披露一個表格的稅率調節,使用百分比和貨幣,幷包含具體類別。公共實體還需提供主要影響州和地方所得稅類別及所繳納的淨所得稅金額的州和地方管轄區的定性描述,按聯邦、州和外國稅以及各個管轄區進行分解。修訂還刪除了某些不再被認爲具有成本效益的披露。該修訂自2024年12月15日之後開始的年度期間起生效,允許提前採用和追溯應用。預計ASU的採用不會對公司的合併基本報表產生重大影響。

證券交易委員會的最終規則未在2024年9月30日通過
2024年3月,美國證券交易委員會("SEC")根據SEC發佈編號33-11275和34-99678,《增強和規範針對投資者的與氣候相關披露》,採納了最終規則,要求報告人在登記聲明和年度報告中披露某些與氣候相關的信息。最終規則包括披露重要的與氣候相關風險;應對或適應這些風險的活動;董事會對與氣候相關風險的監督情況和管理層在處理重要的與氣候相關風險中的作用的信息;以及與對報告人的業務、經營業績或財務狀況具有重要性的任何與氣候相關目標或目標的信息。報告人還需要在財務報表附註中披露嚴重天氣事件和其他自然條件對財務報表的影響。在材料時,某些大型報告人也需要披露範圍1和範圍2的溫室氣體("GHG")排放情況。最終規則爲所有報告人設定了分階段的遵從期限。作爲大型快速提交者,公司的大多披露要求將從截至2025年12月31日的年度開始生效。GHG排放的披露要求將適用於截至2026年12月31日的年度。公司還將被要求在截至2029年12月31日的年度開始對其範圍1和範圍2的GHG排放進行有限保證,從截至2033年12月31日的年度開始需要提供合理保證。2024年4月,SEC發佈了一項命令,暫停最終規則,直至美國第八巡迴上訴法院解決各種法律挑戰。公司目前正在評估最終規則對其合併財務報表和年度披露的影響。

16

目錄
注意事項 3 — 收入
收入確認
公司的營業收入主要來源於產品銷售。與產品銷售相關的營業收入爲 97百分點和 98截至2024年9月30日的三個月和九個月分別爲(98截至2023年9月30日的三個月和九個月分別爲)。其餘銷售主要與公司的保險業務及專利和科技的許可相關。產品銷售包括向製造商和分銷商銷售公司的產品。公司將訂單確認或採購訂單視爲與客戶的合同,在某些情況下這些訂單受主供應協議的約束。公司進入許可協議,將其某些專利和科技的權利許可給客戶。來自公司專利和科技許可的營業收入來源於基於銷售的特許權使用費和根據每份合同中建立的賬單時間表的許可安排。

剩餘績效承諾
剩餘履約義務代表分配給未完成或部分未完成履約義務的交易價格。截至2024年9月30日,公司尚未履行的履約義務爲$775百萬美元($744百萬(截至2023年12月31日)與科技許可相關。公司預計在接下來的五年中會確認剩餘履約義務的營業收入。

公司在產品銷售方面還有其他的剩餘履約義務,這些義務預計持續時間爲一年或更短,針對通過管道交付的材料的產品銷售,公司選擇了「開票權」這一實踐簡便方法,以及與專利和科技許可相關的可變對價。公司已從客戶那裏收到了與長期供應協議相關的預付賬款,這些預付款被遞延並在合同有效期內確認,剩餘的合同期限可達19年。公司將在產品交付給客戶時獲得確認營業收入的未來對價的權利。這些款項包括在合併資產負債表中的「應計及其他當前負債」和「其他非流動負債」中。

訂閱和支持收入包括以下內容(以百萬美元爲單位):
公司按運營部門和業務對與客戶合同的營業收入進行分解,因爲公司認爲這最能呈現其營業收入和現金流的性質、金額、時間及不確定性。請參見下表的詳細信息:

按業務和業務部門劃分的淨貿易銷售額截至三個月截至九個月
單位爲百萬2024年9月30日2023年9月30日2024年9月30日2023年9月30日
碳氫化合物與能源$1,433 $1,441 $4,347 $4,987 
包裝和專用塑料板塊4,083 4,013 12,114 12,521 
包裝與特種塑料$5,516 $5,454 $16,461 $17,508 
工業解決方案 $1,039 $1,012 $3,107 $3,235 
聚氨酯和施工化學品1,919 2,019 5,805 6,343 
其他4 4 9 12 
工業中間體與製造行業$2,962 $3,035 $8,921 $9,590 
塗料和性能單體$891 $839 $2,704 $2,572 
消費解決方案1,323 1,291 3,905 4,031 
性能材料與塗層$2,214 $2,130 $6,609 $6,603 
公司$187 $111 $568 $300 
總計$10,879 $10,730 $32,559 $34,001 

17

目錄
按地域板塊劃分的淨交易銷售截至三個月截至九個月
單位爲百萬2024年9月30日2023年9月30日2024年9月30日2023年9月30日
美國和加拿大$4,149 $3,968 $12,470 $12,667 
EMEAI 1
3,568 3,398 10,624 11,225 
亞太1,890 2,067 5,712 6,172 
拉丁美洲1,272 1,297 3,753 3,937 
總計$10,879 $10,730 $32,559 $34,001 
1.歐洲,中東,非洲和印度。

合同資產和負債
公司根據合同計費時間表從客戶收取款項。當獲得對代價的無條件索取權時,應收賬款予以記錄。合同資產包括與公司完成的履約義務尚未開票的合同代價權利相關的金額。合同負債包括在合同履行前收到的預付款,並在履約義務滿足時確認營業收入。"合同負債 - 現期"主要反映來自客戶的預付款所產生的遞延營業收入,這些產品將在12個月內交付,遞延的特許權使用費將在12個月內確認。"合同負債 - 非現期"包括公司從客戶處收到的與長期供應協議相關的預付款和遞延的特許權使用費,這些款項將在合同有效期內確認。

2024年前九個月從合同負債中計入的營業收入約爲$135 萬元(約爲$2052023年前九個月爲0)。2024年前九個月,由於交易款項考慮權利變爲無條件,導致重新分類爲應收款的合同資產金額微不足道(約爲$452023年前九個月爲0)。

以下表格總結了2024年9月30日和2023年12月31日的合同資產和負債:

合同資產和負債資產負債表分類2024年9月30日2023年12月31日
單位爲百萬
應收賬款和應收票據 - 交易應收賬款和應收票據 - 交易$5,380 $4,718 
合同資產 - 當前 其他流動資產$1 $13 
合同資產 - 非流動性待攤費用和其他資產$2 $4 
合同負債 - 流動負債應計及其他流動負債$251 $195 
合同負債 - 非流動性 其他非流動負債$1,500 $1,642 


18

目錄
注4-關收購和剝離
剝離柔性包裝層壓膠粘劑業務
2024年5月2日,公司宣佈與阿科瑪S.A.達成了一項明確協議,將其柔性包裝層壓膠粘劑業務-製造業-半導體出售給陶氏包裝與特種塑料業務部門,金額約爲$150百萬。此次出售包括位於美國、意大利和墨西哥的五家制造工廠,以及相應的庫存、客戶合同和名單、工藝技術以及部分知識產權。公司旨在於2024年年底前完成交易,需獲得監管批准和其他結算條件。

收購北美聚乙烯再生利用企業
2024年8月1日,該公司以約美元的現金收購了Circulus Holdings,PBLLC,一家將塑料廢物回收成消費後樹脂的美國公司130百萬。此次收購包括位於美國的兩座工廠,總回收能力爲每年50,000公噸,並支持陶氏努力到2030年每年將塑料廢物和其他形式的替代原料轉化爲300萬公噸的循環和可再生解決方案。收購的資產和作爲收購一部分承擔的負債均按收購之日的估計公允價值入賬, 包括財產 $74百萬美元和主要由技術和專有知識組成的無形資產22百萬,收購價格超過收購淨資產公允價值的部分爲美元36百萬美元分配給商譽。估值過程完成後,這些數額有待調整。


注5——重組和資產相關的費用-淨額
重組計劃費用和其他與資產相關的費用,包括資產減值,列入綜合收入報表中的"重組和資產相關費用 - 淨額"。有關公司重組計劃的額外信息,請參閱2023年10-k中包含的基本財務報表第4號注。

2023年重組計劃
2023年1月25日,陶氏公司董事會(「董事會」)批准了重組行動,以實現公司的結構性成本改善計劃,以應對全球衰退環境的持續經濟影響,並增強其在整個經濟週期中的靈活性和長期競爭力。這些行動預計將在2025年第一季度末基本完成。在2024年第一季度,公司錄得的額外稅前重組費用爲美元8百萬美元,用於與關閉工業中間體和基礎設施板塊的某些聚氨酯資產相關的資產減記和註銷。在2024年第三季度,公司錄得的額外稅前重組費用爲美元7百萬美元,用於與關閉高性能材料和塗料板塊的某些有機硅資產相關的資產減記和註銷。預計受影響的設施將在2025年底之前關閉。此外,公司記錄的稅前重組費用爲 $16百萬美元用於遣散費和相關福利費用以及稅前重組費用 $1百萬美元用於與公司相關的額外資產減記和註銷。

19

目錄
以下表格總結了與2023年重組計劃相關的活動,包括部門信息:

2023年重組計劃離職和相關福利成本資產減值和沖銷總計
單位爲百萬
包裝與特種塑料$ $1 $1 
工業中間體與製造行業 40 40 
性能材料與塗層 49 49 
公司344 107 451 
總重組費用$344 $197 $541 
對儲備的指控 (197)(197)
現金支付(11) (11)
2023年3月31日的儲備餘額$333 $ $333 
工業中間體與製造行業$ $8 $8 
總重組費用$ $8 $8 
對儲備的指控 (8)(8)
現金支付(60) (60)
2023年6月30日的儲備餘額$273 $ $273 
現金支付(110) (110)
2023年9月30日的儲備餘額$163 $ $163 
工業中間體與製造行業$ $2 $2 
公司 (16)(16)
總重組費用$ $(14)$(14)
對儲備的扣款 14 14 
現金支付(41) (41)
2023年12月31日的儲備餘額$122 $ $122 
工業中間體與製造行業$ $8 $8 
總重組費用$ $8 $8 
對儲備的費用 (8)(8)
現金支付(48) (48)
2024年3月31日的儲備餘額$74 $ $74 
現金支付$(13)$ $(13)
2024年6月30日儲備餘額$61 $ $61 
性能材料與塗層$ $7 $7 
公司16 1 17 
總重組費用$16 $8 $24 
對儲備的支出 (8)(8)
現金支付(17) (17)
2024年9月30日儲備餘額$60 $ $60 

到2024年9月30日,$60 百萬的儲備餘額被包含在「應計及其他流動負債」中($101 百萬截至2023年12月31日)和 被包含在「其他非流動負債」中($21 百萬截至2023年12月31日)在合併資產負債表中。

公司在2023年重組計劃下記錄了稅前重組費用,金額爲$567百萬,涵蓋了$的裁員和相關福利費用,360百萬的資產減值和資產沖銷。207截至2021年3月27日,未償還本金總額爲$。

20

目錄
重組實施成本,主要是與資產行動相關的退役和拆除活動,以及與公司生產力和效率行動相關的成本,預計將導致約美元的額外現金支出90百萬,主要是到2025年第一季度。重組實施和效率成本總計 $55百萬和美元157截至2024年9月30日的三個月和九個月分別爲百萬美元(美元)82百萬和美元169在截至2023年9月30日的三個月和九個月中分別爲百萬美元)。

資產相關費用
2024年第一季度,公司承認稅前減值費用$37百萬美元,主要與位於美國和意大利的特定製造資產減記有關,這些資產包含在公司計劃剝離的柔性包裝層壓膠粘劑業務中。減值費用已包括在「重組和與資產相關的費用-淨額」中,涉及包裝與專用塑料。有關更多信息,請參閱附註4和20。


附註6 -補充信息
陶氏化學 其他收入(費用) - 淨額截至三個月截至九個月
單位爲百萬2024年9月30日2023年9月30日2024年9月30日2023年9月30日
非運營養老金及其他退休後福利計劃淨收益 1
$61 $97 $183 $290 
外匯損失 2
(14)(39)(49)(236)
其他資產和投資的銷售收益 3
27  46 74 
賠償和其他與交易相關的費用 4
1 21 2 17 
Six Months Ended5
  5  
資產減值及相關費用 6
   (18)
其他 - 淨額44 13 69 75 
其他收入(費用)總額 – 淨額$119 $92 $256 $202 
1.有關更多信息,請參見注釋17。
2.2024年9月30日結束的三個月內,匯率期貨損失主要與阿根廷披索相關,而2024年9月30日結束的九個月內的損失主要與埃及鎊和阿根廷披索相關。2023年9月30日結束的三個月和九個月的匯率期貨損失主要與阿根廷披索相關。
3.2024年9月30日結束的三個月和九個月中,包括一項利潤爲$25百萬美元與倉庫銷售有關。2023年9月30日結束的九個月包括與之前受損權益法投資的股票出售有關的利潤。
4.主要與與杜邦公司("杜邦")和corteva公司("corteva")簽訂的協議相關,這些協議是分離和分配的一部分。
5.有關更多信息,請參閱註釋12。
6.與先前減值的權益法投資相關的某些義務。 與先前減值的權益法投資相關的某些義務。

截至2024年和2023年9月30日的三個月和九個月,TDCC的雜項收入(費用)-淨額與陶氏化學大致相同,主要差異在於陶氏化學記錄的賠償和其他交易相關費用。因此,TDCC的雜項收入(費用)-淨額未單獨披露。

其他投資
公司投資於公司持有的壽險保單,這些保單記錄在每個資產負債表日的贖回價值,如下所示:

公司擁有的壽險投資2024年9月30日2023年12月31日
單位爲百萬
總現金價值$602 $623 
減:已有的提款 1
260 97 
減:提款上的應計利息 2
7  
公司擁有的壽險投資 3
$335 $526 
1.在合併現金流量表中歸類爲 "銷售和到期投資的收益"。
2.在綜合利潤表中的"零星收入(支出)-淨額"中包括。
3.在合併資產負債表中被分類爲「其他投資」
21

目錄
供應商融資計劃
公司在業務常規過程中進行供應鏈融資(「SCF」)計劃,以延長與供應商的付款期限。根據該計劃的條款,供應商可以自願與參與的金融中介簽訂協議,出售其應收款項。供應商從金融中介處收到付款,公司按照與供應商最初協商的條款支付金融中介,這些條款通常包括 90120 天。供應商直接與金融中介協商協議條款,而公司不是該協議的一方。金融中介可能允許參與的供應商利用公司的信用狀況來確定信用價差和相關成本,這可能爲供應商提供比他們自行獲取的更有利的條款。公司不提供與SCF計劃相關的擔保。截至2024年9月30日,根據SCF計劃確認爲有效的未清償義務爲304百萬美元($285百萬美元(2023年12月31日),包括在合併資產負債表中的「應付賬款-貿易」中。


未以公允價值計量的金融工具所得稅
由於陶氏化學公司和TDCC的財務報表基本一致,包括所得稅準備金,在下面對所得稅的討論中沒有提及TDCC的所得稅準備金或其有效稅率。

公司的實際稅率會根據多種因素波動,包括所得來源、所得與稅收屬性的比例以及股權收益水平,因爲大部分公司權益法投資所得的收益是在合資公司層面交納的稅款。在2024年第三季度,公司報告的所得稅準備金爲$84百萬美元,導致實際稅率爲 25.9百分之90百萬美元,在2023年第三季度,導致實際稅率爲 21.6百分之145百萬美元,在2024年前九個月,公司報告的所得稅準備金爲$ 10.5百分之253百萬美元,在2023年前九個月,導致實際稅率爲 25.1 percent).

2023年第三季度受到外國司法管轄區再投資斷言變更和可用稅收抵免增加的積極影響。在2024年前九個月,公司錄得了$的稅收抵免。194與外國司法管轄區稅務事項利息和罰款的重新評估相關,導致有效稅率降低,公司在2023年前九個月的所得稅準備主要受到收入地理分佈的影響,導致較高的有效稅率。


注8 - 非合併關聯公司
有關公司非合併關聯公司的更多信息,請參閱基本報表附註10。 2023 10-K.

公司對採用權益法覈算的公司("非合併的聯營公司")的投資,按合併資產負債表中的分類如下表所示:

對非合併附屬公司的投資2024年9月30日2023年12月31日
單位爲百萬
非併入報表的聯營企業投資$1,303 $1,267 
其他非流動負債(488)(229)
對非合併附屬公司的淨投資$815 $1,038 

截至2024年9月30日,公司在Sadara Chemical Company擁有一筆負面投資餘額爲美元。420百萬美元,包括在「其他非流動負債」(2014年12月31日負$百萬)中。負面投資餘額128Sadara Chemical Company於2024年9月30日的負面投資是由於2024年前九個月受到具有挑戰性的宏觀經濟狀況影響而產生的股權虧損。

截至2024年9月30日,公司在EQUATE石化公司k.S.C.C中的投資餘額爲負$68百萬,計入「其他非流動負債」(截至2023年12月31日爲負$101百萬)在合併資產負債表中。負投資的減少是由於2024年前九個月業績的改善。
22

目錄
NOTE 9 – EARNINGS PER SHARE CALCULATIONS
The following tables provide earnings per share calculations for Dow Inc. for the three and nine months ended September 30, 2024 and 2023. Earnings per share of TDCC is not presented as this information is not required in financial statements of wholly owned subsidiaries.

每股收益計算的淨利潤截至三個月截至九個月
單位爲百萬2024年9月30日2023年9月30日2024年9月30日2023年9月30日
淨利潤$240 $327 $1,236 $755 
歸屬於非控股權益的淨收入26 25 67 61 
可歸屬參與性證券的淨利潤 1
3 2 9 8 
歸屬於普通股股東的淨利潤$211 $300 $1,160 $686 
1.限制性股票單位被視爲參與證券,因爲公司對未歸屬股份的實踐是支付股息等值。

每股收益 - 基本和稀釋截至三個月截至九個月
每股美元2024年9月30日2023年9月30日2024年9月30日2023年9月30日
基本每股收益$0.30 $0.43 $1.65 $0.97 
每股盈利-攤薄$0.30 $0.42 $1.65 $0.97 

分享計數信息截至三個月截至九個月
每股股數(單位:百萬)2024年9月30日2023年9月30日2024年9月30日2023年9月30日
基本每股未來平均流通股數702.3 704.0 703.5 706.4 
加上股權激勵計劃的稀釋效應1.3 3.5 1.4 3.3 
加權平均普通股已發行-攤薄703.6 707.5 704.9 709.7 
股份單位排除在每股收益計算中 1
10.5 9.3 9.6 9.8 
1.這些優秀的股票單位被排除在攤薄每股收益的計算之外,因爲包括它們的影響會導致減少。


注意事項10- 存貨
以下表格提供了存貨的詳細情況:

存貨2024年9月30日2023年12月31日
單位爲百萬
成品$3,853 $3,413 
在製品1,411 1,234 
原材料798 746 
用品1,041 992 
總計$7,103 $6,385 
庫存調整爲後進先出法(362)(309)
總存貨$6,741 $6,076 

23

目錄
注11- 金融資產的轉讓
應收賬款方案
公司與多家金融機構保持應收賬款融資安排,在美國設有承諾和非承諾融資,在歐洲設有承諾融資(統稱爲「融資計劃」),該融資計劃將於2025年11月到期。根據融資計劃的條款,公司可以在任何時間出售某些合格的貿易應收賬款,金額最高可達$900百萬美元用於美國的承諾融資,最高可達€500百萬歐元用於歐洲的承諾融資。根據融資計劃的條款,公司繼續爲客戶提供應收賬款的服務,但對應收賬款不保留任何利息,並將款項匯給金融機構。在截至2024年9月30日和2023年9月30日的三個月和九個月內,應收賬款轉移的損失微不足道。公司還向金融機構提供擔保,以證明應收賬款的信用worthiness和回款情況,以滿足融資安排。有關擔保的更多信息,請參見第13條。

公司可以使用應收賬款貼現設施,這些設施覆蓋來自EMEAI、亞太地區和加拿大的某些銷售所產生的應收賬款(統稱爲「設施」)。根據這些設施的條款,公司在售出後不再保留轉讓的應收賬款的權益,並且應收賬款的轉讓伴隨有限的追索權。公司繼續爲客戶的應收賬款提供服務,並將款項支付給設施。截止至2024年9月30日和2023年9月30日的三個月和九個月內,應收賬款轉讓的損失微不足道。

以下表格總結了截至2024年和2023年9月30日的三個月和九個月與節目和設施相關的現金流量。

與應收賬款轉讓相關的現金流量截至三個月截至九個月
單位爲百萬2024年9月30日2023年9月30日2024年9月30日2023年9月30日
收到來自新轉賬的收入$198 $28 $1,248 $28 

下表提供了截至2024年9月30日和2023年12月31日與項目和設施相關的餘額:

應收賬款轉移相關的餘額2024年9月30日2023年12月31日
單位爲百萬
未償餘額$199$170
已確認的應收賬款 $153$152
在合併資產負債表中確認的金額:
    應計和其他流動負債 1
$46$18
1. 代表公司從客戶那裏收取但尚未匯出的款項。


24

目錄
注12- 應付票據、長期債務和可用信貸設施
應付票據2024年9月30日2023年12月31日
單位爲百萬
應付銀行和其他貸款人的應付款$111$62
期末平均利率期貨39.13 %33.84 %

長期債務
2024年平均匯率
2024年9月30日
2023年平均匯率
2023年12月31日
單位爲百萬
票據和公司債券:
最終到期日2025年5.63 %$333 5.63 %$333 
最終到期日爲2028年4.80 %600 4.80 %600 
最終到期日爲2029年7.58 %1,368 7.58 %1,367 
最終到期日爲2030年及以後 1
5.11 %10,072 5.07 %8,861 
其他設施:
外幣票據和貸款,各種利率和到期日2.13 %2,736 1.18 %2,653 
InterNotes®,截至2054年各種到期日4.26 %644 4.12 %595 
融資租賃負債 2
961 873 
未攤銷的債務折扣和發行成本(254)(258)
一年內到期的長期債務 3
(296)(117)
長期債務$16,164 $14,907 
1.成本包括淨公允價值套期利潤調整收益。f $70百萬美元的運營租賃負債的當前部分,分別爲2023年9月30日和2022年12月31日。 2024年9月30日($49百萬美元,截至2023年12月31日)。有關更多信息,請參閱第19條註釋。
2.有關更多信息,請參見第14條說明。
3.已扣除未攤銷債務發行費的流動部分。

截至2024年9月30日,未來五年長期債務的到期情況
單位爲百萬
2024$35 
2025$525 
2026$131 
2027$1,289 
2028$696 
2029$1,457 

2024 年活動
2024年第一季度,公司發行$1.25 十億美元的優先無擔保票據。該發行包括2034年到期的百分之600百萬的總本金金額爲 5.15 利率的票據和2054年到期的百分之650百萬的總本金金額爲 5.60 利率的票據。該發行是在公司的綠色金融框架下完成的。公司將把收益用於支持其可持續發展策略的執行,並實現其關注氣候保護和循環經濟的目標,包括與公司Fort Saskatchewan Path2Zero項目相關的支出和投資。

在2024年第二季度,公司贖回了$10百萬的總本金金額爲 2.10到期於2030年11月的%債券,$30 總額爲 4.25  到期於2034年10月的債券,$8百萬的總本金金額爲 5.25到期於2041年11月的%債券,$12百萬的總本金金額爲 4.375到期於2042年11月的百分之 的票據。因此,公司確認了早期債務清償的稅前收益爲$5百萬,包含在合併收益表中的「雜項收入(支出)- 淨額」。

2024年前九個月,公司發行了總計xxx美元的本金金額。71百萬美元的InterNotes®。公司還發行了xxx萬美元的外幣貸款。此外,公司償還了xxx百萬美元的長期債務。122百萬美元的外幣貸款。此外,公司償還了xxx百萬美元的長期債務。77百萬美元的長期債務。
25

目錄
可用信用設施
以下表格總結了公司的信貸設施:

截至2024年9月30日的承諾和可用信貸額度
單位爲百萬承諾信貸可用信貸到期日利息
五年期競爭性預支和循環信貸設施$5,000 $5,000 2028年11月浮動利率
雙邊循環信貸額度 375 375 2024年10月浮動利率
雙邊循環信貸額度100 100 2025年3月浮動利率
雙邊循環信貸額度100 100 2025年3月浮動利率
雙邊循環信用額度200 200 2025年9月浮動利率
雙邊循環信用額度175 175 2025年9月浮動利率
雙邊循環信貸額度300 300 2025年11月浮動利率
雙邊循環信貸額度300 300 2026年2月浮動利率
雙邊循環信貸額度100 100 2026年3月浮動利率
雙邊循環信貸額度150 150 2026年11月浮動利率
雙邊循環信貸額度200 200 2026年11月浮動利率
雙邊循環信貸額度250 250 2027年3月浮動利率
雙邊循環信貸便利100 100 2027年5月浮動利率
雙邊循環信貸便利350 350 2027年6月浮動利率
雙邊循環信貸額度200 200 2027年9月浮動利率
雙邊循環信貸額度100 100 2027年10月浮動利率
雙邊循環信貸額度100 100 5.000%到期於2027年的高級票據浮動利率
雙邊循環信貸額度300 300 2028年5月浮動利率
總承諾和可用信貸額度$8,400 $8,400 

債務契約和違約條款
在2024年前九個月,公司未對公司未償長期債務和主要的私人信貸協議相關的債務契約和違約條款進行實質性修改。有關公司債務契約和違約條款的更多信息,請參閱2023年10-k中包含的合併財務報表注13。
26

目錄
註記13——2021年11月18日,公司發行了總額爲($)的可轉換優先票據。2021年11月23日,票據的首次購買者購買了額外的總額爲($)的票據,總票面額爲($)。2023年9月,該公司與某些持有人私下達成了交換協議。在總體上,公司交換了($)。 承諾和 contingencies
公司的承諾和或有事項的摘要可以在2023年10-k的合併基本報表附註14中找到,本文件以此爲參考。

環境事務
根據現行法律和現有技術,當可能發生負債並且可以合理估計責任金額時,將記錄環境事項的應計費用。截至2024年9月30日,該公司的應計債務爲美元1,157百萬美元用於可能的環境修復和恢復費用(美元1,180截至 2023 年 12 月 31 日的百萬美元),包括美元240百萬美元用於修復超級基金場地(美元241截至 2023 年 12 月 31 日,爲百萬美元)。這是管理層對公司應計負債的環境問題進行補救和恢復成本的最佳估計,儘管這些特定問題的最終成本可能高達該金額的兩倍左右。因此,超過應計金額的環境修復和恢復成本有可能對公司的經營業績、財務狀況和現金流產生重大影響。但是,公司管理層認爲,超出披露範圍的成本對公司的經營業績、財務狀況和現金流產生重大影響的可能性微乎其微。這些估算中存在固有的不確定性,這主要是由於未知的條件、有關責任的政府法規和法律標準的變化以及用於處理場地修復和修復的新興補救技術所致。隨着新的或額外的信息的出現和/或某些支出趨勢的公佈,管理層將對此類信息進行評估,以確定當前的環境負債估計。

訴訟
聯合碳化公司與石棉相關事宜
每個季度,聯合碳化公司審查提交的與石棉有關的索賠,已解決和駁回的情況,以及按疾病類別的平均和解費用。聯合碳化公司還考慮了其他定量和定性因素,例如待處理索賠的性質,聯合碳化公司和其他石棉被告的審判經驗,爲防衛和處理成本支出的程度,重要的上訴裁定和立法發展,侵權制度的趨勢,以及它們對預期未來解決成本的影響。聯合碳化公司的管理層結合最近的精算研究考慮這些因素,並確定是否需要調整估計值。根據聯合碳化公司對2024年活動的審查,確定在2024年9月30日不需要調整應計數。

聯合碳化物對待處理和未來索賠以及辯護和處理費用的石棉相關責任總額爲美元807截至 2024 年 9 月 30 日的百萬美元(美元)867截至 2023 年 12 月 31 日,爲百萬美元)。大約 2024 年 9 月 30 日 23記錄的索賠負債中與待處理索賠相關的百分比以及大約 77與未來索賠相關的百分比。

遺產的重要性
公司在多個投訴中成爲焦點,投訴內容涉及根據幾十年前某些農產品化學產品的銷售和應用而導致的地下水污染("地下水問題")。與這些地下水問題相關的費用之前由保險政策覆蓋,但這些保險政策現已耗盡。在2023年第一季度,公司完成了一項關於現在被視爲可能和可估算的地下水問題的研究,該研究基於樣本數據的公共報告和歷史信息,以制定待處理和未來索賠成本的合理估計。因此,公司錄得稅前費用爲$177百萬,計入合併收入報表中的「銷售成本」,與製造行業和製造行業相關。截至2024年9月30日,與這些聲稱的地下水問題和解相關的總負債爲$158百萬美元($232百萬(截至2023年12月31日),該金額包括在合併資產負債表中的「應計和其他當前負債」以及「其他長期義務」。

公司還面臨其他地下水污染的投訴,包括與1,4-二氧六烷相關的索賠。公司在此訴訟中繼續爲自己辯護,並且已確定截至2024年9月30日,公司可能承擔的責任不具備可能性或可估計性。

27

Table of Contents
Separately, on October 10, 2024, the Company executed a settlement agreement related to arbitration for historical product claims from a divested business. As a result, the Company recorded a pretax charge of $75 million in the third quarter of 2024, which is included in "Cost of sales" in the consolidated statements of income, related to Corporate, and included in "Accrued and other current liabilities" in the consolidated balance sheets at September 30, 2024. This is management's best estimate of the loss for which the Company has accrued a liability, although the amount is subject to further arbitration and it is reasonably possible that the total loss could range up to approximately three times that amount.

Indemnifications with Corning Incorporated
The Company had indemnification assets with Corning Incorporated of $58 million at September 30, 2024 ($100 million at December 31, 2023) related to the 2016 ownership restructure of Dow Silicones, which were included in "Other current assets" and "Noncurrent receivables" in the consolidated balance sheets.

獲取備忘錄 - 道氏公司訴nova化學品公司乙烯資產案
由於2019年與乙烯資產事項相關的損害判決,Nova化學品公司被判支付給該公司1.43 十億加元(相當於約美元1.08 十億美元),該公司於2019年10月和2020年3月收款。到2024年9月30日,該公司的資產負債表中"其他非流動負債"中包括了201百萬美元($201 百萬美元(2023年12月31日爲百萬美元)與損害判決爭議部分相關。

購買承諾
在2024年第三季度,公司簽署了一項關於使用水庫資產的承諾,該資產將用於向道達爾在美國海灣沿岸的主要製造業-半導體地點之一供應水。相關合同預計將在2024年第四季度生效,具體需滿足慣例成交條件,合同期爲35年,預計在2028年施工完成後開始。預計在合同期內固定和可確定部分的總價值爲$1.3三、優先票據。2024年4月,公司發行了到2032年到期的650 百萬美元(以2024年9月30日的現值計算)。

擔保
以下表格總結了合併資產負債表中包含的擔保的最終到期、最大未來付款和記錄的負債:

擔保2024年9月30日2023年12月31日
單位爲百萬最終
到期日
最大
未來支付 1
記錄的負債最終
到期日
最大
未來支付 1
記錄的負債
擔保2038$1,361 $179 2038$1,385 $196 
1.此外,TDCC已經根據公司所持有的股份百分比提供了擔保,涵蓋在寬限期內Sadara項目融資債務的所有未來利息支付,預計道公司的股份爲$ 35 百萬(截至2024年9月30日)($232 百萬(截至2023年12月31日)。298公司預計不需要根據擔保進行履行。

擔保是公司與客戶、應收賬款融資以及非合併關聯方業務關係中產生的,當公司承擔擔保責任以保證他人履行(通過提供現金或其他資產)的情況發生時。對於擔保,如商業或金融合同,被擔保方的不履行會觸發公司向擔保受益人支付款項的義務。公司的大部分擔保與非合併關聯方的債務相關,其到期日從不到1年到14年不等。公司目前預計,與他人不履行相關的未來付款或履行被視爲遙遠。

公司與各金融機構簽訂了應收賬款授信協議,在美國擁有承諾和非承諾的授信額度,並在歐洲擁有承諾的授信額度。根據計劃的條款,公司繼續爲客戶的應收賬款提供服務,但不再持有應收賬款利益,並向金融機構支付款項。公司還可以利用應收賬款貼現授信額度,按照有限追索權轉讓應收賬款。公司對應收賬款授信額度的最大擔保責任爲 $123在2024年9月30日爲$150百萬美元(在2023年12月31日爲$百萬美元)。公司預計應收款項的收取和匯款將在接下來的六個月內完成。

28

Table of Contents
TDCC has entered into guarantee agreements related to Sadara, a nonconsolidated affiliate. Sadara reached an agreement with its lenders to re-profile its outstanding project financing debt in the first quarter of 2021. In conjunction with the debt re-profiling, TDCC entered into a guarantee of up to approximately $1.3 billion of Sadara’s debt, proportionate to the Company's 35 percent ownership interest. The debt re-profiling also includes a grace period until June 2026, during which Sadara is obligated to make interest-only payments which are guaranteed by TDCC in proportion to the Company’s 35 percent ownership interest. As part of the debt re-profiling, Sadara established a $500 million revolving credit facility guaranteed by Dow, which would be used to fund Dow’s pro-rata share of any potential shortfall during the grace period.


NOTE 14 – LEASES
For additional information on the Company's leases, see Note 15 to the Consolidated Financial Statements included in the 2023 10-K.

The components of lease cost for operating and finance leases for the three and nine months ended September 30, 2024 and 2023 were as follows:

Lease CostThree Months EndedNine Months Ended
In millionsSep 30, 2024Sep 30, 2023Sep 30, 2024Sep 30, 2023
Operating lease cost$112 $118 $329 $319 
Finance lease cost
Amortization of right-of-use assets - finance31 26 86 77 
Interest on lease liabilities - finance11 8 33 24 
Total finance lease cost42 34 119 101 
Short-term lease cost80 62 242 194 
Variable lease cost280 241 803 683 
Sublease income(2)(2)(7)(6)
Total lease cost$512 $453 $1,486 $1,291 

The following table provides supplemental cash flow and other information related to leases:

Other Lease InformationNine Months Ended
In millionsSep 30, 2024Sep 30, 2023
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows for operating leases$334 $320 
Operating cash flows for finance leases$33 $24 
Financing cash flows for finance leases$95 $83 
Right-of-use assets obtained in exchange for lease obligations:
Operating leases$186 $283 
Finance leases$183 $43 

29

Table of Contents
NOTE 15 – ACCUMULATED OTHER COMPREHENSIVE LOSS
The changes in each component of accumulated other comprehensive loss ("AOCL") for the three and nine months ended September 30, 2024 and 2023 were as follows:

Accumulated Other Comprehensive LossThree Months EndedNine Months Ended
In millionsSep 30, 2024Sep 30, 2023Sep 30, 2024Sep 30, 2023
Unrealized Gains (Losses) on Investments
Beginning balance$(198)$(161)$(253)$(253)
Unrealized gains (losses) on investments59 (33)139 55 
Tax (expense) benefit(15)9 (35)48 
Net unrealized gains (losses) on investments44 (24)104 103 
(Gains) losses reclassified from AOCL to net income 1
(12)4 (19)(41)
Tax expense (benefit) 2
2  4 10 
Net (gains) losses reclassified from AOCL to net income(10)4 (15)(31)
Other comprehensive income (loss), net of tax34 (20)89 72 
Ending balance$(164)$(181)$(164)$(181)
Cumulative Translation Adjustment
Beginning balance$(2,056)$(1,936)$(1,891)$(1,934)
Gains (losses) on foreign currency translation197 (122)42 (122)
Tax (expense) benefit8 (6)5 (16)
Net gains (losses) on foreign currency translation205 (128)47 (138)
(Gains) losses reclassified from AOCL to net income 3
(6)(19)(13)(11)
Other comprehensive income (loss), net of tax199 (147)34 (149)
Ending balance$(1,857)$(2,083)$(1,857)$(2,083)
Pension and Other Postretirement Benefits
Beginning balance$(5,452)$(4,875)$(5,486)$(4,877)
Gains (losses) arising during the period2 (4)2 (7)
Amortization of net loss and prior service credits reclassified from AOCL to net income 4
21 3 64 8 
Tax expense (benefit) 2
(5)(1)(14)(1)
Net loss and prior service credits reclassified from AOCL to net income16 2 50 7 
Other comprehensive income (loss), net of tax18 (2)52  
Ending balance$(5,434)$(4,877)$(5,434)$(4,877)
Derivative Instruments
Beginning balance$(79)$(95)$(51)$(75)
Gains (losses) on derivative instruments37 (58)(9)(242)
Tax (expense) benefit(9)(2)2 34 
Net gains (losses) on derivative instruments28 (60)(7)(208)
(Gains) losses reclassified from AOCL to net income 5
4 45 13 209 
Tax expense (benefit) 2
(1)(10)(3)(46)
Net (gains) losses reclassified from AOCL to net income3 35 10 163 
Other comprehensive income (loss), net of tax31 (25)3 (45)
Ending balance$(48)$(120)$(48)$(120)
Total AOCL ending balance$(7,503)$(7,261)$(7,503)$(7,261)
1.Reclassified to "Net sales" and "Sundry income (expense) - net."
2.Reclassified to "Provision for income taxes."
3.Reclassified to "Sundry income (expense) - net."
4.These AOCL components are included in the computation of net periodic benefit cost (credit) of the Company's defined benefit pension and other postretirement benefit plans. See Note 17 for additional information.
5.Reclassified to "Cost of sales," "Sundry income (expense) - net" and "Interest expense and amortization of debt discount."
30

Table of Contents
NOTE 16 – NONCONTROLLING INTERESTS
Ownership interests in the Company's subsidiaries held by parties other than the Company are presented separately from the Company's equity in the consolidated balance sheets as "Noncontrolling interests." The amount of consolidated net income attributable to the Company and the noncontrolling interests are both presented on the face of the consolidated statements of income.

The following table summarizes the activity for equity attributable to noncontrolling interests for the three and nine months ended September 30, 2024 and 2023:

Noncontrolling InterestsThree Months EndedNine Months Ended

In millions
Sep 30, 2024Sep 30, 2023Sep 30, 2024Sep 30, 2023
Balance at beginning of period$482 $512 $501 $529 
Net income attributable to noncontrolling interests26 25 67 61 
Distributions to noncontrolling interests 1
(2)(15)(41)(43)
Cumulative translation adjustments24 (9)4 (34)
Other  (1) 
Balance at end of period$530 $513 $530 $513 
1.Includes dividends paid to a joint venture of $8 million for the three and nine months ended September 30, 2024 ($8 million for the three and nine months ended September 30, 2023) which were reclassified to "Equity in earnings of nonconsolidated affiliates" in the consolidated statements of income.


NOTE 17 – PENSION AND OTHER POSTRETIREMENT BENEFIT PLANS
A summary of the Company's pension and other postretirement benefit plans can be found in Note 18 to the Consolidated Financial Statements included in the 2023 10-K. The following table provides the components of the Company's net periodic benefit cost (credit) for all significant plans:

Net Periodic Benefit Cost (Credit) for All Significant Plans Three Months EndedNine Months Ended
In millionsSep 30, 2024Sep 30, 2023Sep 30, 2024Sep 30, 2023
Defined Benefit Pension Plans
Service cost$14 $71 $42 $212 
Interest cost 252 280 754 838 
Expected return on plan assets (345)(391)(1,034)(1,170)
Amortization of prior service credit(3)(7)(10)(20)
Amortization of net loss34 24 105 71 
Net periodic benefit credit$(48)$(23)$(143)$(69)
Other Postretirement Benefit Plans
Service cost $1 $1 $3 $3 
Interest cost 11 11 33 34 
Amortization of net gain(10)(14)(31)(43)
Net periodic benefit cost (credit)$2 $(2)$5 $(6)

Net periodic benefit cost (credit), other than the service cost component, is included in "Sundry income (expense) - net" in the consolidated statements of income.


31

Table of Contents
NOTE 18 – STOCK-BASED COMPENSATION
A summary of the Company's stock-based compensation plans can be found in Note 19 to the Consolidated Financial Statements included in the 2023 10-K.

Stock Incentive Plan
The Company grants stock-based compensation to employees and non-employee directors under the 2019 Stock Incentive Plan, as amended. Most of the Company's stock-based compensation awards are granted in the first quarter of each year.

In the first quarter of 2024, Dow Inc. granted the following stock-based compensation awards to employees:
1.3 million stock options with a weighted-average exercise price of $55.17 per share and a weighted-average fair value of $10.94 per share;
2.0 million restricted stock units with a weighted-average fair value of $55.18 per share; and
1.4 million performance stock units with a weighted-average fair value of $58.42 per share.

There was minimal grant activity in the second and third quarters of 2024.

Employee Stock Purchase Plan
The Dow Inc. 2021 Employee Stock Purchase Plan (the "2021 ESPP") was adopted by the Dow Inc. Board on February 11, 2021, and approved by stockholders at the Company's annual meeting on April 15, 2021. Under the 2024 annual offering of the 2021 ESPP, most employees will be eligible to purchase shares of common stock of Dow Inc. valued at up to 10 percent of their annual total base salary or wages. The number of shares purchased is determined using the amount contributed by the employee divided by the plan price. The plan price of the stock is equal to 85 percent of the fair market value (closing price) of the common stock at April 1, 2024 (beginning) or October 4, 2024 (ending) of the offering period, whichever is lower.

In the first quarter of 2024, employees subscribed to the right to purchase shares under the 2021 ESPP. In October 2024, 2.4 million shares were delivered to employees under the plan.


NOTE 19 – FINANCIAL INSTRUMENTS
A summary of the Company's financial instruments, risk management policies, derivative instruments and hedging activities can be found in Note 20 to the Consolidated Financial Statements included in the 2023 10-K.

Refer to Note 20 for a summary of the fair value of financial instruments at September 30, 2024 and December 31, 2023.

Debt Securities
The Company's investments in debt securities are primarily classified as available-for-sale. The following table provides investing results from available-for-sale securities for the nine months ended September 30, 2024 and 2023:

Investing ResultsNine Months Ended
In millionsSep 30, 2024Sep 30, 2023
Proceeds from sales of available-for-sale securities$1,730 $397 
Gross realized gains$34 $59 
Gross realized losses $(15)$(18)

32

Table of Contents
The following table summarizes contractual maturities of the Company's investments in debt securities:

Contractual Maturities of Debt Securities at Sep 30, 2024
 CostFair Value
In millions
Within one year$90 $79 
One to five years1,244 1,166 
Six to ten years422 412 
After ten years537 464 
Total$2,293 $2,121 

Equity Securities
There were no material adjustments to the carrying value of the not readily determinable investments for impairment or observable price changes for the three and nine months ended September 30, 2024. There was $1 million of net unrealized losses recognized in earnings on equity securities for the three and nine months ended September 30, 2024 ($4 million of net unrealized losses for the three months ended September 30, 2023 and $6 million of net unrealized gains for the nine months ended September 30, 2023).

Investments in Equity SecuritiesSep 30, 2024Dec 31, 2023
In millions
Readily determinable fair value$14 $17 
Not readily determinable fair value$173 $171 

Derivative Instruments
The notional amounts of the Company's derivative instruments at September 30, 2024 and December 31, 2023 were as follows:

Notional Amounts 1
Sep 30, 2024Dec 31, 2023
In millions
Derivatives designated as hedging instruments:
Interest rate contracts$1,745 $3,000 
Foreign currency contracts$6,207 $2,316 
Derivatives not designated as hedging instruments:
Interest rate contracts$286 $59 
Foreign currency contracts$14,798 $5,824 
1.Notional amounts represent the absolute value of open derivative positions at the end of the period. Multi-leg option positions are reflected at the maximum notional position at expiration.

The notional amounts of the Company's commodity derivatives at September 30, 2024 and December 31, 2023 were as follows:

Commodity Notionals 1
Sep 30, 2024Dec 31, 2023Notional Volume Unit
Derivatives designated as hedging instruments:
Hydrocarbon derivatives4.7 3.7 million barrels of oil equivalent
Derivatives not designated as hedging instruments:
Hydrocarbon derivatives1.6 1.4 million barrels of oil equivalent
1.Notional amounts represent the net volume of open derivative positions outstanding at the end of the period.

Maturity Dates of Derivatives Designated as Hedging InstrumentsYear
Interest rate contracts2025
Foreign currency contracts2026
Commodity contracts2028
33

Table of Contents
The following table provides the fair value and balance sheet classification of derivative instruments at September 30, 2024 and December 31, 2023:

Fair Value of Derivative InstrumentsSep 30, 2024Dec 31, 2023
In millionsGross
Counterparty and Cash Collateral Netting 1
Net 2
Gross
Counterparty and Cash Collateral Netting 1
Net 2
Asset derivatives
Derivatives designated as hedging instruments:
Interest rate contracts 3
$107 $(68)$39 $73 $(73)$ 
Interest rate contracts 4
   59 (56)3 
Foreign currency contracts 3
29 (21)8 21 (5)16 
Foreign currency contracts 4
8  8 5  5 
Commodity contracts 3
38 (17)21 27 (21)6 
Commodity contracts 4
45 (39)6 2 (1)1 
Total$227 $(145)$82 $187 $(156)$31 
Derivatives not designated as hedging instruments:
Interest rate contracts 3
$2 $(2)$ $4 $(3)$1 
Foreign currency contracts 3
20 (10)10 33 (16)17 
Commodity contracts 3
20 (11)9 33 (28)5 
Commodity contracts 4
8 (3)5    
Total$50 $(26)$24 $70 $(47)$23 
Total asset derivatives $277 $(171)$106 $257 $(203)$54 
Liability derivatives
Derivatives designated as hedging instruments:
Interest rate contracts 5
$68 $(68)$ $95 $(73)$22 
Interest rate contracts 6
   56 (56) 
Foreign currency contracts 5
61 (21)40 8 (5)3 
Commodity contracts 5
25 (17)8 34 (22)12 
Commodity contracts 6
42 (39)3 2 (1)1 
Total$196 $(145)$51 $195 $(157)$38 
Derivatives not designated as hedging instruments:
Interest rate contracts 5
$2 $(2)$ $3 $(3)$ 
Foreign currency contracts 5
44 (10)34 38 (16)22 
Commodity contracts 5
21 (11)10 34 (28)6 
Commodity contracts 6
6 (3)3    
Total$73 $(26)$47 $75 $(47)$28 
Total liability derivatives $269 $(171)$98 $270 $(204)$66 
1.Counterparty and cash collateral amounts represent the estimated net settlement amount when applying netting and set-off rights included in master netting arrangements between the Company and its counterparties and the payable or receivable for cash collateral held or placed with the same counterparty.
2.Represents the net amounts included in the consolidated balance sheets.
3.Included in "Other current assets" in the consolidated balance sheets.
4.Included in "Deferred charges and other assets" in the consolidated balance sheets.
5.Included in "Accrued and other current liabilities" in the consolidated balance sheets.
6.Included in "Other noncurrent obligations" in the consolidated balance sheets.

34

Table of Contents
Assets and liabilities related to forward contracts, interest rate swaps, currency swaps, options and other conditional or exchange contracts executed with the same counterparty under a master netting arrangement are netted. Collateral accounts are netted with corresponding assets or liabilities, when applicable. The Company posted cash collateral of $15 million at September 30, 2024 ($22 million at December 31, 2023). There was zero cash collateral posted by counterparties with the Company at September 30, 2024 and December 31, 2023.

The following table summarizes the gain (loss) of derivative instruments in the consolidated statements of income and comprehensive income for the three and nine months ended September 30, 2024 and 2023:

Effect of Derivative Instruments
Gain (loss) recognized in OCI 1
Gain (loss) recognized in income 2
Three Months EndedNine Months EndedThree Months EndedNine Months Ended
In millionsSep 30, 2024Sep 30, 2023Sep 30, 2024Sep 30, 2023Sep 30, 2024Sep 30, 2023Sep 30, 2024Sep 30, 2023
Derivatives designated as hedging instruments:
Fair value hedges:
Interest rate contracts 3
$ $ $ $ $7 $ $(16)$ 
Excluded components 3, 4
51 (88)9 (93)    
Cash flow hedges:
Interest rate contracts 3
  1 5 (2)(3)(11)(7)
Foreign currency contracts 5
16 5 (5)6 1  6 1 
Commodity contracts 5
 4 22 (145)(2)(42)(3)(203)
Excluded components 4, 5
(2) (8) (1) (5) 
Net foreign investment hedges:
Foreign currency contracts(45)69 (37)72     
Excluded components 4, 6
6 4 16 35 5 19 12 26 
Total derivatives designated as hedging instruments$26 $(6)$(2)$(120)$8 $(26)$(17)$(183)
Derivatives not designated as hedging instruments:
Interest rate contracts 3
$ $ $ $ $ $ $1 $1 
Foreign currency contracts 6
    (95)(101)(35)(95)
Commodity contracts 5
    (2)(1) 3 
Total return swap 5
    23 (16)49 (13)
Total derivatives not designated as hedging instruments$ $ $ $ $(74)$(118)$15 $(104)
Total derivatives$26 $(6)$(2)$(120)$(66)$(144)$(2)$(287)
1.OCI is defined as other comprehensive income (loss).
2.Pretax amounts.
3.Included in "Interest expense and amortization of debt discount" in the consolidated statements of income.
4.The excluded components are related to the time value of the derivatives designated as hedges.
5.Included in "Cost of sales" in the consolidated statements of income.
6.Included in "Sundry income (expense) - net" in the consolidated statements of income.

The following table provides the net after-tax gain (loss) expected to be reclassified from AOCL to income within the next 12 months:

Expected Reclassifications from AOCL within the next 12 monthsSep 30, 2024
In millions
Cash flow hedges:
Interest rate contracts$(4)
Commodity contracts$11 
Foreign currency contracts$(1)
Excluded components$(5)
Net foreign investment hedges:
Excluded components$5 
35

Table of Contents
NOTE 20 – FAIR VALUE MEASUREMENTS
A summary of the Company's recurring and nonrecurring fair value measurements can be found in Note 21 to the Consolidated Financial Statements included in the 2023 10-K.

Fair Value Measurements on a Recurring Basis
The following table summarizes the bases used to measure certain assets and liabilities at fair value on a recurring basis:

Fair Value Measurements on a Recurring BasisSep 30, 2024Dec 31, 2023
In millionsFair Value LevelCostGainLossFair ValueCostGainLossFair Value
Assets at fair value:
Cash equivalents:
Held-to-maturity securities 1
Level 2$105 $ $ $105 $485 $ $ $485 
Money market fundsLevel 21,190   1,190 663   663 
Marketable securities 2
Level 2403  (42)361 1,361  (61)1,300 
Nonconsolidated affiliates 3
Level 3 7 
Other investments:
Debt securities: 4
Government debt 5
Level 21,101 14 (92)1,023 766 3 (107)662 
Corporate bondsLevel 118   18 24  (3)21 
Corporate bondsLevel 2974 10 (77)907 1,148 17 (99)1,066 
Corporate bondsLevel 3200  (27)173 200  (89)111 
Equity securities 4, 6
Level 14 10  14 5 12  17 
Derivatives relating to: 7
Interest ratesLevel 2— 109  109 — 136  136 
Foreign currencyLevel 2— 57  57 — 59  59 
CommoditiesLevel 1— 8  8 — 2  2 
CommoditiesLevel 2— 103  103 — 60  60 
Total assets at fair value$4,068 $4,589 
Liabilities at fair value:
Long-term debt including debt due within one year 8
Level 2$(16,460)$1,029 $(764)$(16,195)$(15,024)$1,089 $(747)$(14,682)
Guarantee liability 9
Level 3(161)(178)
Derivatives relating to: 7
Interest ratesLevel 2—  (70)(70)—  (154)(154)
Foreign currencyLevel 2—  (105)(105)—  (46)(46)
CommoditiesLevel 1—  (4)(4)—  (2)(2)
CommoditiesLevel 2—  (90)(90)—  (68)(68)
Total liabilities at fair value$(16,625)$(15,130)
1.The Company's held-to-maturity securities are primarily treasury bills and time deposits. At September 30, 2024, $66 million is included in "Cash and cash equivalents" ($485 million at December 31, 2023) and $39 million is included in "Other current assets" (zero at December 31, 2023) in the consolidated balance sheets.
2.The Company’s investments in marketable securities are included in “Other current assets” in the consolidated balance sheets.
3.Estimated asset for an investment in a limited liability company included in "Investment in nonconsolidated affiliates" in the consolidated balance sheets.
4.The Company’s investments in debt securities, which are primarily available-for-sale, and equity securities are included in “Other investments” in the consolidated balance sheets.
5.U.S. Treasury obligations, U.S. agency obligations, U.S. agency mortgage-backed securities and other municipalities’ obligations.
6.Equity securities with a readily determinable fair value.
7.See Note 19 for classification of derivatives in the consolidated balance sheets.
8.Cost includes fair value hedge adjustment gains of $70 million at September 30, 2024 and $49 million at December 31, 2023 on $5,129 million of debt at September 30, 2024 and $4,479 million at December 31, 2023.
9.Estimated liability for TDCC's guarantee of Sadara's debt which is included in "Other noncurrent obligations" in the consolidated balance sheets.
36

Table of Contents
Cost approximates fair value for all other financial instruments.

For equity securities calculated at net asset value per share (or its equivalent), the Company had $90 million in private market securities and $16 million in real estate at September 30, 2024 ($86 million in private market securities and $18 million in real estate at December 31, 2023). There are no redemption restrictions and the unfunded commitments on these investments were $84 million at September 30, 2024 and $75 million at December 31, 2023.

For assets classified as Level 3 measurements, fair value is based on significant unobservable inputs including assumptions where there is little, if any, market activity. The level 3 asset values represent the fair value of an investment in a corporate bond, accounted for as a debt security. At December 31, 2023, the level 3 asset values also included an investment in a limited liability company, accounted for as an investment in nonconsolidated affiliates, and with no unfunded commitment.

For liabilities classified as Level 3 measurements, fair value is based on significant unobservable inputs including assumptions where there is little, if any, market activity. The fair value of the Company’s accrued liability related to the guarantee of Sadara’s debt is in proportion to the Company’s 35 percent ownership interest in Sadara. The estimated fair value of the guarantee was calculated using a "with" and "without" method. The fair value of the debt was calculated "with" the guarantee less the fair value of the debt "without" the guarantee. The "with" and "without" values were calculated using a discounted cash flow method based on contractual cash flows as well as projected prepayments made on the debt by Sadara.

Fair Value Measurements on a Nonrecurring Basis
In the first quarter of 2024, the Company recognized impairment charges of $37 million related primarily to write-downs of certain manufacturing assets in the United States and Italy. The assets, classified as Level 3 measurements, were valued at $60 million using unobservable inputs. The impairment charges were included in "Restructuring and asset related charges - net" in the consolidated statements of income and related to Packaging & Specialty Plastics.

In the first quarter of 2024, as part of the 2023 Restructuring Program, the Company recorded impairment charges of $8 million for asset write-downs and write-offs related to the shutdown of certain polyurethanes assets, included in "Restructuring and asset related charges - net" in the consolidated statements of income and related to Industrial Intermediates & Infrastructure.

In the third quarter of 2024, as part of the 2023 Restructuring Program, the Company recorded impairment charges of $7 million for asset write-downs and write-offs related to the shutdown of certain silicones assets, included in "Restructuring and asset related charges - net" in the consolidated statements of income and related to Performance Materials & Coatings. Additionally, the Company recorded impairment charges of $1 million for asset write-downs and write-offs, included in "Restructuring and asset related charges - net" in the consolidated statements of income and related to Corporate.


37

Table of Contents
NOTE 21 – SEGMENTS AND GEOGRAPHIC REGIONS
Dow’s measure of profit/loss for segment reporting purposes is Operating EBIT as this is the manner in which the Company's chief operating decision maker assesses performance and allocates resources. The Company defines Operating EBIT as earnings (i.e., "Income before income taxes") before interest, excluding the impact of significant items. Operating EBIT by segment includes all operating items relating to the businesses; items that principally apply to Dow as a whole are assigned to Corporate.

Segment InformationPack. & Spec. PlasticsInd. Interm. & Infrast.Perf. Materials & CoatingsCorp.Total
In millions
Three months ended Sep 30, 2024
Net sales$5,516 $2,962 $2,214 $187 $10,879 
Equity in earnings (losses) of nonconsolidated affiliates$16 $(17)$1 $2 $2 
Dow Inc. Operating EBIT 1
$618 $(53)$140 $(64)$641 
Three months ended Sep 30, 2023
Net sales$5,454 $3,035 $2,130 $111 $10,730 
Equity in earnings (losses) of nonconsolidated affiliates$50 $(63)$5 $1 $(7)
Dow Inc. Operating EBIT 1
$476 $21 $179 $(50)$626 
Nine months ended Sep 30, 2024
Net sales$16,461 $8,921 $6,609 $568 $32,559 
Equity in earnings (losses) of nonconsolidated affiliates$96 $(63)$9 $3 $45 
Dow Inc. Operating EBIT 1
$1,926 $41 $327 $(160)$2,134 
Nine months ended Sep 30, 2023
Net sales$17,508 $9,590 $6,603 $300 $34,001 
Equity in earnings (losses) of nonconsolidated affiliates$90 $(219)$14 $3 $(112)
Dow Inc. Operating EBIT 1
$2,036 $109 $280 $(206)$2,219 
1.Operating EBIT for TDCC for the three and nine months ended September 30, 2024 and 2023 is substantially the same as that of Dow Inc. and therefore has not been disclosed separately in the table above. A reconciliation of "Net income" to Operating EBIT is provided in the following table.

Reconciliation of "Net income" to Operating EBIT Three Months EndedNine Months Ended
In millionsSep 30, 2024Sep 30, 2023Sep 30, 2024Sep 30, 2023
Net income$240 $327 $1,236 $755 
+ Provision for income taxes84 90 145 253 
Income before income taxes$324 $417 $1,381 $1,008 
- Interest income36 44 143 186 
+ Interest expense and amortization of debt discount199 192 595 549 
- Significant items(154)(61)(301)(848)
Operating EBIT$641 $626 $2,134 $2,219 

38

Table of Contents
The following tables summarize the pretax impact of significant items by segment excluded from Operating EBIT:

Significant Items by Segment
Three Months Ended Sep 30, 2024
Nine Months Ended Sep 30, 2024
Pack. & Spec. PlasticsInd. Interm. & Infrast.Perf. Mat. & CoatingsCorp.TotalPack. & Spec. PlasticsInd. Interm. & Infrast.Perf. Mat. & CoatingsCorp.Total
In millions
Restructuring, implementation and efficiency costs, and asset related charges - net 1
$ $ $(7)$(72)$(79)$(37)$(8)$(7)$(174)$(226)
Indemnification and other transaction related costs 2
   (75)(75)   (75)(75)
Total$ $ $(7)$(147)$(154)$(37)$(8)$(7)$(249)$(301)
1.Includes restructuring charges and implementation and efficiency costs associated with the Company's 2023 Restructuring Program. The three and nine months ended September 30, 2024 also include impairment charges related to the write-down of certain manufacturing assets. See Note 5 for additional information.
2.Includes a charge related to an arbitration settlement agreement for historical product claims from a divested business. See Note 13 for additional information.

Significant Items by Segment
Three Months Ended Sep 30, 2023
Nine Months Ended Sep 30, 2023
Pack. & Spec. PlasticsInd. Interm. & Infrast.Perf. Mat. & CoatingsCorp.TotalPack. & Spec. PlasticsInd. Interm. & Infrast.Perf. Mat. & CoatingsCorp.Total
In millions
Restructuring, implementation and efficiency costs, and asset related charges - net 1
$ $ $ $(82)$(82)$(1)$(48)$(67)$(572)$(688)
Litigation related charges, awards and adjustments 2
      (177)  (177)
Indemnification and other transactions related costs 3
   21 21    17 17 
Total$ $ $ $(61)$(61)$(1)$(225)$(67)$(555)$(848)
1.Includes restructuring charges and implementation and efficiency costs associated with the Company's 2023 Restructuring Program. The nine months ended September 30, 2023 also includes certain gains and losses associated with previously impaired equity investments.
2.Includes a loss associated with legacy agricultural products groundwater contamination matters. See Note 13 for additional information.
3.Primarily related to charges associated with agreements entered into with DuPont and Corteva as part of the separation and distribution which, among other matters, provides for cross-indemnities and allocations of obligations and liabilities for periods prior to, at and after the completion of the separation.

39

Table of Contents
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.
This Quarterly Report on Form 10-Q is a combined report being filed by Dow Inc. and The Dow Chemical Company and its consolidated subsidiaries (“TDCC” and together with Dow Inc., “Dow” or the "Company") due to the parent/subsidiary relationship between Dow Inc. and TDCC. The information reflected in the report is equally applicable to both Dow Inc. and TDCC, except where otherwise noted. Each of Dow Inc. and TDCC is filing information in this report on its own behalf and neither company makes any representation to the information relating to the other company.

Pursuant to General Instruction H(1)(a) and (b) for Form 10-Q "Omission of Information by Certain Wholly-Owned Subsidiaries," TDCC is filing this Form 10-Q with a reduced disclosure format.

Except as otherwise indicated by the context, the term "Union Carbide" means Union Carbide Corporation and the term "Dow Silicones" means Dow Silicones Corporation, both wholly owned subsidiaries of the Company. Additionally, the term "EMEAI" refers to the geographic region of Europe, Middle East, Africa and India.

Dow's website and its content are not deemed incorporated by reference into this report.


OUTLOOK
The Company continues to operate with discipline as it capitalizes on areas of demand strength and leverages its global scale and advantaged cost positions. As cycle dynamics improve, the Company remains well-positioned to enable higher returns to shareholders. The Company's financial strength will continue to support its counter-cyclical growth investments, which are focused on higher-value businesses and regions, particularly where demand is resilient and the Company has a competitive cost advantage. Altogether, these investments are expected to deliver more than $3 billion in underlying earnings to the Company by 2030.


OVERVIEW
The following is a summary of the results for the three months ended September 30, 2024:
The Company reported net sales in the third quarter of 2024 of $10.9 billion, up 1 percent from $10.7 billion in the third quarter of 2023, and mixed by operating segment; Packaging & Specialty Plastics (up 1 percent), Industrial Intermediates & Infrastructure (down 2 percent) and Performance Materials & Coatings (up 4 percent). Net sales increased in the U.S. & Canada and EMEAI (both up 5 percent), partially offset by decreases in Asia Pacific (down 9 percent) and Latin America (down 2 percent).
Volume increased 1 percent compared with the third quarter of 2023 and was mixed by operating segment; Packaging & Specialty Plastics (flat), Industrial Intermediates & Infrastructure (down 2 percent) and Performance Materials & Coatings (up 5 percent). Volume increased in the U.S. & Canada and EMEAI (both up 3 percent), decreased in Asia Pacific (down 6 percent) and was flat in Latin America.
Local price was flat compared with the third quarter of 2023, and mixed by operating segment; Packaging & Specialty Plastics (up 1 percent), Industrial Intermediates & Infrastructure (flat) and Performance Materials & Coatings (down 1 percent). Local price increased in the U.S. & Canada and EMEAI (both up 2 percent) and decreased in Asia Pacific and Latin America (both down 2 percent).
Equity in earnings of nonconsolidated affiliates was $2 million in the third quarter of 2024, compared with equity in losses of nonconsolidated affiliates of $7 million in the third quarter of 2023, primarily due to improved results at the Company's Kuwait joint ventures, partially offset by lower results at the Company's Thai and Sadara joint ventures.
Net income available for Dow Inc. and TDCC common stockholder(s) was $214 million and $224 million, respectively, in the third quarter of 2024, compared with $302 million and $285 million, respectively, in the third quarter of 2023. Earnings per share for Dow Inc. was $0.30 in the third quarter of 2024, compared with $0.42 per share in the third quarter of 2023.
Cash provided by operating activities - continuing operations was $800 million in the third quarter of 2024, down $858 million compared with the third quarter of 2023. Cash provided by operating activities - continuing operations was down $32 million compared with the second quarter of 2024.
40

Table of Contents
Dow Inc. repurchased $94 million of the Company's common stock in the third quarter of 2024.
On July 1, 2024, Fitch Ratings affirmed TDCC's BBB+ and F1 rating, and affirmed its outlook of stable. Also on July 1, 2024, Standard & Poor's affirmed TDCC's BBB and A-2 rating, and affirmed its outlook of stable.
On August 1, 2024, the Company acquired Circulus Holdings, PBLLC, a U.S. mechanical recycling company that converts plastic waste into post-consumer resin, for approximately $130 million.
On August 6, 2024, Moody's Ratings affirmed TDCC's Baa1 and P-2 rating, and affirmed its outlook of stable.
On August 14, 2024, Dow Inc. announced that its Board declared a dividend of $0.70 per share, payable on September 13, 2024, to shareholders of record as of August 30, 2024.
In addition, the following events occurred subsequent to the third quarter of 2024:
On October 10, 2024, Dow Inc. announced that its Board declared a dividend of $0.70 per share, payable on December 13, 2024, to shareholders of record as of November 29, 2024.
On October 24, 2024, the Company announced that it will complete a strategic review of select assets in Europe, primarily certain polyurethanes assets within the Industrial Intermediates & Infrastructure segment, as part of an effort to continue to optimize its global asset footprint.


RESULTS OF OPERATIONS
Net Sales
The following tables summarize net sales and sales variances by operating segment and geographic region from the prior year:

Summary of Sales ResultsThree Months EndedNine Months Ended
In millionsSep 30, 2024Sep 30, 2023Sep 30, 2024Sep 30, 2023
Net sales$10,879 $10,730 $32,559 $34,001 

Sales Variances by Operating Segment and Geographic Region
Three Months Ended Sep 30, 2024
Nine Months Ended Sep 30, 2024
Local Price & Product MixCurrencyVolumeTotalLocal Price & Product MixCurrencyVolumeTotal
Percentage change from prior year
Packaging & Specialty Plastics%— %— %%(4)%— %(2)%(6)%
Industrial Intermediates & Infrastructure— — (2)(2)(7)(1)(7)
Performance Materials & Coatings(1)— (4)(1)— 
Total— %— %%%(5)%— %%(4)%
Total, excluding the Hydrocarbons & Energy business— %— %%%(5)%(1)%%(3)%
U.S. & Canada%— %%%(4)%— %%(2)%
EMEAI— (5)— — (5)
Asia Pacific(2)(1)(6)(9)(6)(1)— (7)
Latin America(2)— — (2)(5)— — (5)
Total— %— %%%(5)%— %%(4)%
41

Table of Contents
Net sales in the third quarter of 2024 were $10.9 billion, up 1 percent from $10.7 billion in the third quarter of 2023. Volume was up 1 percent and local price was flat. Net sales increased in all operating segments except Industrial Intermediates & Infrastructure. Volume increased 1 percent, driven by the U.S. & Canada and EMEAI (both up 3 percent), partially offset by a decline in Asia Pacific (down 6 percent), and Latin America was flat. Volume was flat in Packaging & Specialty Plastics, decreased in Industrial Intermediates & Infrastructure (down 2 percent), and increased in Performance Materials & Coatings (up 5 percent). Local price remained flat, with gains in the U.S. & Canada and EMEAI (both up 2 percent) offset by declines in Asia Pacific and Latin America (both down 2 percent). Local price increased in Packaging & Specialty Plastics (up 1 percent), was flat in Industrial Intermediates & Infrastructure, and declined in Performance Materials & Coatings (down 1 percent). Excluding the Hydrocarbons & Energy business, net sales increased 2 percent.

Net sales for the first nine months of 2024 were $32.6 billion, down 4 percent from $34.0 billion in the same period last year, with local price down 5 percent and volume up 1 percent. Net sales decreased in all geographic regions and all operating segments except Performance Materials & Coatings, which was flat. Local price decreased in all geographic regions and in Packaging & Specialty Plastics (down 4 percent), Industrial Intermediates & Infrastructure (down 7 percent), and Performance Materials & Coatings (down 4 percent). Volume increased in the U.S. & Canada, and was flat in all other geographic regions. Volume decreased in Packaging & Specialty Plastics (down 2 percent), and increased in Industrial Intermediates & Infrastructure (up 1 percent) and Performance Materials & Coatings (up 5 percent). Excluding the Hydrocarbons & Energy business, net sales decreased 3 percent.

Cost of Sales
Cost of sales ("COS") was $9.8 billion in the third quarter of 2024, compared with $9.6 billion in the third quarter of 2023. For the first nine months of 2024, COS was $28.9 billion compared with $30.1 billion in the first nine months of 2023. COS for the three months ended September 30, 2024 increased on higher volume and a charge related to an arbitration settlement agreement for historical product claims from a divested business, and was partially offset by lower global energy and feedstock costs. COS for the nine months ended September 30, 2024 decreased primarily due to lower raw material costs, lower global energy and feedstock costs and the impact of structural cost improvements, partially offset by increased planned maintenance turnaround spending and a charge related to an arbitration settlement agreement for historical product claims from a divested business. COS as a percentage of net sales was 90.2 percent in the third quarter of 2024 (89.4 percent in the third quarter of 2023) and 88.7 percent for the first nine months of 2024 (88.5 percent for the first nine months of 2023).

Research and Development Expenses
Research and development ("R&D") expenses totaled $208 million in the third quarter of 2024, compared with $197 million in the third quarter of 2023. R&D expenses for the first nine months of 2024 were $608 million compared with $616 million in the first nine months of 2023.

Selling, General and Administrative Expenses
Selling, general and administrative ("SG&A") expenses totaled $396 million in the third quarter of 2024, compared with $380 million in the third quarter of 2023. SG&A expenses increased in the third quarter of 2024 primarily due to higher bad debt expense and performance-based compensation costs. For the first nine months of 2024, SG&A expenses were $1,228 million, compared with $1,216 million in the first nine months of 2023. SG&A expenses for the first nine months of 2024 increased primarily due to higher bad debt expense, including expense incurred as a result of a resolution of a dispute with a customer, which was partially offset by the impact of structural cost improvements.

Amortization of Intangibles
Amortization of intangibles was $76 million in the third quarter of 2024 compared with $81 million in the third quarter of 2023. In the first nine months of 2024, amortization of intangibles was $234 million, compared with $243 million in the first nine months of 2023.

Equity in Earnings (Losses) of Nonconsolidated Affiliates
The Company's share of equity in earnings of nonconsolidated affiliates was $2 million in the third quarter of 2024, compared with equity in losses of nonconsolidated affiliates of $7 million in the third quarter of 2023, an increase of $9 million, primarily due to improved performance at the Kuwait joint ventures and slightly offset by lower results at the Sadara and Thai joint ventures. The Company's share of equity in earnings of nonconsolidated affiliates was $45 million for the first nine months of 2024, compared with equity in losses of nonconsolidated affiliates of $112 million for the first nine months of 2023, primarily due to improved performance at the Kuwait and Sadara joint ventures and slightly offset by lower results at the Thai joint ventures. Cash dividends from nonconsolidated
42

Table of Contents
affiliates were $266 million in the first nine months of 2024, compared with $188 million in the first nine months of 2023.

Sundry Income (Expense) – Net
Sundry income (expense) - net for the three months ended September 30, 2024 was income of $119 million and $118 million for Dow Inc. and TDCC, respectively, compared with income of $92 million and $71 million, respectively, for the three months ended September 30, 2023. The increase in sundry income is primarily due to higher gains on the sales of assets and investments and lower foreign currency exchange losses, which were partially offset by a decrease in non-operating pension and postretirement benefit plan credits.

Sundry income (expense) - net for the nine months ended September 30, 2024 was income of $256 million and $253 million for Dow Inc. and TDCC, respectively, compared with income of $202 million and $169 million, respectively, for the nine months ended September 30, 2023. The increase in sundry income is primarily due to lower foreign currency exchange losses and higher gains on the sales of assets and investments, which were partially offset by a decrease in non-operating pension and postretirement benefit plan credits.

Interest Expense and Amortization of Debt Discount
Interest expense and amortization of debt discount was $199 million in the third quarter of 2024, compared with $192 million in the third quarter of 2023. Interest expense and amortization of debt discount was $595 million in the first nine months of 2024 compared with $549 million in the first nine months of 2023. The increase in interest expense is primarily due to borrowings outside of the United States and $1.25 billion of senior unsecured notes issued in the first quarter of 2024.

Provision for Income Taxes
The Company's effective tax rate fluctuates based on, among other factors, where income is earned, the level of income relative to tax attributes and the level of equity earnings, since most earnings from the Company's equity method investments are taxed at the joint venture level. In the third quarter of 2024, the Company reported a provision for income taxes of $84 million, resulting in an effective tax rate of 25.9 percent and 25.1 percent for Dow Inc. and TDCC, respectively. In the third quarter of 2023, the Company reported a provision for income taxes of $90 million, resulting in an effective tax rate of 21.6 percent and 22.5 percent for Dow Inc. and TDCC, respectively. For the first nine months of 2024, the Company reported a provision for income taxes of $145 million, resulting in an effective tax rate of 10.5 percent and 10.4 percent for Dow Inc. and TDCC, respectively. For the first nine months of 2023, the Company reported a provision for income taxes of $253 million, resulting in an effective tax rate of 25.1 percent and 25.7 percent for Dow Inc. and TDCC, respectively. See Note 7 to the Consolidated Financial Statements for additional information about the Company's income taxes and effective tax rates.

The Company continues to monitor and evaluate legislative developments related to the Global Anti-Base Erosion Proposal Regime ("GloBE") established by the Organization of Economic Cooperation and Development’s ("OECD") Pillar Two framework. Several countries in which the Company operates have adopted GloBE into their legislation and several others are expected to enact these rules in the future. To date, such legislation has not materially impacted the Company's effective tax rate.

Net Income Available for Common Stockholder(s)
Dow Inc.
Net income available for Dow Inc. common stockholders was $214 million, or $0.30 per share, in the third quarter of 2024, compared with $302 million, or $0.42 per share, in the third quarter of 2023. Net income available for Dow Inc. common stockholders was $1,169 million, or $1.65 per share, in the first nine months of 2024, compared with $694 million, or $0.97 per share, in the first nine months of 2023. See Note 9 to the Consolidated Financial Statements for details on Dow Inc.'s earnings per share calculations.

TDCC
Net income available for the TDCC common stockholder was $224 million in the third quarter of 2024, compared with $285 million in the third quarter of 2023. Net income available for the TDCC common stockholder was $1,186 million in the first nine months of 2024, compared with $672 million in the first nine months of 2023. TDCC's common shares are owned solely by Dow Inc.


43

Table of Contents
SEGMENT RESULTS
For further discussion of the Company's segments, see Part I, Item 1. Business of the combined Dow Inc. and TDCC Annual Report on Form 10-K for the fiscal year ended December 31, 2023 ("2023 10-K"), filed with the SEC on January 31, 2024.

Dow’s measure of profit/loss for segment reporting purposes is Operating EBIT as this is the manner in which the Company's chief operating decision maker assesses performance and allocates resources. The Company defines Operating EBIT as earnings (i.e., "Income before income taxes") before interest, excluding the impact of significant items. Operating EBIT by segment includes all operating items relating to the businesses; items that principally apply to Dow as a whole are assigned to Corporate.

PACKAGING & SPECIALTY PLASTICS
Packaging & Specialty PlasticsThree Months EndedNine Months Ended
In millionsSep 30, 2024Sep 30, 2023Sep 30, 2024Sep 30, 2023
Net sales$5,516 $5,454 $16,461 $17,508 
Operating EBIT$618 $476 $1,926 $2,036 
Equity earnings$16 $50 $96 $90 

Packaging & Specialty PlasticsThree Months EndedNine Months Ended
Percentage change from prior yearSep 30, 2024Sep 30, 2024
Change in Net Sales from Prior Period due to:
Local price & product mix%(4)%
Currency— — 
Volume— (2)
Total%(6)%

Packaging & Specialty Plastics net sales were $5,516 million in the third quarter of 2024, up 1 percent from net sales of $5,454 million in the third quarter of 2023, with local price up 1 percent and volume and currency flat. Local price increased in Packaging and Specialty Plastics, primarily in EMEAI and the U.S. & Canada, driven by higher pricing of polyethylene which more than offset lower pricing of downstream polymers. Local price increased in Hydrocarbons & Energy, primarily in the U.S. & Canada and EMEAI from third-party olefins sales. Volume increased in Packaging and Specialty Plastics due to higher demand for downstream polymers and an increase in non-recurring licensing sales, which was partially offset by lower polyethylene volumes. Volume decreased in Hydrocarbons & Energy in all geographic regions, led by the U.S. & Canada, primarily driven by lower third-party aromatics and energy sales.

Operating EBIT was $618 million in the third quarter of 2024, up $142 million from Operating EBIT of $476 million in the third quarter of 2023. Operating EBIT increased due to lower raw material costs and higher selling prices, which more than offset the impact of an unplanned ethylene facility outage.

Packaging & Specialty Plastics net sales were $16,461 million in the first nine months of 2024, down 6 percent from net sales of $17,508 million in the first nine months of 2023, with local price down 4 percent, volume down 2 percent and currency was flat. Local price decreased in Packaging and Specialty Plastics in all geographic regions, primarily driven by lower pricing of downstream polymers. Local price was flat in Hydrocarbons & Energy. Volume increased in Packaging and Specialty Plastics, primarily in EMEAI and the U.S. & Canada, due to higher downstream polymers and polyethylene demand. Volume decreased in Hydrocarbons & Energy in all geographic regions, led by EMEAI, primarily driven by higher internal derivative demand and lighter feedslate cracking.
Operating EBIT was $1,926 million in the first nine months of 2024, down $110 million from Operating EBIT of $2,036 million in the first nine months of 2023. Operating EBIT decreased primarily due to lower selling prices, lower volumes in Hydrocarbons & Energy, higher planned maintenance costs and the impact of an unplanned ethylene facility outage, which were partially offset by lower raw material, energy and feedstock costs.
44

Table of Contents
INDUSTRIAL INTERMEDIATES & INFRASTRUCTURE
Industrial Intermediates & InfrastructureThree Months EndedNine Months Ended
In millionsSep 30, 2024Sep 30, 2023Sep 30, 2024Sep 30, 2023
Net sales$2,962 $3,035 $8,921 $9,590 
Operating EBIT$(53)$21 $41 $109 
Equity losses$(17)$(63)$(63)$(219)

Industrial Intermediates & InfrastructureThree Months EndedNine Months Ended
Percentage change from prior yearSep 30, 2024Sep 30, 2024
Change in Net Sales from Prior Period due to:
Local price & product mix— %(7)%
Currency— (1)
Volume(2)
Total(2)%(7)%

Industrial Intermediates & Infrastructure net sales were $2,962 million in the third quarter of 2024, down 2 percent from net sales of $3,035 million in the third quarter of 2023, with volume down 2 percent and local price and currency flat. Volume decreased in Polyurethanes & Construction Chemicals and in all geographic regions except Latin America and reflected the impact of a force majeure in methylene diphenyl diisocyanate following a third-party supplier outage in the U.S. & Canada. Volume increased in Industrial Solutions, led by EMEAI and Latin America, and included the benefit of increased supply availability following the restart from an outage in 2023 related to a significant unplanned event at the Louisiana Operations Glycol-2 unit in Plaquemine, Louisiana. Local price decreased in Polyurethanes & Construction Chemicals, offset by an increase in Industrial Solutions.

Operating EBIT was a loss of $53 million in the third quarter of 2024, down $74 million from Operating EBIT of $21 million in the third quarter of 2023. Operating EBIT decreased primarily due to higher planned maintenance activity and lower integrated margins, partially offset by improved equity earnings at the EQUATE joint venture.

Industrial Intermediates & Infrastructure net sales were $8,921 million in the first nine months of 2024, down 7 percent from net sales of $9,590 million in the first nine months of 2023, with local price down 7 percent, volume up 1 percent and an unfavorable currency impact of 1 percent. Local price decreased in both businesses and across all geographic regions. Volume increased in Polyurethanes & Construction Chemicals, with gains in EMEAI and Latin America partially offset by declines in Asia Pacific and the U.S. & Canada and led by building and construction and industrial applications. Volume was flat in Industrial Solutions, as increased demand for coatings and mobility applications was offset by declines in the U.S. & Canada, reflecting the impact from an outage in 2023 at the Louisiana Operations Glycol-2 unit in Plaquemine, Louisiana, which successfully restarted at the end of June 2024. Currency had an unfavorable impact on sales in Polyurethanes & Construction Chemicals, driven by EMEAI and Asia Pacific, and was flat in Industrial Solutions.

Operating EBIT was $41 million in the first nine months of 2024, down $68 million from Operating EBIT of $109 million in the first nine months of 2023. Operating EBIT decreased primarily due to lower selling prices in both businesses and an outage in 2023 at the Louisiana Operations Glycol-2 unit in Plaquemine, Louisiana, which successfully restarted at the end of June 2024, which were partially offset by lower raw material, energy and feedstock costs and improved results at the EQUATE and Sadara joint ventures.
45

Table of Contents
PERFORMANCE MATERIALS & COATINGS
Performance Materials & CoatingsThree Months EndedNine Months Ended
In millionsSep 30, 2024Sep 30, 2023Sep 30, 2024Sep 30, 2023
Net sales$2,214 $2,130 $6,609 $6,603 
Operating EBIT$140 $179 $327 $280 
Equity earnings$$$$14 

Performance Materials & CoatingsThree Months EndedNine Months Ended
Percentage change from prior yearSep 30, 2024Sep 30, 2024
Change in Net Sales from Prior Period due to:
Local price & product mix(1)%(4)%
Currency— (1)
Volume
Total%— %

Performance Materials & Coatings net sales were $2,214 million in the third quarter of 2024, up 4 percent from net sales of $2,130 million in the third quarter of 2023, with volume up 5 percent, local price down 1 percent and currency was flat. Volume increased in Consumer Solutions and in all geographic regions, primarily in downstream silicones, led by home and personal care and consumer and electronics applications. Volume increased in Coatings & Performance Monomers and in all geographic regions except EMEAI, primarily due to gains in industrial coatings and plastic additives which were partially offset by declines in acrylic monomers. Local price decreased in Consumer Solutions across all geographic regions and was broad-based. Local price increased in Coatings & Performance Monomers, as a result of higher raw material costs, in all geographic regions except Latin America, which was flat.

Operating EBIT was $140 million in the third quarter of 2024, down $39 million from Operating EBIT of $179 million in the third quarter of 2023. Operating EBIT decreased primarily due to higher raw material costs, partially offset by improved demand.

Performance Materials & Coatings net sales were $6,609 million in the first nine months of 2024 compared with net sales of $6,603 million in the first nine months of 2023, with volume up 5 percent, local price down 4 percent, and an unfavorable currency impact of 1 percent. Volume increased in both businesses and in all geographic regions. Volume increased in Consumer Solutions across all end-markets. The volume increase in Coatings & Performance Monomers was led by acrylic monomers and industrial and architectural coatings. Price decreased in both businesses and was broad-based. Local price decreased in Consumer Solutions across all geographic regions and in Coatings & Performance Monomers in all geographic regions except Asia Pacific. Currency unfavorably impacted sales in Consumer Solutions, driven by Asia Pacific, and was flat in Coatings & Performance Monomers.

Operating EBIT was $327 million in the first nine months of 2024, up $47 million from Operating EBIT of $280 million in the first nine months of 2023. Operating EBIT increased primarily due to improved demand and higher operating rates, which were partially offset by lower selling prices and higher raw materials costs.
46

Table of Contents
CORPORATE
CorporateThree Months EndedNine Months Ended
In millionsSep 30, 2024Sep 30, 2023Sep 30, 2024Sep 30, 2023
Net sales$187 $111 $568 $300 
Operating EBIT$(64)$(50)$(160)$(206)
Equity earnings$$$$

Net sales for Corporate, which primarily relate to the Company's insurance operations, were $187 million in the third quarter of 2024, an increase from net sales of $111 million in the third quarter of 2023. Net sales were $568 million in the first nine months of 2024, an increase from net sales of $300 million in the first nine months of 2023.

Operating EBIT was a loss of $64 million in the third quarter of 2024, compared with a loss of $50 million in the third quarter of 2023. Operating EBIT was a loss of $160 million in the first nine months of 2024, compared with a loss of $206 million in the first nine months of 2023. Operating EBIT loss improved primarily due to lower environmental costs and increased income from insurance operations.


CHANGES IN FINANCIAL CONDITION
The Company had cash and cash equivalents of $2,883 million at September 30, 2024 and $2,987 million at December 31, 2023, of which $1,600 million at September 30, 2024 and $1,984 million at December 31, 2023 was held by subsidiaries in foreign countries, including U.S. territories. For each of its foreign subsidiaries, Dow makes an assertion regarding the amount of earnings intended for permanent reinvestment, with the balance available to be repatriated to the United States.

Cash held by foreign subsidiaries for permanent reinvestment is generally used to finance the subsidiaries' operational activities and future foreign investments. Dow has the ability to repatriate additional funds to the United States, which could result in an adjustment to the tax liability for foreign withholding taxes, foreign and/or U.S. state income taxes and the impact of foreign currency movements. At September 30, 2024, management believed that sufficient liquidity was available in the United States. The Company has and expects to continue repatriating certain funds from its non‑U.S. subsidiaries that are not needed to finance local operations; however, these particular repatriation activities have not and are not expected to result in a significant incremental tax liability to the Company.

The Company's cash flows from operating, investing and financing activities, as reflected in the consolidated statements of cash flows, are summarized in the following table:

Cash Flow SummaryDow Inc.TDCC
Nine Months EndedNine Months Ended
Sep 30, 2024Sep 30, 2023Sep 30, 2024Sep 30, 2023
In millions
Cash provided by (used for):
Operating activities - continuing operations$2,092 $3,536 $2,116 $3,567 
Operating activities - discontinued operations— — 
Operating activities$2,100 $3,540 $2,116 $3,567 
Investing activities$(1,456)$(1,846)$(1,456)$(1,846)
Financing activities$(723)$(2,404)$(739)$(2,431)

Cash Flows from Operating Activities
Cash provided by operating activities from continuing operations in the first nine months of 2024 was primarily driven by the Company's cash earnings and dividends from equity method investments, which were partially offset by cash used for working capital and performance-based compensation payments. Cash provided by operating activities from continuing operations in the first nine months of 2023 was primarily driven by the Company's cash earnings, cash provided by working capital and dividends from equity method investments, which were partially offset by performance-based compensation payments.

47

Table of Contents
Net Working CapitalDow Inc.TDCC
Sep 30, 2024Dec 31, 2023Sep 30, 2024Dec 31, 2023
In millions
Current assets$17,977 $17,614 $17,953 $17,676 
Current liabilities10,827 9,957 10,738 9,849 
Net working capital$7,150 $7,657 $7,215 $7,827 
Current ratio1.66:11.77:11.67:11.79:1

Working Capital MetricsThree Months Ended
Sep 30, 2024Jun 30, 2024Sep 30, 2023
Days sales outstanding in trade receivables44 43 47 
Days sales in inventory62 61 61 
Days payables outstanding64 65 62 

Cash provided by operating activities from discontinued operations in the first nine months of 2024 and 2023 reflected cash payments and receipts for certain agreements and matters related to the separation from DowDuPont Inc. ("DowDuPont").

Cash Flows from Investing Activities
Cash used for investing activities in the first nine months of 2024 and 2023 were primarily for capital expenditures and purchases of investments, which were partially offset by proceeds from sales and maturities of investments. In addition, cash used for investing activities in the first nine months of 2024 included the acquisition of Circulus Holdings, PBLLC, a U.S. mechanical recycling company.

The Company's capital expenditures were $2,173 million in the first nine months of 2024, compared with $1,598 million in the first nine months of 2023. The Company expects full year capital spending in 2024 to be approximately $3 billion, which includes the ramp up of the construction of the Fort Saskatchewan Path2Zero project aligned to the Company's Decarbonize & Grow strategy. The Company expects capital spending for this key growth project to average approximately $1 billion annually through 2029. Enterprise-wide capital spending is expected to exceed depreciation and amortization through 2027, during the first phase of the project, and average depreciation and amortization over the economic cycle. As evidenced across prior economic cycles, the Company will adjust its spending as economic conditions evolve.

Cash Flows from Financing Activities
Cash used for financing activities in the first nine months of 2024 for Dow Inc. was primarily related to dividends paid to stockholders, purchases of treasury stock and payments on long-term debt, which were partially offset by proceeds from issuance of long-term debt. Cash used for financing activities in the first nine months of 2024 for TDCC was primarily related to dividends paid to Dow Inc. and payments on long-term debt, which were partially offset by proceeds from issuance of long-term debt. Cash used for financing activities in the first nine months of 2023 was primarily for debt related activities. In addition, Dow Inc. included cash outflows for dividends paid to stockholders and purchases of treasury stock. TDCC included cash outflows for dividends paid to Dow Inc.

Dow Inc. Non-GAAP Cash Flow Measures
Free Cash Flow
Dow defines Free Cash Flow as "Cash provided by operating activities - continuing operations," less capital expenditures. Under this definition, Free Cash Flow represents the cash generated by Dow from operations after investing in its asset base. Free Cash Flow, combined with cash balances and other sources of liquidity, represents the cash available to fund obligations and provide returns to shareholders. Free Cash Flow is an integral financial measure used in the Company's financial planning process.

Operating EBITDA
Dow defines Operating EBITDA as earnings (i.e., "Income before income taxes") before interest, depreciation and amortization, excluding the impact of significant items.

48

Table of Contents
Cash Flow Conversion (Cash Flow from Operations to Operating EBITDA)
Dow defines Cash Flow Conversion (Cash Flow from Operations to Operating EBITDA) as "Cash provided by operating activities - continuing operations," divided by Operating EBITDA. Management believes Cash Flow Conversion is an important financial metric as it helps the Company determine how efficiently it is converting its earnings into cash flow.

These financial measures are not recognized in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and should not be viewed as alternatives to GAAP financial measures of performance. All companies do not calculate non-GAAP financial measures in the same manner and, accordingly, Dow's definitions may not be consistent with the methodologies used by other companies.

Reconciliation of Free Cash Flow
Nine Months Ended
Sep 30, 2024Sep 30, 2023
In millions
Cash provided by operating activities - continuing operations (GAAP)$2,092 $3,536 
Capital expenditures(2,173)(1,598)
Free Cash Flow (non-GAAP)$(81)$1,938 

Reconciliation of Cash Flow Conversion (Cash Flow from Operations to Operating EBITDA)
Nine Months Ended
Sep 30, 2024Sep 30, 2023
In millions
Net income (GAAP)$1,236$755
+ Provision for income taxes145253
Income before income taxes$1,381$1,008
- Interest income143186
+ Interest expense and amortization of debt discount595549
- Significant items ¹(301)(848)
Operating EBIT (non-GAAP)$2,134$2,219
+ Depreciation and amortization2,1431,954
Operating EBITDA (non-GAAP)$4,277$4,173
Cash provided by operating activities - continuing operations (GAAP)$2,092$3,536
Cash flow from operations to net income (GAAP)169.3 %468.3 %
Cash Flow Conversion (Cash flow from operations to Operating EBITDA) (non-GAAP)48.9 %84.7 %
1.The nine months ended September 30, 2024 includes restructuring charges and implementation and efficiency costs associated with the Company's 2023 Restructuring Program, impairment charges related to write-downs of certain manufacturing assets and activity related to the separation from DowDuPont. The nine months ended September 30, 2023 includes restructuring charges and implementation and efficiency costs associated with the Company's 2023 Restructuring Program, certain gains and losses associated with previously impaired equity investments, a loss associated with legacy agricultural products groundwater contamination matters and activity related to the separation from DowDuPont. See Note 21 to the Consolidated Financial Statements for additional information.

Liquidity & Financial Flexibility
The Company’s primary source of incremental liquidity is cash flows from operating activities. The generation of cash from operations and the Company's ability to access capital markets is expected to meet the Company’s cash requirements for working capital, capital expenditures, debt maturities, contributions to pension plans, dividend distributions to stockholders, share repurchases and other needs. In addition to cash from operating activities, the Company’s current liquidity sources also include TDCC's U.S. and Euromarket commercial paper programs, committed and uncommitted credit facilities, committed accounts receivable facilities, a medium-term notes program, a U.S. retail note program (“InterNotes®”) and other debt markets.

The Company continues to maintain a strong financial position with all of its committed credit facilities undrawn and fully available at September 30, 2024. Cash and committed and available forms of liquidity were $12.7 billion at September 30, 2024. The Company also has no substantive long-term debt maturities due until 2027. As a well-known seasoned issuer, the Company may issue debt at any time as an additional source of liquidity. Additional details on sources of liquidity are as follows:

49

Table of Contents
Commercial Paper
TDCC issues promissory notes under its U.S. and Euromarket commercial paper programs. TDCC had no commercial paper outstanding at September 30, 2024. TDCC maintains access to the commercial paper market at competitive rates. Amounts outstanding under TDCC's commercial paper programs during the period may be greater or less than the amount reported at the end of the period. Subsequent to September 30, 2024, TDCC issued approximately $700 million of commercial paper.

Committed Credit Facilities
The Company also has the ability to access liquidity through TDCC's committed and available credit facilities. At September 30, 2024, TDCC had total committed and available credit facilities of $8.4 billion.

Uncommitted Credit Facilities
The Company has entered into various uncommitted bilateral credit arrangements as a potential source of excess liquidity. These lines can be used to support short-term liquidity needs and for general purposes. The Company had no drawdowns outstanding at September 30, 2024.

Accounts Receivable Securitization Facilities
In addition to the above credit facilities, the Company maintains a committed accounts receivable facility in the United States where eligible trade accounts receivable, up to $900 million, may be sold at any point in time. The Company also maintains a committed accounts receivable facility in Europe where eligible trade accounts receivable, up to €500 million, may be sold at any point in time. In the first nine months of 2024, there were $289 million in sales of receivables under the U.S. and Europe committed accounts receivable facilities ($28 million in sales of receivables in the first nine months of 2023). At September 30, 2024, approximately $26 million of sold receivables were outstanding.

In addition, the Company has an uncommitted accounts receivable facility in the United States providing additional liquidity. Sales of receivables under this facility were $378 million in the first nine months of 2024 (no sales of receivables in the first nine months of 2023). At September 30, 2024, approximately $19 million of sold receivables were outstanding. See Note 11 to the Consolidated Financial Statements for additional information.

Early Settlement of Letters of Credit
The Company utilizes, from time-to-time, letters of credit discounting programs to manage and expedite the settlement of letters of credit in certain regions. These letters of credit are associated with accounts receivable and the Company retains no interest in the transferred letters of credit or receivables once sold.

Accounts Receivable Discounting Facilities
The Company has access to accounts receivable discounting facilities, under which receivables are transferred with limited recourse. The Company retains no interest in the transferred receivables once sold. Sales of receivables under this facility were $581 million in the first nine months of 2024 (no sales of receivables in the first nine months of 2023). At September 30, 2024, approximately $154 million of sold receivables were outstanding. See Note 11 to the Consolidated Financial Statements for additional information.

The Company maintains these facilities and also participates in certain customers’ supply chain financing and other early pay programs as a routine source of working capital.

Company-Owned Life Insurance
The Company has investments in company-owned life insurance ("COLI") policies, which are recorded at their cash surrender value as of each balance sheet date. The Company has the ability to monetize its investment in its COLI policies as an additional source of liquidity. At September 30, 2024, the Company had monetized $260 million of its existing COLI policies' surrender value ($97 million at December 31, 2023). See Note 6 to the Consolidated Financial Statements for additional information.

50

Table of Contents
Debt
As the Company continues to maintain its strong balance sheet and financial flexibility, management is focused on net debt (a non-GAAP financial measure), as the Company believes this is the best representation of its financial leverage at this point in time. As shown in the following table, net debt is equal to total gross debt minus "Cash and cash equivalents" and "Marketable securities."

Total DebtDow Inc.TDCC
Sep 30, 2024Dec 31, 2023Sep 30, 2024Dec 31, 2023
In millions
Notes payable$111$62$111$62
Long-term debt due within one year296117296117
Long-term debt16,16414,90716,16414,907
Gross debt$16,571$15,086$16,571$15,086
 - Cash and cash equivalents2,8832,9872,8832,987
 - Marketable securities 1
3611,3003611,300
Net debt$13,327$10,799$13,327$10,799
Total equity$18,841$19,108$19,039$19,406
Gross debt as a percent of total capitalization46.8 %44.1 %46.5 %43.7 %
Net debt as a percent of total capitalization41.4 %36.1 %41.2 %35.8 %
1.Included in "Other current assets" in the consolidated balance sheets.

The Company may at any time repurchase certain debt securities in the open market or in privately negotiated transactions subject to: the applicable terms under which any such debt securities were issued, certain internal approvals of the Company, and applicable laws and regulations of the relevant jurisdiction in which any such potential transactions might take place. This in no way obligates the Company to make any such repurchases nor should it be considered an offer to do so.

TDCC's public debt instruments and primary, private credit agreements contain, among other provisions, certain customary restrictive covenant and default provisions. TDCC's most significant debt covenant with regard to its financial position is the obligation to maintain the ratio of its consolidated indebtedness to consolidated capitalization at no greater than 0.70 to 1.00 at any time the aggregate outstanding amount of loans under the Five Year Competitive Advance and Revolving Credit Facility Agreement ("Revolving Credit Agreement") equals or exceeds $500 million. The ratio of TDCC's consolidated indebtedness to consolidated capitalization as defined in the Revolving Credit Agreement was 0.44 to 1.00 at September 30, 2024. Management believes TDCC was in compliance with all of its covenants and default provisions at September 30, 2024. For information on TDCC's debt covenants and default provisions, see Note 13 to the Consolidated Financial Statements included in the 2023 10-K. There were no material changes to the debt covenants and default provisions related to TDCC’s outstanding long-term debt and primary, private credit agreements in the first nine months of 2024.

In the first quarter of 2024, the Company issued $1.25 billion of senior unsecured notes. The offering included $600 million aggregate principal amount of 5.15 percent notes due 2034 and $650 million aggregate principal amount of 5.60 percent notes due 2054. The issuance was completed under the Company's Green Finance Framework, which is available on the Company's website. The Company will distribute the proceeds toward projects that support the execution of its sustainability strategy and achieve its targets focused on climate protection and a circular economy, including applicable expenditures and investments related to the Company's Fort Saskatchewan Path2Zero project, which is expected to deliver organic growth while decarbonizing 20 percent of the Company’s global ethylene capacity.

In the second quarter of 2024, the Company redeemed $10 million aggregate principal amount of 2.10 percent notes due November 2030, $30 million aggregate principal amount of 4.25 percent notes due October 2034, $8 million aggregate principal amount of 5.25 percent notes due November 2041 and $12 million aggregate principal amount of 4.375 percent notes due November 2042. As a result of the redemption, the Company recognized a pretax gain on the early extinguishment of debt of $5 million, included in "Sundry income (expense) - net" in the consolidated statements of income and related to Corporate.

51

Table of Contents
In the first nine months of 2024, the Company issued an aggregate principal amount of $71 million of InterNotes®. The Company also issued $122 million of foreign currency loans. Additionally, the Company repaid $77 million of long-term debt.

While taking into consideration the current economic environment, management expects that the Company will continue to have sufficient liquidity and financial flexibility to meet all of its business obligations.

Credit Ratings
At September 30, 2024, TDCC's credit ratings were as follows:

Credit RatingsLong-Term Rating Short-Term RatingOutlook
Fitch RatingsBBB+F1Stable
Moody’s RatingsBaa1P-2Stable
Standard & Poor’sBBBA-2Stable

On July 1, 2024, Fitch Ratings affirmed TDCC's BBB+ and F1 rating, and affirmed its outlook of stable. On July 1, 2024, Standard & Poor's also affirmed TDCC's BBB and A-2 rating, and affirmed its outlook of stable. On August 6, 2024, Moody's Ratings affirmed TDCC's Baa1 and P-2 rating, and affirmed its outlook of stable. These credit agencies' decisions were made as part of their annual review process and reflect the Company's supportive financial policies, scale, liquidity and cost-advantaged footprint.

Dividends
Dow Inc.
Dow Inc. has paid dividends on a quarterly basis since the separation from DowDuPont and expects to continue to do so, subject to approval by the Dow Inc. Board. Dividends declared by the Board align to the Company's strategy announced in 2018 of returning approximately 45 percent of Operating Net Income to shareholders through dividends and total shareholder remuneration of approximately 65 percent, when including share repurchases, over the economic cycle. The Company defines Operating Net Income, a non-GAAP measure, as "Net income available for Dow Inc. common stockholders," excluding the impact of significant items. The following table summarizes dividends declared and paid to common stockholders of record in 2024:

Dow Inc. Dividends Declared and Paid
Declaration DateRecord DatePayment DateAmount (per share)
February 15, 2024February 29, 2024March 8, 2024$0.70 
April 11, 2024May 31, 2024June 14, 2024$0.70 
August 14, 2024August 30, 2024September 13, 2024$0.70 
October 10, 2024November 29, 2024December 13, 2024$0.70 

TDCC
TDCC has committed to fund Dow Inc.'s dividends paid to common stockholders and share repurchases, as approved by the Dow Inc. Board, as well as certain governance expenses. Funding is accomplished through intercompany loans. TDCC's Board reviews and determines a dividend distribution to Dow Inc. to settle the intercompany loans. For the three months ended September 30, 2024, TDCC declared and paid a dividend of $600 million to Dow Inc. ($2,077 million of dividend declared and $1,984 million of dividend paid to Dow Inc. for the nine months ended September 30, 2024). At September 30, 2024, TDCC's intercompany loan balance with Dow Inc. was insignificant.

Share Repurchase Program
On April 13, 2022, the Dow Inc. Board approved a share repurchase program authorizing up to $3 billion for the repurchase of the Company's common stock, with no expiration date. The Company repurchased $94 million of its common stock in the third quarter of 2024 ($494 million in the first nine months of 2024). At September 30, 2024, approximately $931 million of the share repurchase program authorization remained available for repurchases. As previously announced, the Company intends to repurchase shares at a minimum to cover dilution over the cycle. The Company may from time to time expand its share repurchases beyond dilution, based on a number of factors including macroeconomic conditions, free cash flow generation, and the Dow share price. Any share repurchases, when coupled with the Company's dividends, are intended to implement the long-term strategy of targeting shareholder remuneration of approximately 65 percent over the economic cycle.
52

Table of Contents
Pension Plans
The Company has both funded and unfunded defined benefit pension plans that cover employees in the United States and a number of other countries. The Company's funding policy is to contribute to funded plans when pension laws and/or economics either require or encourage funding. In the second quarter of 2024, the Company received a pension asset reversion of approximately $70 million (approximately $90 million in the second quarter of 2023) for a portion of the excess funding of one of its plans in Europe. These plan asset reversions are included in "Other assets and liabilities, net" in the consolidated statements of cash flows.

As announced in 2021, all U.S. pension plans were frozen for substantially all employees who participated in the U.S. defined benefit pension programs effective December 31, 2023. In the fourth quarter of 2023, the Company spun off a portion of each of the Company’s two existing tax-qualified U.S defined benefit pension plans into two new tax-qualified pension plans, which includes the tax-qualified benefit obligations for substantially all employees hired after January 1, 2008. These employees earned benefits based on a set percentage of annual pay, plus interest, and the spin of these plans provide the Company the ability to separately manage the assets and obligations of these plans with like benefits. In the second quarter of 2024, as part of its ongoing pension de-risking initiatives, the Company initiated the termination of the two new tax-qualified pension plans. As part of the plan termination process, the Company will offer participants of these plans annuity or lump sum distribution options. Final asset distributions are expected to be paid from plan assets in the fourth quarter of 2025, with minimal additional funding, if any, required from the Company, and are anticipated to result in pension settlement charges, with the amounts dependent on various factors, including interest rates, plan asset returns, annuity pricing and participant distribution elections.

See Note 17 to the Consolidated Financial Statements, and Note 18 to the Consolidated Financial Statements included in the 2023 10-K for additional information related to the Company's pension plans.

Restructuring
The actions related to the 2023 Restructuring Program are expected to result in additional cash expenditures of $60 million, primarily through the first quarter of 2025, and consist of severance and related benefit costs. Restructuring implementation costs, primarily decommissioning and demolition activities related to asset actions, and costs associated with the Company's productivity and efficiency actions, are expected to result in additional cash expenditures of approximately $90 million, primarily through the first quarter of 2025. Restructuring implementation and efficiency costs totaled $55 million and $157 million for the three and nine months ended September 30, 2024, respectively.

The Company expects to incur additional costs in the future related to its restructuring activities, which will be recognized as incurred. The Company also expects to incur additional employee-related costs, including involuntary termination benefits related to its other optimization activities. These costs cannot be reasonably estimated at this time. See Note 5 to the Consolidated Financial Statements for additional information on the Company's restructuring activities.
53

Table of Contents
Contractual Obligations
Information related to the Company’s contractual obligations, commercial commitments and expected cash requirements for interest can be found in Notes 13, 14, 15 and 18 to the Consolidated Financial Statements included in the 2023 10-K. With the exception of the items noted below, there have been no material changes in the Company’s contractual obligations since December 31, 2023.

Contractual Obligations at Sep 30, 2024
Payments Due In
In millions20242025-20262027-20282029 and beyondTotal
Dow Inc.
Long-term debt obligations 1
$35 $656 $1,985 $14,038 $16,714 
Expected cash requirements for interest 2
230 1,536 1,453 9,269 12,488 
Purchase obligations 3
890 3,234 2,330 7,014 13,468 
Total$1,155 $5,426 $5,768 $30,321 $42,670 
1.Excludes unamortized debt discount and issuance costs of $254 million. Includes finance lease obligations of $961 million.
2.Cash requirements for interest on long-term debt was calculated using current interest rates at September 30, 2024, and includes $154 million of various floating rate notes.
3.Includes a $1.3 billion purchase commitment for the use of a water supply reservoir asset expected to commence in 2028, as discussed in Note 13 to the Consolidated Financial Statements, and outstanding purchase orders and other commitments greater than $1 million obtained through a survey conducted within the Company.

Fair Value Measurements
See Note 20 to the Consolidated Financial Statements for information concerning fair value measurements.


OTHER MATTERS
Critical Accounting Estimates
The preparation of financial statements and related disclosures in accordance with accounting principles generally accepted in the United States of America requires management to make judgments, assumptions and estimates that affect the amounts reported in the consolidated financial statements and accompanying notes. Note 1 to the Consolidated Financial Statements included in the 2023 10-K describes the significant accounting policies and methods used in the preparation of the consolidated financial statements. The Company’s critical accounting policies that are impacted by judgments, assumptions and estimates are described in Management’s Discussion and Analysis of Financial Condition and Results of Operations included in the 2023 10-K. Since December 31, 2023, there have been no material changes in the Company’s accounting policies that are impacted by judgments, assumptions and estimates.

Asbestos-Related Matters of Union Carbide Corporation
Union Carbide is and has been involved in a large number of asbestos-related suits filed primarily in state courts during the past four decades. These suits principally allege personal injury resulting from exposure to asbestos‑containing products and frequently seek both actual and punitive damages. The alleged claims primarily relate to products that Union Carbide sold in the past, alleged exposure to asbestos-containing products located on Union Carbide’s premises, and Union Carbide’s responsibility for asbestos suits filed against a former Union Carbide subsidiary, Amchem Products, Inc. (“Amchem”). In many cases, plaintiffs are unable to demonstrate that they have suffered any compensable loss as a result of such exposure, or that injuries incurred in fact resulted from exposure to Union Carbide’s products.

54

Table of Contents
The table below provides information regarding asbestos-related claims pending against Union Carbide and Amchem based on criteria developed by Union Carbide and its external consultants:

Asbestos-Related Claim Activity20242023
Claims unresolved at Jan 16,367 6,873 
Claims filed3,472 3,097 
Claims settled, dismissed or otherwise resolved(4,469)(3,428)
Claims unresolved at Sep 305,370 6,542 
Claimants with claims against both Union Carbide and Amchem(963)(1,452)
Individual claimants at Sep 304,407 5,090 

Plaintiffs’ lawyers often sue numerous defendants in individual lawsuits or on behalf of numerous claimants. As a result, the damages alleged are not expressly identified as to Union Carbide, Amchem or any other particular defendant, even when specific damages are alleged with respect to a specific disease or injury. For these reasons and based upon Union Carbide’s litigation and settlement experience, Union Carbide does not consider the damages alleged against Union Carbide and Amchem to be a meaningful factor in its determination of any potential asbestos-related liability.

For additional information, see Asbestos-Related Matters of Union Carbide Corporation in Note 13 to the Consolidated Financial Statements; Part II, Item 1. Legal Proceedings; and Note 14 to the Consolidated Financial Statements included in the 2023 10-K.


ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
See Note 19 to the Consolidated Financial Statements and Part II, Item 7A. Quantitative and Qualitative Disclosures About Market Risk in the combined Dow Inc. and TDCC Annual Report on Form 10-K for the year ended December 31, 2023, for information on the Company's utilization of financial instruments and an analysis of the sensitivity of these instruments.

ITEM 4. CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures
As of the end of the period covered by this Quarterly Report on Form 10-Q, Dow Inc. and The Dow Chemical Company (the "Companies") carried out an evaluation, under the supervision and with the participation of the Companies' Disclosure Committee and the Companies' management, including the Chief Executive Officer and the Chief Financial Officer, of the effectiveness of the design and operation of the Companies' disclosure controls and procedures pursuant to paragraph (b) of Exchange Act Rules 13a-15 and 15d-15. Based upon that evaluation, the Chief Executive Officer and the Chief Financial Officer concluded that the Companies' disclosure controls and procedures were effective.

Changes in Internal Control Over Financial Reporting
There were no changes in the Companies' internal control over financial reporting identified in connection with the evaluation required by paragraph (d) of Exchange Act Rules 13a-15 and 15d-15 that was conducted during the quarter ended September 30, 2024, that have materially affected, or are reasonably likely to materially affect, the Companies' internal control over financial reporting.
55

Table of Contents
Dow Inc. and Subsidiaries
The Dow Chemical Company and Subsidiaries
PART II – OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
Asbestos-Related Matters of Union Carbide Corporation
No material developments regarding this matter occurred in the first nine months of 2024. For a current status of this matter, see Note 13 to the Consolidated Financial Statements.

Environmental Proceedings
On December 16, 2022, the U.S. Department of Justice filed a complaint and proposed consent decree on behalf of the U.S. Environmental Protection Agency ("EPA") relating to environmental contamination at the Lower Passaic River Study Area Superfund Site in New Jersey. The EPA filed an amended complaint and proposed consent decree on January 17, 2024. The proposed consent decree includes a requirement that 85 settling defendants, including the Company’s Essex Chemical Corporation subsidiary ("Essex"), make a collective payment of $150 million for the EPA’s past and anticipated future response costs, with Essex's share of the group settlement costs being $1.15 million. On January 31, 2024, the EPA filed a motion for approval and entry of the consent decree.


ITEM 1A. RISK FACTORS
Since December 31, 2023, there have been no material changes to the Company's Risk Factors.


ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
Issuer Purchases of Equity Securities
The following table provides information regarding purchases of Dow Inc. common stock by the Company during the three months ended September 30, 2024:

Issuer Purchases of Equity SecuritiesTotal number of shares purchased as part of the Company's publicly announced share repurchase program
Approximate dollar value of shares that may yet be purchased under the Company's publicly announced share repurchase program 1
(In millions)
PeriodTotal number of shares purchasedAverage price paid per share
July 2024112,764 $53.21 112,764 $1,019 
August 20241,247,017 $53.11 1,247,017 $952 
September 2024419,114 $51.66 419,114 $931 
Third quarter 20241,778,895 $52.78 1,778,895 $931 
1.On April 13, 2022, the Dow Inc. Board approved a share repurchase program authorizing up to $3.0 billion for the repurchase of the Company's common stock, with no expiration date.


ITEM 4. MINE SAFETY DISCLOSURES
Not applicable.


ITEM 5. OTHER INFORMATION
Not applicable.


56

Table of Contents
ITEM 6. EXHIBITS
EXHIBIT NO.DESCRIPTION
4.3Dow Inc. agrees to provide the SEC, on request, copies of all other such indentures and instruments that define the rights of holders of long-term debt of Dow Inc. and its consolidated subsidiaries, including The Dow Chemical Company, pursuant to Item 601(b)(4)(iii)(A) of Regulation S-K.
23 *
Ankura Consulting Group, LLC's Consent.
Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INSThe instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCHInline XBRL Taxonomy Extension Schema Document.
101.CALInline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEFInline XBRL Taxonomy Extension Definition Linkbase Document.
101.LABInline XBRL Taxonomy Extension Label Linkbase Document.
101.PREInline XBRL Taxonomy Extension Presentation Linkbase Document.
104Cover Page Interactive Data File. The cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

* Filed herewith


TRADEMARK LISTING

The following registered trademark of InspereX Holdings LLC appears in this report: InterNotes®



























® ™ Trademark of The Dow Chemical Company ("Dow") or an affiliated company of Dow, except as otherwise specified.
57

Table of Contents
Dow Inc. and Subsidiaries
The Dow Chemical Company and Subsidiaries
Signature

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrants have duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

DOW INC.
THE DOW CHEMICAL COMPANY

Date: October 25, 2024


/s/ ANDREA L. DOMINOWSKI
Andrea L. Dominowski
Controller and Vice President of Controllers
(Authorized Signatory and
Principal Accounting Officer)
58